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Many lesions and disorders of the oral cavity may affect the tongue as well. On the other hand, 
some lesions have a strong preference for occurrence on the tongue or may be even limited to the 
tongue. A selection of both categories will be discussed, emphasizing the diagnostic and 
management aspects. 
Lymphangioma is a developmental disorder that arises at a young age. The clinical presentation 
is more or less diagnostic. Nevertheless, the taking of a biopsy is recommended. Treatment 
possibilities are limited, except for small lesions that may be removed without causing much 
morbidity. 
Geographic tongue is not so much a rare lesion, but probably often remains undiagnosed by 
clinicians, particularly when occurring in children (Figure 1). A rare phenomenon is the occurrence 
of geographic tonguelike lesion elsewhere in the mouth, being referred to as ectopic geographic 
tongue or geographic stomatitis. There are no possibilities to cure geographic tongue and the disease 
may last lifelong. 
Figure 1. Geographic tongue in a 3-year-old boy. 
Median rhomboid glossitis is usually easy to diagnose based on clinical features alone. If a biopsy 
is taken, it should be realized that the pathologist may be challenged by the presence of elongated 
rete ridges that may mimic squamous cell carcinoma. Treatment is only indicated in case of 
symptoms and consists of elimination of possible causative factors, e.g., tobacco habits and the use of 
corticoid inhalation spray for pulmonary disease and the use of topical antifungals. In rare instances 
a Kaposi sarcoma may arise in the foramen cecum area, somewhat mimicking median rhomboid 
glossitis. It should be realized that Kaposi sarcoma (KS) may be the first manifestation of an 
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underlying HIV-infection. At the same time, oral KS has been reported in immunocompetent 
patients [1]. 
Lingual papillitis is a poorly understood inflammation of the fungiform papillae, showing a quite 
distinct clinical picture. Lingual papillitis is usually self-healing (‘Transient lingual papillitis’) [2]. 
A persistent ulcer on the dorsum of the tongue may have a specific cause, e.g., syphilis I. The 
occurrence of a squamous cell carcinoma at that particular site is rare. A rather rare entity, mainly 
occurring on the tongue, is traumatic ulcerative granuloma with stromal eosinophilia (TUGSE). The 
histopathologic features are quite diagnostic. Occasionally, CD30 positive lymphocytes may indicate 
a peculiar type of T-cell lymphoma. In such cases the patient should be staged for possible 
involvement elsewhere in the body [3]. 
A granular cell tumor may occur everywhere in the body but has a strong preference for the 
mouth, particularly for the tongue. The diagnosis is based on histopathologic aspect. A well-known 
pitfall is the occurrence of pseudoepitheliomatous hyperplasia of the overlying epithelium, that may 
be misdiagnosed as squamous cell carcinoma. 
Lymphoid (follicular) hyperplasia may occur on the borders of the tongue at the junction of the 
anterior part (‘oral tongue’) and the base of the tongue [4]. There is usually a bilateral presentation of 
slightly swollen, soft elastic mucosa. Symptoms are usually absent and in such event a biopsy nor 
follow-up is indicated. In symptomatic cases, particularly when unilateral, the possibility of a 
squamous cell carcinoma should be considered. 
A range of lesions and conditions may present as bilateral white changes at the borders of the 
tongue (Table 1). These lesions can sometimes be diagnosed based on the presence of similar lesions 
elsewhere in the oral cavity, e.g., morsicatio, but others may require a biopsy (Figure 2). This is 
particularly true when hairy leukoplakia is suspected in a patient with a negative medical history. The 
histopathologic features, including positivity of an Epstein Barr Virus (EBV) immunohistochemical 
stain, are diagnostic. Although hairy leukoplakia is mainly known as manifestation of an underlying 
HIV-infection, also other causes of immunosuppression may result in this lesion. 
Table 1. Differential diagnosis of bilateral white lesions of the tongue (in alphabetical order). 
Candidiasis, hyperplastic
Hairy leukoplakia  
Leukoplakia (‘true’) 
Lichen planus  
Morsicatio  
Pachyonychia congenita 
Syphilis, second stage 
White sponge nevus 
Figure 2. Verrucous lesion, bilateral, on the border of the tongue, being caused by morsicatio. 
In the second stage of syphilis multiple white lesions (‘plaques muceuses’) may occur in the oral 
mucosa, often of the tongue. Another manifestation may be the occurrence of red, patchy and 
sometimes aphthouslike changes of the oral mucosa, particularly on the dorsal surface of the tongue. 
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Such lesions may follow a recurrent pattern. A suspected diagnosis of syphilis should be confirmed 
by serological tests. 
A rather unusual tumor, often benign and more or less limited to the anterior tongue, is the 
ectomesenchymal chondromyxoid tumor. The clinical presentation of the tumor is not characteristic, just 
being a non-ulcerative firm elastic swelling with an intact mucosal surface. Since its first description 
in the nineties of the last century less than fifty cases have been reported. The challenge is with the 
histopathologic interpretation, including the use of various immunohistochemical stains. The tumor 
may be wrongly diagnosed, e.g., as a salivary gland tumor or a (rhabdomyo)sarcoma [5].  
Conflicts of Interest: The author declares no conflict of interest. 
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1. Introduction
Desquamative gingivitis (DG) isn’t a specific disorder; it simply represents the gingival
manifestation associated with some heterogeneous mucocutaneous disorders, such as oral lichen 
planus (OLP), mucous membrane pemphigoid (MMP), pemphigus vulgaris (PV), plasma cell 
gingivitis (PCG) and few others. Epithelial desquamation, erythema and erosive and/or vesciculo-
bullous lesions on the gingiva usually characterise it. The DG appears more frequently in old women 
and menopause, although it can debut in young people and children. Clinically, it presents moderate 
pain, partly due to the deposit of plaque in gingival margin, being in some cases the first 
manifestation of the disease. 
Usually of unknown aetiology, the most probable hypothesis is the autoimmune origin of these 
disease. For these reasons topical treatment has been indicated, as the use of corticosteroid in different 
forms and prescribed with different posologies, or also systemic drugs administration such as 
corticosteroids, other immunosuppressants and broad-spectrum antibiotics. 
Even if this condition has been reported as non-plaque induced, effective dentogingival plaque 
control sometimes could resolve the gingival inflammation.  
Some studies of periodontal status in patients with DG suggest that in patients MMP the 
gingivo-periodontal status is worse than health control, in the same case, patients with OLP and PV 
present deeper pockets and higher loss of the clinical attachment level [1]. 
A recent study revealed a variation of the “microbiota” in DG-patients with prevalence of some 
bacterial strains as high-risk pathogen Aggregatibacter Actinomycetemcomitans or moderate risk 
pathogens Eikenella Corrodens or Fusobacterium Nucleatum [2]. 
For these reasons, we postulated that efficient plaque control could have been helpful in treating 
DG. 
We report the results of various prospective studies in which the purpose was to evaluate the 
clinical efficiency of an oral hygiene protocol in patients affected by DG [3–7]. 
2. Results
From January 2006 to August 2019 at the Oral Medicine Section, University of Turin, we
followed 150 patients affected by DG as shown in Figure 1. The patients received a complete 
periodontal examination at baseline visit, during protocol and at final treatment, including: full 
mouth plaque scores (FMPS) Sillness and Loe (grading 0-1-2-3), full mouth bleeding upon probing 
scores (FMBS), probing pocket depth (PPD), mobility index sec Miller (grading 1-2-3), DGCS by 
Arduino et al. (score 0–4) and detection of perceived pain with VAS scale. All patients received non-
surgical periodontal therapy, including oral hygiene instructions, supra- and sub-gingival scaling if 
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required. Oral hygiene instructions were given by the same experienced dental hygienist; she also 
provided thorough supra-gingival scaling with elimination of all deposits, over three visits and 
completion within 3 weeks. During each visit, subjects were instructed about proper oral hygiene 
maintenance at home. Moreover, the instructions were reinforced at each visit and personalised 
whenever necessary. A cohort of patients was also treated in combination with a solution of sodium 
iodide associated to salicylic acid (SISA). The solution was used at the end of each session, with an 
impregnated gauze (with 5 mL of the solution) applied for 15 minutes for both the dental arches, and 
for other 15 minutes with new gauzes. A second cohort received alternative approaches with ozone 
therapy. Its use in oral pathology is based on the principle of the liberation of O3 through the 
formation of an electromagnetic field, similar to what happens during the discharge of lightning in 
nature (Chapman effect). The ozone therapy has antimicrobial power (against aerobic and anaerobic 
bacteria, fungi, viruses), exerts a stimulation of the circulatory system with improvement of tissue 
oxygenation and modulation of immune cell and shows pain reduction and repeated insufflations 
stimulate neoangiogenesis with formation of epithelial tissue.  
Figure 1. subdivision by type of DG of the 150 patients followed from January 2006 to August 2019 at 
the Oral Medicine Section, University of Turin. 
In our various studies [1,3–6], we have shown that professional oral hygiene procedures are 
related to significant improvements of gums status, and decreases related pain, in subjects affected 
by autoimmune diseases as DG with specific gingival localization (Figure 2). 
Figure 2. results of SISA protocol reported in Carcieri P et al. [6]. 
3. Conclusions
Regular plaque and tartar removal is therefore a fundamental requirement for a favorable
prognosis at a distance in DG-patients [7]. Non-surgical periodontal therapy, and oral hygiene 
instructions, in combination with S.I.S.A or ozone therapy, could be a possible mean in reducing 
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clinical gingival inflammation and improve patient related outcomes in the different forms of DG. 
These protocols are conceived to recommend this as complementary line therapeutic intervention, 
especially in patients with only gingival involvement, during any other medical treatment, helping 
affected patients in maintaining a good oral hygiene. 
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Medication-related osteonecrosis of the jaw (MRONJ) is a relatively rare but potentially serious 
and debilitating complication. It consists of progressive bone destruction in the maxillofacial area of 
patients exposed to the treatment with drugs associated with the risk of ONJ (antiresorptive and 
antiangiogenic agents), in the absence of a previous radiation treatment [1]. 
In order to adjudicate MRONJ case, many considerations are essential for the clinician. 
Firstly, in absence of bone exposure and or fistula, other signs or symptoms (e.g., abscess, 
periodontal instability, presence of swelling and/or pus, severe pain, lockjaw, sequestrum) are not 
diagnosed. This is due to restricted criteria of AAOMS definition in which these clinical findings are 
not included but already recognized and reported in literature [2–4]. 
Furthermore, many times the clinical history of the patient is not complete and all identified and 
reported drugs related to ONJ are not identified from the dentist, the practitioner, or the oncologist. 
Many clinicians take in account only bisphosphonates as drugs related to ONJ risk. Nowadays, many 
other drugs have been related to this adverse event, from antiresorptive to antiangiogenic agents 
(e.g., Bisphosphonates, Denosumab, Bevacizumab, Sunitinib). The lack of knowledge and the 
necessity of a continuous update is an essential element for all clinicians. 
After, other critical point for MRONJ diagnosis is the disclaimer of imaging whereas this is 
essential for unexposed clinical form of osteonecrosis. The adding of radiological findings in case of 
suspicious of MRONJ determine not also an underestimation of frequency data but also a delay for 
staging and management [5,6]. 
It is important to note that in few years, many data are added to the definition of MRONJ and, 
probably, much more should be discovered. This is the main controversy in terms of diagnosis. The 
uniformity in terms of clinical and radiological findings must be achieved in short time since the 
underestimation and delay diagnosis have to avoid in order to support the affected patient, already 
overloaded from primary disease (i.e., cancer). 
The main challenge is to create a multidisciplinary network for a standardized approach, with a 
sustained dialogue among specialists involved, should be always adopted in order to improve the 
efficacy of diagnosis process and to ameliorate the patient’s quality of life 
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On April 2016, a 24-year-old male patient came to our facilities for multiple mouth ulcers 
involving the tongue borders and the cheek mucosa (Figure 1). Patient didn’t refer any systemic 
disease, but several episodes of diarrhea for a month; he was also diagnosed of incontinent cardia 
associated with hypersecretory antral gastropathy, HP negative. Blood test was slightly positive for 
anti-BP180 (20 U/mL—n.v. < 9) and negative for coeliac antibodies. Patient did not want to undergo 
biopsy because of the summer period but, because of the symptoms, he requested a therapy. 
Clobetasol propionate ointment and 3 mg Betamethasone tablets once a day were prescribed for a 
month with improvement in symptoms. While tapering, symptoms re-occurred. Few months later, 
after therapy suspension, patient underwent a triple biopsy of the lesions. New blood test was 
negative for pemphigoid and an altered CD4/CD8 ratio (0.9 vs. 1.4–1.9 n.v.) became evident. Report 
from biopsy was an epitheliotropic CD4+ lymphoproliferative disorder without clear monoclonality; 
a diagnosis of suspected lymphomatoid papulosis, without signs of cutaneous lesions and 
spontaneous remission, was hypothesized. [1]. The fecal calprotectin was 10 times higher (49,898 
mg/Kg; n.v. 50 mg/Kg); although the biopsy of intestinal villi was negative, genetic typing of HLA 
locus DQ2/DQ8 [2], showed a predisposition for coeliac disease. Later, patient developed 
erythematous plaques involving the forearms and trunk, worsening after sun exposure. Abdomen 
MRI didn’t show any alteration. Blood testing for HIV, Treponema pallidum, EBV, ASCA, ANCA, 
ANA and ENA were all negative. A year later, patient reported asymmetrical arthralgia, first in 
elbows, wrists and shoulders with muscular pain in flexor muscles of the forearms. Ventricular 
extrasystoles have been diagnosed recently: Holter ECG reported 30051 monomorphic isolated 
ventricular extrasystoles. The patient was visited by numerous specialist physicians, e.g. 
Dermatologist, Cardiologist, Rheumatologist but he is still undiagnosed (Figure 2) and finds 
improvement for oral ulcers with topical corticosteroids and occasionally systemic cortison (1 mg). 
Seloken (beta blocker) and Dibase 50.000 UI are also administered.  
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Figure 1. multiple mouth ulcers involving the tongue. 
Figure 2. multiple mouth ulcers. Reticular lichenoid lesion (base and border of the tongue—4 years 
later). 
Conflicts of Interest: The authors declare no conflict of interest. 
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1. Introduction
Fibromyalgia syndrome is a common form of diffuse musculoskeletal pain and fatigue
(asthenia), which affects approximately 2% of world population. 
The term fibromyalgia means pain in the muscles and fibrous connective structures (ligaments 
and tendons). This condition is called a “syndrome” because there are clinical signs and symptoms 
that are simultaneously present [1,2]. 
Fibromyalgia mainly affects the muscles and their insertions on the bones [3,4]. Although it 
may resemble an articular pathology, it is not arthritis and does not cause deformity of joint 
structures. Fibromyalgia is actually a form of extra-articular rheumatism or soft tissue. 
The fibromyalgia syndrome lacks laboratory alterations. In fact, the diagnosis depends mainly 
on the symptoms the patient reports. Some people may consider these symptoms to be imaginary 
or unimportant. Over the past 10 years, however, fibromyalgia has been better defined through 
studies that have established guidelines for diagnosis. These studies have shown that certain 
symptoms, such as diffuse musculoskeletal pain, and the presence of specific algogenic areas for 
acupressure (tender points) are present in patients with fibromyalgia syndrome and not commonly 
in healthy people or in patients suffering from other painful rheumatic diseases. Tender point may 
be present at the level of temporo-mandibular junction and may overlap with temporo and 
cranio-mandibular disorders [5–8]. 
2. Therapeutically Approach
The anti-inflammatory drugs used to treat many rheumatic diseases do not show important
effects in fibromyalgia. However, low doses of aspirin, ibuprofen and paracetamol can give some 
pain relief. Central analgesic drugs can reduce the painful symptoms of the fibromyalgic patient. 
Cortisones are ineffective and should be avoided due to their potential side effects. Drugs that 
facilitate deep sleep and muscle relaxation help many fibromyalgia patients to rest better. These 
drugs include tricyclic antidepressants (amitriptyline) and selective serotonin reuptake inhibitors 
(SSRIs) (paroxetine, fluoxetine) and other predominantly muscle relaxant drugs but structurally 
similar to antidepressants (cyclobenzaprine). 
3. Exercise and Physical Therapies
Two of the main goals of fibromyalgia treatment are muscle stretching and training techniques
for painful muscles and the gradual increase in cardiovascular (aerobic) fitness. Low or no impact 
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aerobic activity, such as walking, cycling, swimming or exercising in water is generally the best way 
to start an exercise program. 
4. Alternative Therapies
Even the so-called unconventional therapies such as dietary supplements or
non-pharmacological treatments such as biofeed-back, acupuncture, gentle exercise and yoga can 
have positive effects on the symptoms of the fibromyalgic patient. 
5. Case Report
39-year-old man suffered from significant chronic pain to arms, legs and extended to all body,
non-restorative sleep, chronic fatigue, cutaneous rushes (Figure 1a,b). The chronic pain was referred 
to face, mouth and temporo-mandibular junction also. The patient was referred to a rheumatologist 
and then to a dermatologist. Blood testing was then performed: rheumatoid factor, anti-nuclear 
antibodies, anti-nDNA antibodies research, anti-ENA antibodies, and anti-cyclic citrullinated 
peptide antibodies were all negative. The dermatologist diagnosed atopic dermatitis. The patient 
was diagnosed with Fibromyalgia syndrome by the rheumatologist (FMS).  
The onset of lower back pain, restless legs, and morning stiffness occurred one month before 
the visit. The symptoms were first described as severe pain. One-month later, lower back pain and 
legs pain forced the patient to bed rest. Similar symptoms of lower back pain during the following 
2 months were attributed to the same cause. These episodes affected life quality and mobility, and 
forcing patient to bed.  
The symptoms increased progressively and constantly. Migrant cutaneous rushes extended to 
hands, arms, neck, chest, legs and feet. A modest improvement was observed during summer and 
hot weather conditions, in particular during holydays. These had considerable impact on the 
everyday life, affecting social interaction and professional performance.  
The ineffectiveness of pharmacological therapies in FMS came to patient’s knowledge. The 
patient was prescribed selective serotonin–norepinephrine re-uptake inhibitor (SNRI) (i.e., 
paroxetine 10 mg die) and he referred a reduction in pain, cutaneous rushes and chronic fatigue. 
(a) (b) 
Figure 1. Rushes on skin of the (a) hand and (b) neck associated with fibromyalgia. 
Conflicts of Interest: The authors declare no conflict of interest. 
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Leishmaniasis is a parasitic infectious disease caused by protozoan species belonging to the 
genus Leishmania. The leishmaniases are the third most important group of vectorborne diseases; it is 
endemic in 88 countries and it represents a major public health problem worldwide. In the 
Mediterranean area, most cases usually affect immunocompromised patients. Depending on the 
location of the lesions, the WHO described 11 human different clinical forms; the more common 
clinical forms can be categorized into four main groups: visceral leishmaniasis (VL); cutaneous 
leishmaniasis (CL); mucosal leishmaniasis (ML) and mucocutaneous leishmaniasis (MCL). Primary 
oral mucosal lesion can be the first sign of the infectious disease in all the clinical forms; usually oral 
lesions may be related to several symptoms (e.g., swallowing difficulties, dyspnea, dysphonia) [1–3]. 
In this case report, we presented a unusual case of MCL in a immunocompromised patients in South 
of Italy; whose presentation mimicked an oral squamous cell carcinoma (OSCC).  
A Caucasian man was complaining about a cheeck lesion that began one-month prior the first 
visit appointment and was slowly involving the right lower lip. Patient reported to be affected by 
cutaneous psoriasis, in treatment with methotrexate and cyclosporine; additionally, he was a heavy 
smoker (Pack years: 26). Physical examination revealed a whitish, nodular and ulcerated lesion 
affecting the right oral commissure measuring approximately 2.5 × 1.5 cm, involving the lower lip 
right corner and buccal mucosa with hard consistency (Figure 1). Oral hygiene was poor, lower 
incisors were missing and mechanical trauma was present on the lesion. Palpation of the lesion 
revealed a firm consistency, the neck lymph nodes were slightly swelled. 
Because a high suspicion of malignancy; the patient was included into a multidisciplinary care 
paths, named “GOTeC” (“Gruppo Oncologico Testa e Collo”—Policlinico “P. Giaccone” of Palermo), 
which deals with the entire diagnostic-therapeutic process of the patient suffering from H&N cancers, 
from the suspected diagnosis to therapeutic complete plans. Patient underwent a magnetic resonance 
imaging that highlighted an oval lesion measuring 1.2 × 2.9 × 2.1 cm (Figure 2), The neoformation 
extends anteriorly to the outer profile of the lower lip involving the orbicular and contiguous 
buccinator muscles, there was the evidence of swollen submandibular lymph nodes. Subsequently, 
an incisional biopsy was carried out, which showed non-specific chronic inflammation without 
neoplastic signs. At the post-surgical follow-up visit, the patient reported the evolution of the 
cutaneous psoriatic-like cutaneous lesions on the right harm, knees and especially foot towards a 
suppurative aspect. The patient was then referred to the dermatologic and infectious disease unit for 
further investigations; he underwent abdominal ultrasound imaging, serological test and a 
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polymerase chain reaction test on skin mucosa biopsy samples to investigate the main causes of skin 
and soft-tissue Infections.  Both results showed the leishmania infection, so the diagnosis of 
mucocutaneous leishmaniasis was established. Patient was pharmacologically treatment with 
liposomal amphotericin B and topical therapy for psoriasis; after discontinuation of 
immunosuppressive therapy. At the latest follow-up visit at 8 months, a complete remission of the 
oral and skin lesions was observed. 
As well as for OSCC, it is important to emphasizes the importance of a multidisciplinary 
approach in the diagnosis and treatment of mucocutaneous leishmaniasis, whose diagnosis remains 
a challenge due to the heterogeneous clinical presentation. The diagnostic difficulties shown in this 
case were related to the development of such lesion in a patient who lived in a non-endemic area and 
the high suspicious presentation of the oral lesion for OSCC. Additionally, even if the Leishmaniasis 
usually affects immunocompromised patients, such as transplant recipients or those who are affected 
by HIV, it should be evaluated also in patients with long-term immunosuppressive pharmacological 
treatments. 
Figure 1. Clinical view of the oral lesion affecting the right labial commissure. 
Figure 2. Magnetic resonance axial section. 
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1. Introduction
The latest WHO classification of salivary glands tumors includes more than 30 different benign
and malignant histo-types [1]. Molecular genetic findings and immunohistochemistry have been 
integrated into the tumors profiles in order to obtain homogenous and reproducible diagnostic 
criteria. Nevertheless, the extreme clinical and morphological variability, does not always lead to 
conclusions that fully fit into the WHO parameters [2,3]. 
2. Case Presentation
A 36 years old man presented to our attention for a firm mass of the right hard palate (Figure
1a). The patient reported his dentist had noted the lesion about 12 months before. No pain or 
bleeding was reported. The clinical evaluation confirmed a tense-elastic, sessile nodule of 1.5 cm of 
diameter, covered by normal mucosa. Endodontic and periodontal evaluation, supported by 
radiograms (panoramic and intra-oral x-rays) excluded an abscessual origin. CT scan revealed a 
well-defined, circumscribed and captant mass, which caused bone saucerization but not complete 
palatal bone resorption. We decided to perform a diagnostic excisional biopsy. The neoplasm 
appeared macroscopically encapsulated and about 1 cm of diameter. The surgical wound healed 
with no complications. Microscopically, the capsule resulted partially incomplete with a focal 
intacapsular tumor localization. The myoepithelial cells were scarce and with plasmacytoid 
appearance. Neither marked cellular polymorphism nor atypical mitoses were noted on H&E. 
Immunohistochemical examination revealed positivity for CK7 and CK19 (this data excluded an 
adenoido-cystic adenoma) while CK14 was only weakly positive. PAS-diastase-stain was negative, 
thus ruling out acinic cell carcinoma. GFAP, usually overexpressed in polymorphous 
adenocarcinoma (PAC) and pleomorphic adenoma (PA) was only focally detectable. Myoepithelial 
markers, such as p40, p63, smooth muscle actin, myosin and calponin were not 
immunohistochemically evident. Absence of perineural invasion was confirmed by S100 protein 
immunostain stain. The percentage of Ki 67+ proliferating neoplastic cells was 3–4% (Figure 1b). 
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(a) (b) 
Figure 1. (a) Clinical picture of the lesion; (b) k67 immunohistochemistry stain (10×). 
3. Discussion
The current case recapitulates many of the problems that may arise in the differential diagnosis
among the very different histotypes of salivary glands tumors. Partial capsular involvement by the 
tumor suggested a malignant neoplasm while the lack of atypical mitoses, perineural invasion, 
cellular atypicalities and necrosis supported for a benign lesion. The plausible differential diagnosis 
that we formulated included PA (with scarce myoepitelial component), PAC (ex “PLGA”) and 
carcinoma ex-PA at an early stage. Due to the rarity of this kind of morpho-phenotypic features, 
further evaluation to possibly identify PLAG1 and HMGA2 genes mutations would be helpful to 
confirm a diagnosis in this still unsolved case.  
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The term “cheilitis” refers to an inflammatory condition of the lip and encompasses an 
heterogeneous group of lesions of different etiology, clinical aspects, management and prognosis [1]. 
The lips cosmetically characterize the face of a person; they are fundamental to speach, eat and 
acting as a tattile organ. For such reasons, even a little alterations of the anatomy or functionality, 
are experienced by the patient with a certain discomfort and embarrassment. 
Althought cheilitis has been identified and recognized for a long time, until now there have 
been confusion among clinicians due to poor knowledge, use of improper terminology, no clear 
recommendations for its work-up and classification [2]. 
Literature reports many papers on cheilitis but they are mostly case reports and overviews of 
therapeutic or diagnostic procedures based on personal experiences and results without specific 
criteria for classification.  
In fact, about 30 articles were identified, performing a research using MEDLINE/PubMed and 
Cochrane Library databases with the keywords “cheilitis, lip cheilitis, lip inflammation, 
classification” and the Boolean operators “AND” and “OR” in order to combine the keywords, 
Apart from that, some types of cheilitis requires a multidisciplinary approach between oral 
pathologists, dermatologists, otorhinolaryngologists, which additionally complicates adoption of a 
classification system.  
According to our opinion, the classification proposed by Lugovic-Mihic et al. based on the 
duration and etiology of cheilitis is useful, but should be integrate with some forms of cheilitis in 
order to guarantee simplification of the diagnosis, appropriate treatment and benefits for patients. 
The classification is shown in Table 1. 
Table 1. Lugovic-Mihic et al. modified classification of cheilitis. 


























Proceedings 2019, 35, 8 
Mostly reversible and irreversible cheilitis are competence of stomatologists; instead, for the 
cheilits connected to dermatoses and systemic diseases the multidisciplinary care is mandatory. 
Cheilitis of more clinical interest will be treated below. 
Cheilitis simplex is one of the most common types and presents as cracked, fissured, 
desquamated lips. Frequent lip licking or sucking promote dryness and irritation, ending in 
separation of the mucosa and cracking. Therapy mostly involves advice on dealing with 
environmental conditions, application of lip balms and sometimes topical corticosteroids. 
Angular cheilitis, also called perlèche, typically manifests at the corners of the mouth. Vitamin 
and mineral deficiencies (B vitamins, iron, zinc, etc.), the loss of skin turgor due to aging, the loss of 
vertical dimension of the face due to severe edentulous states, retrognathic malocclusion are the 
most frequent causes [3]. Concurrence of bacterial (staphylococcal and betahemolytic streptococcal) 
or candidal infectionsis common. Therapy includes elimination of predisposing factors and often 
topical antimycotics, antiseptics and sometimes corticosteroids.  
Contact cheilitis (Figure 1) is caused by the irritating or allergic effects of various substances 
found in many products such as lipsticks, oral hygiene products (toothpastes), food (e.g., eggs and 
crustaceans), spices or flavouring agents and dental materials [4]. Patch tests can play a pivotal role 
in the diagnosis, although its diagnostic use is still controversial in the literature [5]. 
Figure 1. Contact cheilitis. 
Post –radio and/or –chemotherapy cheilitis is a lips localization of oral mucositis that may 
occur in 30–60% of patients receveing radiotherapy for head-neck cancer, 90% of patients receiving 
concomitant chemoteraphy and in 75% of patients receveing high-dose of myeloablative drugs used 
for conditioning regimens for allogenic hematopoietic stemcell transplantation. The lesion undergo 
spontaneous resolution. 
Actinic cheilitis (Figure 2) is due to prolonged sun exposure and occurs almost exclusively in 
fair-skinned people who work outdoors or spend too much time in the sun. It occurs more 
frequently on the lower lip, probably because the site is more directly exposed to sunlight. Clinical 
aspects consist in painless whitish discolorations at the border of the lips and the skin. The lips may 
gradually become scaly and indurated and chronic focal ulcerations can occur. Actinic cheilitis is a 
potential malignant disorder: the malignant transformation ranges from 10% to 30% [4]. Smoking 
might produce a synergistic effect. Follow-up is recommended with the execution of incisional 
biopsies in lesions with more severe clinical aspects. Surgery treatment options include 
cryosurgery, electrosurgery, laser vaporization and scalpel vermilionectomy. In a systematic review 
conducted by Vasconcelos Carvalho et al. remission rate and recurrence rate of actinic cheilitis were 
higher and lower respectively for surgical treatment compared to non surgical treatment [6]. 
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Figure 2. Actinic cheilitis. 
Cheilitis granulomatosa (of Miescher) is a rare, painless and idiophatic swelling of the lip 
belonging to the larger group of orofacial granulomatosis caused by non-caseating granulomatous 
inflammation. When accompanied by facial palsy and plicated tongue, it is referred as Melkersson– 
Rosenthal syndrome. The association between cheilitis granulomatosa and Crohn’s disease has 
been documented widely in the literature: sometimes cheilitis granulomatosa may precede Crohn’s 
disease by up to several years. Therapy may include topical, intralesional and systemic 
corticosteroids/antibiotics and surgery in severely disfiguring cases [7]. 
Plasmacellular cheilitis is a rare entities and manifests tipically on the lower lip with a 
circumscribed erosive and erithematous plaques or patches accompanied by pricking. The etiology 
is unknow and histologically is characterized by dense plasmacells infiltration in dermis. The 
clinical examination frequently leads to an initial misdiagnosis, which requires biopsy. Treatment 
include intralesional or systemic steroid and local application of immunomodulatory agents (e.g., 
tacrolimus, pimecrolimus) [8]. 
With the term cheilitis associated with systemic diseases refers to the lip manifestations of 
diseases such lupus erythematosus, oral lichen planus, pemphigus, pemphigoid, erytema 
multiforme, etc. We would like to suggest the introduction in this category of peri-oral psoriasis. 
Clinicians must pay attentions because sometimes lip lesions are the first manifestation of psoriasis, 
without skin involvement [9]. 
Angioedema results from vascular leakage due to release of vasoactive mediators such as 
histamine, serotonin, and bradykinin with extravasations of fluid into the superficial tissues causing 
edema. It can be classified as allergic, pseudo-allergic, or non-allergic atopic eczema. 
Knowledge gaps amongst clinicians about different forms of cheilitis may influence the 
misdiagnosis and the mismanagement. Complete medical history, physical examination, 
appropriate diagnostic workup and interdisciplinary collaboration are the key factors in 
recognizing the right type of cheilitis and of its successful treatment. A small number of lip lesions, 
however, are potentially lethal and thus require appropriate intervention to prevent further 
morbidity and mortality. 
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Treatment of oral leukoplakia remains largely a debatable problem [1]. According to widely 
accepted opinions the diagnosis of oral leukoplakia should have two steps [2]: the provisory 
diagnosis should include general patient evaluation (sex, age) and a local thorough oral exam: 
clinical form, unilocular, multilocular, topographical site. Other diseases that could produce similar 
lesions should be eliminated following a specific protocol. In the same time, any local favoring 
factors (smoking, alcohol, other habits, trauma, infections, etc.) should be eliminated. After 3–4 
months a definitive diagnosis will be put accordingly [2]. In some instances the lesions could 
considerably diminish or even disappear (Figures 1 and 2). If the lesions persist a histopathological 
evaluation with degree of dysplasia, immunological markers and genetic tests are recommended. 
The degree of dysplasia should be evaluated according to the WHO scale or according to the binary 
system [3,4]. If possible genetic tests of the surrounding area of the lesion are recommended. Brush 
cytology is the best method to be used. Following that complex evaluation protocol, the risk of 
malignisation could be higher or lower. 
Figure 1. 2015 Male, 70 years, smoker, drinker, Candida positive. Clinical Diagnosis: 
Non-homogenous diffuse ulcerated lingual leukoplakia. Treatment: Quit smoking, Antifungal 
treatment. Biopsy. 
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Figure 2. Same patient. 2019. Clinical aspect. The patient quit smoking; 6 months later residual 
keratotic lesions were removed. No sign of relapse 
Lesions with high degree of dysplasia, genetic disturbances (Loss of heterozigosy), multilocular 
type, speckled, location in high-risk zones should be eliminated. Surgical methods should be 
adapted according to the width, length, and position of the lesion keeping in mind the borders of 
oncological security. Classic scalpel removal, laser surgery, cryotherapy should be adapted in 
accordance with the clinical and histopathological data. A significant percentage of relapse is to be 
expected in case of idiopathic leukoplakia [1]. A post surgical, strict clinical follow-up must be 
instituted. 
In the same time, some of the patients do not accept a surgical treatment or simply don’t come 
back for control and parts of the lesions evolve without treatment. In this group some of the lesions 
disappear spontaneously, other enlarge, other shrink and other turn to cancer [5]. Thus, the 
wait-and-see attitude is an option and a reality. Patients included in this group should be closely 
followed and if the clinical aspect changes, new biopsies are recommended and a surgical treatment 
becomes an option. In our opinion that is a valid medical option. 
No unified therapeutical guidelines exist so far [1]. 
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The diagnosis and treatment of oral erosion/ulceration is often challenging due to the clinician’s 
limited exposure to the conditions that may cause the lesions and their similar appearances. While 
many oral ulcers and erosions are the result of chronic trauma, some may indicate an underlying 
systemic condition such as a gastrointestinal dysfunction, malignancy, immunologic abnormality, or 
cutaneous disease. Correctly establishing a definitive diagnosis is of major importance to clinicians 
who manage patients with oral mucosal disease [1]. 
A 77-year-old male edentulous former smoker (stopped in 1962) suffering of hypertension, 
angina and glaucoma in pharmacological treatment, was admitted to our Oral Medicine and Oral 
Oncology Clinic on January 2010 with severe and persistent eroded lesions noticed 3 months prior to 
his visit (Figure 1A). Lesions involved the left buccal mucosa; extending to left labial commissure and 
the vermillion. No other lesions could be detected at an oral and cutaneous examination. Map 
biopsies under Velscope® guide were performed but the pathological assessment didn’t highlight any 
alteration in the oral mucosa. Miconazole 2% gel (3 applications per day per 15 days) and 
Chlortetracycline 3% ointment (3 applications per day per 15 days) treatment improved the clinical 
aspect of the lesion. After 3 months since the erosion didn’t show up any more improvement, the 
patient underwent cryosurgery. A nearly complete regression of the erosion was obtained (Figure 
1B). On March 2011, meanwhile two new denture were performed, a worsening of the clinical aspect 
and of the symptoms had led to the execution of new biopsy samples, which highlighted the presence 
of mild-moderate dysplasia (Figure 1C). The patient decided to do not perform the excision, so a new 
biopsy was performed on November 2011(Figure 1D). The pathological assessment showed the 
presence of an in situ carcinoma. The patient underwent photodynamic therapy in 2012. During the 
follow-up on March 2013 (Figure 1E) a new severe worsening appeared, with the involvement of the 
buccal mucosa and also of the skin of the labial commissure by erosion with scabs. The histologic 
examination ruled out a relapse. Until 2016 the erosion changed several time his clinical aspect. 
Hematological and Quantiferon exams were required, but they excluded a Tuberculosis infection and 
a lymphoproliferative disorder. Several pharmacological treatments (antimicotic and antibiotic 
topical use) couldn’t heal the lesion, biopsies were repeated in the years (September 2013 (Figure 
1F,G), March 2014) until April 2016 (Figure 1H,I) when the pathological assessment disclosed a mild 
dysplasia. Because of the worsening of the systemic condition of the patient (since 2015 the patient 
was suffering of Alzheimer disease), according with the son of the patient, was decided to keep only 
clinical follow-up. On August 2017 the patient died due to a complication of senile dementia. 
Diagnosis of oral erosion-ulceration can be challenging and requires careful clinical examination 
and history taking. Persistent oral ulcerations can result from a variety of disparate etiologies and, 
therefore, may pose a diagnostic challenge. Historically, the diagnosis of many of these conditions 
has been made based only on clinical presentation, sometimes along with tissue biopsy [2]. However, 
not every case will present the typical clinical or histological features associated with a certain 
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condition. The management of many of these conditions has been similarly nonspecific, often 
involving non-targeted anti-inflammatory or immunosuppressive agents. 
Figure 1. (A) Clinical aspects of the buccal mucosa lesion at first examination January 2010. (B) Erosion 
healing after cryotherapy on June 2010. (C) Worsening of the erosion on May 2011 with a pathological 
assessment of mild-moderate dysplasia. (D) November 2011 in situ carcinoma. (E) After 
photodinamic therapy a relapse of the erosion was highlighted on March 2013 with a pathological 
assessment of dense inflammatory infiltrate of plasma cells without dysplasia. (F,G) September 2013: 
worsening of the lesion with a skin’s involvement, biopsies ruled out the presence of dysplasia. (H,I) 
April 2016: Enlargement of the lesion with the presence of mild dysplasia. 
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Osteonecrosis or aseptic and avascular necrosis of the jaws (ONJ), has been defined as an area 
of intra-oral and/or extra-oral exposed bone and may result in significant patient morbidity. In the 
last period osteonecrosis of the jaws related to Bisphosphonate (BRONJ) and, recently, Denosumab 
related osteonecrosis of the jaws (DRONJ) and other medicaments such as antiangiogenic agents 
(MRONJ) have been abundantly reported [1], but different etiologies may cause a maxillo-
mandibular osteonecrosis. In the present report we describe the case of a patient affected by Crohn’s 
Disease referred to Department of Biomedical and Neuromotor Sciences, unit of Oral Medicine, 
University of Bologna on September 2108 for the presence of a painful lesion in the hard palate. His 
medical history revealed a diagnosis of Crohn’s disease in 2016. Medical treatment with mesalazine, 
prednisone and later with adalimumab and infliximab didn’t significantly improve the clinical 
condition of the patient. In June 2018 a surgical resection of intestinal tract affected by Crohn’s disease 
was performed. Finally, in July 2018 a laboratory test revealed a positivity for HLA B51, a genetic 
marker related to Behcet’s disease.  
In the clinical examination we revealed the presence of a 3–4 cm of painful bone exposure in the 
right side of hard palate and presence of a generalized severe periodontitis (Figure 1a,b). In this 
patient various local or systemic phenomena might take part in osteonecrosis of the oral cavity. ONJ 
may be related to adalimumab and/or infliximab therapy, 2 anti TNF-  antibody used to treat Crohn’s 
disease and other autoimmune diseases. Few authors reported a relationship between infliximab 
and/or adalimumab therapy and appearance of ONJ [2–4]. In this particular case the area of exposed 
bone didn’t appear after a surgical odontostomatological procedure, but the patient showed a severe 
generalized periodontitis, a well known ONJ risk factor. Chronic osteomyelitis, a rare infection of the 
medullary portion of the jawbone with purulent exudate related with immunocompromised 
conditions of the patient, was the second considered hypothesis. Finally, oral manifestation of 
systemic condition was the third hypothesis, even if an intra-oral osteonecrosis is not a typical oral 
manifestation Crohn related. 
Different clinical and instrumental investigations were performed. An incisional biopsy in the 
hard palate was scheduled. At histology, Hematoxylin Eosin stained sections revealed acanthosis, 
hyperkeratosis and the presence of a dense trans-mural non necrotizing granulomatous chronic 
inflammation. PAS staining methods and additional colorations with Ziehl Neelsen and Giemsa did 
not reveal fungal, bacterial or parasite presence. A CT scan showed a massive maxillary bone loss in 
the right hard palate region without maxillary sinus involvement. Clinical investigations were also 
performed with the aim to reconsider the initial diagnosis of Crohn’s disease. Indeed, HLA-B51 
positivity is strongly related to Behcet’s Disease [5] and when the gastrointestinal tract is involved, a 
differential diagnosis between Behcet’s Disease and Crohn’s Disease may be very difficult [6]. Clinical 
systemic investigations revealed multiple ulcers in ipo-pharingeal and laryngeal tract and a painful 
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purulent ulceration on the skin, diagnosed as Pyoderma gangrenosum. At the same time, the patient 
didn’t show ocular and genital ulcers and pathergy test was negative. Unexpectedly, in the 18th of 
October 2018 patient presented a fatal cardiovascular complication and died. Parents refused the 
autopsy.  
Unfortunately, in this case the formulation of a definitive diagnosis consistent with the clinical 
presentation and a consequent treatment plan was not possible. Diagnosis of multisystemic 
inflammatory conditions is based on clinical findings and different Crohn’s disease manifestations 
are similar to Behcet’s Disease manifestations. Diagnosis of MRONJ is also based on clinical findings 
and few informations still exist about the exact relationship between biological agents and ONJ. In 
the future presence of specific pathognomonic laboratory tests may be fundamental in cases with 
multiple comobordities to avoid a delay in diagnosis and treatment.  
(a) (b) 
Figure 1. Presence of intra-oral bone exposure in the right side of the hard palate (a) and presence of 
a severe generalized periodontitis (b). 
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Oral squamous cell carcinoma survival is still poor, although the improvement in treatments 
both in surgical and chemotherapy [1]. Conventional treatments are also associated with acute and 
chronic toxicity, which leads to a decrease of quality life [2]. Natural compounds are a promising 
alternative, since they can affect the different steps of tumor cell development, with poor toxic events. 
E. Tenuifolia L. showed promising anticancer activities in several cancer models, due to its antioxidant 
activity [3,4]. In order to verify its anticancer activity in a cellular model of squamous cell carcinoma,
HSC-2, we performed a MTT cell proliferation assay, by adding this compound at time 0 (t0). HSC-2
were cultured in cell culture flask at 37 °C with 5% CO2 in RPMI medium supplemented with 10%
fetal bovine serum (FBS), 1% penicillin-streptomycin and 1% L-Glutammine. We used the
inflorescences total extract (20 mg/mL in EtOH 70%) and we evaluated the production of formazan
in order to determine the cell viability, at 24 h, 48 h and 72 h. When comparing these results, with
results coming from cells in addition with ethanol only, we observed a decrease in cell viability of
40%. Future studies should deeply investigate the role of Echinophora Tenuifolia L. as possible adjuvant 
in cancer therapy, in order to understand its role in pathways and molecular targets.
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1. Introduction
Osseointegration can be affected by oral conditions, in particular the micro gap at the
implant-abutment-connection (IAC) represents a site for dental plaque aggregation favoring 
bacterial leakage that can increase inflammatory cells at the level of the IAC, causing peri-implantitis 
[1]. This micro gap, once early colonized, may constitute a bacterial reservoir, that could 
subsequently contaminate fixture’s surroundings and interfere with peri-implant tissues health [2,3]. 
2. Aim
The aim of this review is to describe, according to the most recent literature, the different kind
of implant-abutment connection and their ability to reduce bacterial leakage and thus preventing 
peri-implantitis. 
3. Materials and Methods
The following database were consulted: Pubmed (n = 26), Scopus (n = 90), Research gate (n = 7)
and were found a total of 123 articles. Duplicates were excluded and after reading abstract and titles, 
were excluded those articles that were off topic. The remaining ones (n = 24) were assessed for 
full-text elegibility: we excluded 5 articles because they were case report, 2 because there was no 
clear reference to the relationship IAC and bacterial leakage and 2 because was not pertinent with 
the argument. Fifteen articles were included in the review. 
4. Results and Conclusions
From the review, it’s clear that exists a relationship between the IAC and bacterial leakage. All
the connection presented an amount of micro-gap and bacterial micro-leakage but conical and mixed 
connection systems seem to behave better. Moreover, both connections seem to have a better load’s 
distribution and mixed one has also anti-rotational properties very useful during the positioning of 
the prosthesis [4]. 
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Cardiovascular disease (CVD) is a common cause of death, representing 29% of the mortality all 
over the word. Estimates for 2006 show that CVD is one of the world’s main cause of death, with 17.1 
million death per year. More than 70 million Americans have been diagnosed with various forms of 
CVD, including high blood pressure, coronary artery disease (acute myocardial infarction and angina 
pectoris), disorders of peripheral arteries etc. There is strong evidence that periodontal disease (PD) 
is associated with an increased risk of CVD. In addiction many patients with CVD are also affected 
by PD, which can be mild or severe [1,2]. The aim of this manuscript is to investigate the effects of 
periodontal therapy on the management of CVD. 34 randomised controlled trials and reviews were 
included in this mauscript to test the effects of different periodontal therapies for patients with CVD. 
In conclusion we may affirm that there is some lack of knowledge on relations between PD and CVD, 
however there is sufficient evidence to justify a periodontal treatment to prevent CVD, in fact PD is 
very prevalent in middle-aged population and can have a significant impact on the cardiovascular 
function [3,4].  
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Diabetes mellitus (DM) and periodontal disease (PD) are both chronic diseases. 
From one side, DM have an adverse effect on PD, and on the other side PD may influence DM. 
Systemic therapy of DM with glycaemic control, affects the progress of PD. Reversely treatment of 
PD combined with the administration of systemic antibiotics seems to have a double effect on 
diabetic patients reducing the periodontal infection and improving the glycaemic control [1,2]. 
Inflammation, altered host responses, altered tissue homeostasis are common characteristic of 
both DM and PD. The potential common pathophysiologic pathways of direct or reverse 
relationship of DM and PD are still unknown and further in vitro and in vivo studies are needed to 
explore this relationship [3,4]. 
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Helicobacter pylori (H. pylori) gastric infection is considered one of the most common human 
infections. It occurs in half of the world’s population is the most common cause of adenocarcinoma 
of the distal stomach [1]. 
The risk in developing gastric cancer is believed to be related to differences among H. pylori 
strains and the inflammatory responses mediated by host genetic factors.  
The accepted evidence is that the H. pylori strains reach the stomach by ingestion through the 
mouth, and because of its non-invasive nature, the stomach is the definitive site for colonization [2,3]. 
One of the key issues related to the eradication of gastric H. pylori has been the importance of 
oral hygiene and periodontal procedures. Dental plaque control and periodontal therapy can 
prevent gastric H. pylori infection recurrence for patients with gastric diseases associated with H. 
pylori [4]. 
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Periodontal diseases (PD) affect about half of the adult population all over the world. PD is 
caused by bacterial infection inducing an inflammatory response with progressive destruction of the 
periodontal tissues and finally the lost of teeth. Tobacco smoking (TS), alcohol consumption, and 
systemic conditions such as diabetes, osteoporosis, malnutrition and stress are considered additional 
risk factors [1,2]. This short review examines the potential causal association between TS and PD. 
There are many studies for a higher level of PD among smokers. Greater levels of clinical alveolar 
bone loss, tooth mobility, probing pocket depth and tooth loss are more frequent in smokers than in 
non-smokers. The modification of the periodontitis micro-flora in smokers influences the 
development of PD. Also, there are data suggesting smoking effects on both host responses in 
humans. Response to periodontal treatment is different in smokers and non-smokers. Various 
clinical studies have demonstrated that TS is a major risk factor for poor response to periodontal 
therapy. TS is a factor that has the potential to negatively affect healing and the outcome of implant 
treatment [3]. It is mandatory for dentists and dental hygienist to promote smoking-cessation 
programs as well as educate our community on the benefits of not smoking [3,4]. 
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Tongue squamous cell carcinoma (TSCC) accounts for 40% of all squamous cell carcinoma 
involving the mucosal surface of the oral cavity. TSCC is highly invasive and aggressive and, 
nowadays, TNM staging system is considered the gold standard in predicting patients’ outcomes. 
Nevertheless, patients with tumors classified under the same TNM stage, can undergo different 
outcomes, with differences in behavior, aggressiveness and therapy response. This panorama calls 
for new biomarkers which could be used in clinical practice in a precision medicine point of view [1]. 
TCGA Database [2] offers wide genome sequencing analysis, including mRNA expression of whole 
genome. We included patients with TSCC and we downloaded data of mRNA expression per 
patient and survival outcome [3]. We performed a differential expression analysis and ranking 
according to the outcome. This bioinformatics approach led to the detection of 12 promising genes 
which resulted to be able to predict patients’ prognosis. Poor is known about the detected genes and 
future studies are needed to test this gene panel in order to assess the accuracy in predicting death in 
an external cohort of patients. In addition, since these genes could be linked to a higher risk of 
patient’s death, they could be actor in some pathological pathways, which characterize the tumor 
biology, for example in chemotherapy resistance, metastasis or tumor growth [4]. 
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1. Aim
Desquamative gingivitis (DG) is a clinical representation of many autoimmune diseases,
presenting with erythema, shedding and ulceration of free and attached gingiva. In the last decade, 
evidence suggested that DG could play a role in increasing the long-term risk for periodontal tissue 
breakdown, leading to the inclusion of periodontal therapies as additional treatment for DG patients 
[1]. Topical doxycycline gel has been tested successfully as additional option to scaling and root 
planing (SRP), triggering the reduction of periodontal pathogens [2]. Aim of the present work was to 
assess the role of 14% doxycycline gel (Ligosan®, Dental Trey, Turin, Italy) as an additional tool to 
non-surgical periodontal treatment on patients affected by Oral Lichen Planus (OLP)-related DG, 
and active periodontitis. 
2. Methods
Patients referred to the Department of Oral Medicine, CIR Dental School, Turin, were enrolled.
Inclusion criteria were: symptomatic DG, caused by histologically confirmed OLP, and active 
periodontitis, with at least three periodontal intraosseous defects of 5 mm or more. The eligible 
patients were randomly assigned either to “cases”, where Ligosan® was administered with SRP, or 
to “controls”, undergoing SRP alone. Severity of DG and periodontitis were evaluated through the 
following parameters: visual analogue scale (VAS), full-mouth plaque score (FMPS), full-mouth 
bleeding score (FMBS), and desquamative gingivitis clinical score (DGCS) [3]. Statistical analysis 
was performed through Wilcoxon and signed rank test. Table 1 shows the main characteristics of 
each therapeutic protocol.  
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Table 1. Treatment designed for Cases and Controls. 
Timing Cases Controls
T0 
Anamnesis; oral examination and 
orthopantomography (OPT); photographic 
documentation; fulfilment of periodontal chart; 
evaluation of VAS, FMBS, FMPS, DGCS 
Anamnesis; oral examination and 
orthopantomography (OPT); 
photographic documentation; 
fulfilment of periodontal chart; 
evaluation of VAS, FMBS, FMPS, 
DGCS 
T1 (one week 
after T0) 
Ultrasonic scaling; instructions for domiciliary oral 
hygiene; Chlorexidine 0.20% mouthrinse three times 
daily for one month 
Ultrasonic scaling; instructions for 
domiciliary oral hygiene; 
Chlorexidine 0.20% mouthrinse 
three times daily for one month 
T2 (one week 
after T1) 
Root planing of maxillary teeth; reinforcement of 
motivation for oral hygiene 
Root planing of maxillary teeth; 
reinforcement of motivation for 
oral hygiene 
T3 (one week 
after T2) 
Root planing of mandibular teeth; application of 
Ligosan® in the maxillary intraosseous pockets; no 
flossing and sole occlusal brushing for 7 days; soft 
diet for 3 days 
Root planing of mandibular teeth; 
reinforcement of motivation for 
oral hygiene 
T4 (one week 
after T3) 
Application of Ligosan® in the mandibular 
intraosseous pockets; no flossing and sole occlusal 
brushing for 7 days; soft diet for 3 days 
Conventional oral and 
radiographic (OPT) examination; 
photographic documentation; 
fulfilment of periodontal chart; 





conventional oral and radiographic (OPT) 
examination; photographic documentation; 
fulfilment of periodontal chart; re-evaluation of VAS, 
FMBS, FMPS, DGCS 
/ 
3. Results
Ten patients were recruited: six cases (4 M; 2 F; mean age: 54 years old; range 48–84), and four
controls (1 M; 3 F; mean age: 72 years old; range 64–74). Among cases, statistical analysis revealed a 
significant decrease of FMPS and FMBS (p < 0.05), a quasi-significant decrease of DGCS (p = 0.07), 
with no significant variations of VAS (p > 0.05), after treatment. Controls experienced no significant 
fluctuations for either of the aforesaid parameters (p > 0.05). When compared, only FMPS was 
significantly decreased in cases rather than controls (p < 0.05). 
4. Conclusions
To our knowledge, this is the first attempt of experimenting the reliability of topical
doxycycline in patients with DG and active periodontitis. The main limitation of this work relies in 
the very small sample of patients recruited. Ligosan® showed encouraging results in the reduction of 
DG severity, and improvement of the periodontal status. Further studies on larger samples could be 
useful to establish the consistency of these preliminary results.  
Acknowledgments: The Authors would like to thank Dental Trey for providing free Ligosan® samples. 
Conflicts of Interest: The Authors declare no conflict of interest. Dental Trey had no role in the design of the 
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript. 
References 
1. Guiglia, R.; Di Liberto, C.; Pizzo, G.; Picone, L.; Lo Muzio, L.; Gallo, P.D.; Campisi, G.; D’Angelo, M. A
combined treatment regimen for desquamative gingivitis in patients with oral lichen planus. J. Oral Pathol. 
Med. 2007, 36, 110–116.
38
Proceedings 2019, 35, 19 
2. Ratka-Krüger, P.; Schacher, B.; Bürklin, T.; Böddinghaus, B.; Holle, R.; Renggli, H.H.; Eickholz, P.; Kim,
T.S. Non-surgical periodontal therapy with adjunctive topical doxycycline: A double-masked,
randomized, controlled multicenter study. II. Microbiological results. J. Periodontol. 2005, 76, 66–74.
3. Arduino, P.G.; Broccoletti, R.; Sciannameo, V.; Scully, C. A practical clinical recording system for cases of
desquamative gingivitis. Br. J. Dermatol. 2017, 177, 299–301.
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons 
Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
39
Proceedings 2019, 35, 20; doi:10.3390/proceedings2019035020 www.mdpi.com/journal/proceedings
Extended Abstract 
Primordial Odontogenic Tumour: A Systematic 
Review † 
Fabio Croveri 1,*, Vittorio Maurino 2, Alessandro d’Aiuto 1, Marta Dani 1, Andrea Boggio 1 and 
Lorenzo Azzi 1 
1 Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi, Dental Clinic, Unit of Oral 
Medicine and Pathology, 21100 Varese, Italy; daiuto.alex@gmail.com (A.d.); marta.dani92.md@gmail.com 
(M.D.); andreaboggio90@gmail.com (A.B.); lorenzoazzi86@hotmail.com (L.A.) 
2 Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi, Dental Clinic, Unit of 
Pediatric Dentistry, 21100 Varese, Italy; vittorio.maurino@gmail.com 
* Correspondence: Fabio.croveri@icloud.com; Tel.: +39-0332825623
† Presented at the XV National and III International Congress of the Italian Society of Oral Pathology and
Medicine (SIPMO), Bari, Italy, 17–19 October 2019. 
Published: 11 December 2019 
1. Introduction
Primordial odontogenic tumor (POT) is a novel entity that was described in 2014 and that is
included in the group of benign mixed epithelial and mesenchymal odontogenic tumors [1]. 
In recent years, several papers have added new cases with some clinical and histopathological 
aspects that slightly differ from those described in the original report, or that had not been previously 
observed. 
The aim of this systematic review is to update all available data on POT published in the 
literature and to identify those features of the neoplasm that require further investigation. 
2. Materials and Methods
A systematic review of literature was conducted using PubMed, Embase, Web of Science and
Scopus and following PRISMA guidelines [2]. J-Stage, LILACS and Google Scholar were also 
checked. Publications reporting cases with enough clinicopathological information were included, 
without any time or language restrictions. Histopathological, immunohistochemical or radiological 
studies were considered for qualitative analysis. 
3. Results
A total of 28 publications were included (Figure 1). Sixteen papers were used for quantitative
analysis (Figure 2; Table 1). A total of 17 cases of POT were identified in the literature. POT is a benign 
mixed epithelial and mesenchymal odontogenic tumour composed of a loose fibrous connective 
tissue resembling the dental papilla. The distinguishing feature of the neoplasm is the presence of a 
single layer of columnar cells resembling the inner enamel epithelium of the developing tooth that 
entirely covers the lesion peripherally. 
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Figure 1. Study screening process. 
Figure 2. Ages of patients with POT. There were three subpopulations: infants in the deciduous 
dentition stage, children in a mixed dentition stage and adolescent/young adults in the permanent 
dentition stage. 
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4. Conclusions
Some issues about POT remain unclear and require future reports.
The description of the odontogenic epithelium covering the ectomesenchyme was often 
contradictory, while it remains debatable whether peripheral ameloblastic islands or hard dental 
tissue deposition can occasionally occur within the tumor [3,4]. 
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1. Introduction
Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease, affecting one
or more mucosae. The oral cavity is generally involved, often in form of desquamative gingivitis 
(Figure 1).  
Immunofluorescence (direct and indirect), histopathology (Figure 2), together with sera 
autoantibodies dosage by enzyme-linked immunosorbent assay (ELISA) are currently used to 
diagnose this disease. Saliva is currently employed for diagnostic purposes in multiple fields, 
providing a wide pool of biomarkers, and representing a not-invasive method suitable for screening 
and follow-up procedures [1,2]. 
Figure 1. Desquamative gingivitis: common clinical oral manifestation of mucous membrane 
pemphigoid. 
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Figure 2. Histopathological picture of MMP (4× magnification). 
2. Aim
The aims of the present study were to analyze the efficacy of ELISA in the detection of anti BP180 
NC 16a antibodies, comparing salivary and sera specimens, in patients affected by MMP; and to 
evaluate the correlation between the severity of the clinical manifestations and the anti BP180 titers 
detected.  
3. Materials & Method
Patients referred to Oral Medicine unit of Policlinico di Bari, from January 2011 to December
2016, with a histopathological diagnosis of MMP confirmed by direct immunofluorescence (DIF) test 
were enrolled. Every patient underwent a serum and a saliva sample collection at the beginning of 
the diagnostic process. BP180 titers were assessed using commercially available ELISA kit (cut off: 9 
U/mL). Clinical Harman’s score was recorded for every patient. Sensitivity, specificity, negative 
predictive value (NPV), positive predictive value (PPV) and accuracy of ELISA performed on salivary 
samples were calculated in comparison to sera specimens. The concordance between the two tests 
was evaluated using the Cohen’s kappa coefficient (k). The correlation between clinical Harman’s 
scores and ELISA titers was evaluated using t-Student test (significative values with p < 0.05). 
4. Results
Twenty-five patients were enrolled, 19 females and 6 males (F:M = 3.16), mean age 63.5 (SD ±
10.9). Patients data are resumed in Table 1. Sensitivity and specificity values were 83.3% and 53.8% 
respectively, NPV was 77.8% and PPV was 62.5%, accuracy resulted with a value of 68%. The Cohen’s 
k value was 0.367 (concordance: “fair”). The association between the clinical scores and both the 
salivary and sera anti-BP180 titers resulted to be statistically significant (p < 0.05). 
Table 1. Enrolled patients’ demographic data, anti-BP 180 sera and saliva titers detected using ELISA, 
and Harman’s scores. The positive values (>9 U/mL) are bolded. 
Patient Sex Age Anti-BP180 Serum Titer Anti-BP180 Saliva Titer Herman Score 
1 F 66 6.6 4.5 2 
2 F 82 43.2 26 3 
3 F 67 13.6 19.7 3 
4 M 50 28.8 44.3 1 
5 M 59 30 9.1 1 
6 F 46 3 11.2 1 
7 M 45 0.8 2.9 1 
8 F 65 2.3 40.9 2 
9 F 82 26.3 11.2 1 
10 F 62 3.8 3.3 3 
11 F 73 5 42.1 2 
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12 F 59 8.2 0.5 1
13 F 78 19.4 66.1 3 
14 F 56 1.1 2.4 1 
15 M 74 6.5 7.2 3 
16 F 59 14.3 17.3 1 
17 F 48 16.4 2.5 3
18 M 61 12.7 60 1 
19 F 74 2 10 3 
20 F 77 27.1 13 2 
21 F 69 8.3 31.8 1 
22 F 65 12.7 46.2 2 
23 F 66 0.3 11.7 2 
24 F 58 34.8 7.4 2
25 M 47 3.9 7.4 2
5. Discussion
From this study a good sensitivity of ELISA performed on saliva emerged, while specificity
resulted lower when compared to sera data. Nowadays, few studies about ELISA effectiveness in 
patients affected by pemphigoid are available, and even less about muco-membranous forms. The 
concordance between the two samples used resulted to be fair, suggesting the chance to employ 
saliva as a not-invasive tool to help the diagnostic process and to track the course of the pathology 
[1–4]. In fact, this study showed a statistical correlation between clinical conditions and antibodies 
titers. A greater reliability of ELISA could be achieved extending the range of dosable antigens of the 
commercial kits, and using crevicular fluid samples instead of whole saliva, providing higher levels 
of antibodies. 
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1. Objectives
The main goals of the management of osteonecrosis of the jaw (ONJ) are to slow the progression 
of the disease and, when it is achievable, to remove all the necrotic bone promoting the tissues’ 
healing. In particular, the gold standard is represented by the surgical procedures (conservative or 
invasive) [1]. 
Recently, the use of medical ozone is increasingly applied in oral surgery, due to is valuable 
features, thanks to antimicrobial effect, regenerative and angiogenic activities [2]. 
This study aimed to evaluate the efficacy and safety of ozone application in the conservative 
surgical treatment of ONJ. 
2. Materials and Methods
Twenty-three patients have been referred to our Sector of Oral Medicine (UNIPA) for ONJ
treatment and have been enrolled in this study. 
All patients have been staged, according to SICMF-SIPMO clinical and radiological staging system. 
After informed consent, the PROMaF protocol [3] has been modified, adding 
insufflation/injection of ozone: 
1. Antibiotic prophylaxis and one-minute mouthrinse with 0.2% Chlorhexidine from the day
before and for six days after the surgical procedure.
2. Local anesthesia achieved using 3% mepivacaine hydrochloride without adrenaline
3. Elevation of a full-thickness mucoperiosteal flap
4. Curettage of the necrotic bone
5. Insufflation inside the bone defect (15 mL dosage) (by pink Venocat cannula 20Gx1.1/4 /1.10 ×
32 mm) and injection around its edges (15 mL dosage) (by 26Gx½” needle—0.45 × 13 mm) of an
oxygen-ozone mixture (15  concentration)
6. Tension-free suture
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One week after, sutures have been removed; the follow-up has been expected at 15 days, 1, 3, 6 
and 12 months after surgery; radiological evaluation has been carried out at 90 days, 6 and 12 months. 
Local Ethics Committee (Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone di 
Palermo) approved the study (record number N°1/2018). 
3. Results
During the study period, twenty-three patients have been recruited, whose descriptive statistics 
are shown in Table 1. 
At the most recent follow-up visit (mean follow-up 8.72  5.2 mo), complete clinical healing 
has been observed in nine patients under bisphosphonates therapy (75%) and nine patients in 
treatment with denosumab or denosumab + bevacizumab (81%); in five patients, only clinical 
improvement has been observed. No recurrence signs have been showed in radiological findings. 
Table 1. Patients’ descriptive statistics. 









I A 4 (17%) 
I B 5 (22%) 
II A 4 (17%) 
II B 7 (31%) 




Denosumab + Bevacizumab 4 (17%) 
Time of administration of ONJ-related medications (mo) 
Cancer 21.3  14.1 
Non-Cancer 152  77.1 
* ONJ stage according to SICMF-SIPMO clinical and radiological staging system.
4. Conclusions
Although with the great limitation of these preliminary results, the authors suppose that ozone
application may act as local regulators of wound healing, improving the results of ONJ surgical 
treatment. 
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1. Aim or Purpose
Cancer patients and survivors are increasing [1] and may present with unique oral health needs. 
The majority of dentists do not have adequate education [2], training and experience [3] in the 
management of toxicities secondary to cancer therapy [4]. As such, we implemented a new oral 
oncology and oral medicine fellowship to meet these needs. The goal of this study was to determine 
the number of cancer patient visits, patient demographic information, and diagnoses in a single 
center training program.  
2. Materials and Methods
A retrospective electronic medical record review was conducted from October 2018 till January
2019 for all patients seen by the fellow while rotating through the medical oncology departments at 
Dana Farber Cancer Institute. Patients were evaluated by the medical oncologist and the fellow at 
each visit. Data were tabulated into an electronic spreadsheet and descriptive statistics were used. 
3. Results
586 patients (349 females, 59.6%) with a median age of 62 (range: 25-88) were seen. Of all patients
seen, 402 (68.6%) had cancer. The most common cancer diagnoses included hematologic (179; 44.5%), 
head and neck (77; 18.6%), breast (73; 18.1%), thoracic (22; 5.5%) and bone malignancies (17; 
4.2%).Oral complications were present in 96 (23.8%) patients and included dry mouth (60; 14.9%), 
ulcers (49; 12.2%), and chronic GHVD (25; 6.2%).Over the year, 122 procedures were performed 
(which 67.2% represented surgical extractions and biopsies) and 196 prescriptions for medications 
were done. Patients affected by head and neck cancer (35/77; 45.4%) and hematologic malignancies 
(55/179; 30.7%) had the highest risk of presenting with oral toxicities. 
4. Conclusions
Oral complications from cancer therapy are common and may require a multidisciplinary
approach. Adequately trained dentists are a valuable resource for the community to provide safe and 
effective oral care for oncology patients.  
Conflicts of Interest: The authors declare no conflict of interest. The funding sponsors had no role in the design 
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1. Introduction
Clinical studies have demonstrated the effectiveness of low-level laser therapy (LLLT) in
patients with unresponsive oral lichen planus (OLP). OCT can reveal, in real time, the architecture of 
epithelial and sub-epithelial tissues and surrounding structures [1]. Aim of the present work was to 
assess the in-vivo changes of oral mucosa before and after LLLT treatment in a patient affected by 
erosive OLP. 
2. Methods
OCT: a recent variant of a commercial frequency domain OCT dermatological instrument
(SS-OCT, VivoSight®, version 2.0, Kent, UK) was deployed with a novel probe manufactured 
specifically for oral cavity. Length of probe = 124 mm; probe shaft diameter = 15 mm. Field of view = 
6 mm2. Dynamic scans—duration = 30 s, 120 frames, depth = 6 mm  allowing hyporeflectiveness to 
be displayed as red area, were deployed. OCT scans were carried out before biopsy, and before/after 
each LLLT session. 
LLLT: 980 nm diode laser (Raffaello DMT Italy) was kept perpendicularly at 2 mm from the area 
of irradiation, with the following parameters: application time for each point = 16 s; total energy = 4 J; 
output power = 250 mW; power density = 500 mW/cm2; energy density = 8 J/cm2; spot size = 0.5 cm2. 
A “spot” technique with slight overlapping was performed. 
Patient: 74 years-old female, affected by histologically confirmed OLP, undergoing one weekly 
session of LLLT until complete clinical healing, for an atrophic-erosive cheek lesion of 1 cm2, 
unresponsive to topical steroids.   
3. Results
Before biopsy OCT revealed a wide red hyporeflective area beneath and above the basement
membrane (BM, green line in Figure 1). Comparison between biopsy specimen and OCT scan 
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suggested that hyporeflectiveness beneath BM might be ascribed to an uprising of the blood flow in 
the inflamed connective tissue, whereas above BM, hyporeflectiveness might be attributed to the 
edema within the epithelial layers. Immediately after the first LLLT session, despite any detectable 
clinical modifications, OCT revealed a decrease of the hyporeflectiveness of the upper third of the 
epithelium (Figure 2). After the second LLLT session, OCT showed a supplementary decrease of the 
red area beneath and above BM. Finally, after the third LLLT session, clinical healing was 
accomplished, with OCT showing a homogeneous red zone limited to the area beneath BM, whereas 
epithelium regained a usual hyper-reflective gray pattern intertwined with red spikes. 
Figure 1. OCT dynamic scan of the cheek lesion before biopsy, showing widespread red 
hyporeflective areas both in Epithelium and Lamina Propria. 
Figure 2. OCT dynamic scan of the cheek lesion immediately after the first LLLT session, showing a 
decrease of the hyporeflectiveness of the upper third of the epithelium. 
To our knowledge, this is the first evidence of application of OCT in oral medicine as an 
additional tool to assess LLLT reliability for OLP. Interestingly, OCT seemed to reveal modifications 
of the epithelial ultrastructure before the appearance of visible clinical changes. Larger samples of 
OLP patients should be tested to assess the validity of these preliminary results. 
Acknowledgments: Thanks to Vivosight® for leasing of the OCT. 
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1. Introduction
Psoriasis is a systemic, immune-mediated, inflammatory skin disease of unknown aetiology [1]. 
It affects 2–4% of the population in western countries and it is characterized by circumscribed, 
circular, red papules or plaques with a grey or silvery-white, dry scale.  
Although many studies reported possible association between psoriasis and several oral 
conditions [2], some questions still remain unsolved. 
The aim of this review was to analyze all the existing literature on oral manifestations in 
psoriatic patients and to determine their prevalence compared with healthy subjects. 
2. Methods
PubMed, Scopus, and Web of Science were used as search engines. Only observational,
full-length, English language studies were investigated. PRISMA checklist was used as guideline for 
this review. PROSPERO registration code is CRD42019127178.  
3. Results
Among 3580 records screened, only 40 were included in this review. Meta-analysis was
performed on the included case-control studies and mean prevalence and pooled odds ratio were 
calculated. 
Among the included studies, the mean prevalence of geographic tongue was 11.80% in case 
group vs. 6.59% in control group (OR= 2.81, 95% CI 2.2–3.6); the mean prevalence of fissured tongue 
was 29.96% in case group vs. 13.90% in control group (OR = 2.93, 95% CI 2.5–3.5); the mean 
prevalence of periodontitis was 26.29% in case group vs. 11.48% in control group (OR = 3.5, 95% CI 
2.49–4.23); the mean prevalence of candidiasis was 6.67% in case group vs 1.04% in control group 
(OR = 3.17, 95% CI 1.8–5.7); the mean prevalence of Candida spp. was 45.81% in case group vs. 20.53% 
in control group (OR = 3.79, 95% CI 2.3–6.4); the mean prevalence of TMD was 40.67% in case group 
vs. 16.96% in control group (OR = 2.94, 95% CI 1.1–7.9). 
Due to dis-homogeneity across studies no quantitative analysis was performed on salivary 
biochemical composition. Nevertheless, psoriatic patients presented a lower mean concentration of 
salivary IgA, lysozyme and cortisol than controls, whereas IL-1  was higher.  
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4. Discussion
This systematic review revealed that geographic tongue, fissured tongue, periodontitis,
candidiasis and TMD are more frequent in psoriatic patients than general population. Moreover, 
psoriatic patients showed biochemical alterations in the saliva composition compared to healthy 
subjects. Future research should be conducted to rule out the mechanism underlying these 
associations and to investigate the behavior of oral manifestation in psoriatic patients in relation to 
their severity and treatment response. 
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Osteoradionecrosis (ORN) of the jaws is the most severe side effect, and in some case life-
threatening, of radiotherapy for head and neck cancer [1]. Tooth extractions during and after 
radiotherapy are the major risk factor of ORN onset, nevertheless the real ORN rate and its risk factors 
are still unclear. Recently, a systematic review [2] tried to better estimate the ORN rate following 
tooth extractions after RT, pointing out an overall rate of 7%, nevertheless the high number of 
variables involved in the onset of ORN makes the topic particularly complex and many information 
still lack to prevent the ORN onset after tooth extraction. The aim of this systematic review is to assess 
the incidence of ORN in those patients who underwent tooth extraction during and after 
radiotherapy for head and neck cancer and to identify any possible risk factors. 
PRISMA protocol was used to evaluate and present the results. PubMed, Scopus, and Web of 
Science were used as search engines: only English full-length papers of clinical trial and observational 
studies both prospective and retrospective, published in peer-reviewed journals, were investigated. 
Inclusion criteria were: minimum sample size 10 patients who underwent tooth extractions during 
and after radiotherapy; 6 months mean follow-up after tooth extraction; no previous ORN at 
extraction site; the ORN diagnosis criteria must be clearly defined in the text; must be specified if 
ORN developed at extraction site or not. Cumulative meta-analysis was performed calculating the 
pooled proportion (PP) of the rate of ORN occurrence. Meta-analysis was performed at random 
effects model with the Der-Simonian Liard method. All the statistical analyses were performed with 
the software Open Meta-Analyst version 10. PROSPERO registration code is CRD42018079986. 
Among 2020 records screened, only 9 were included in this review (Figure 1). Forty-one of 462 
patients who underwent tooth extraction during and after radiotherapy developed ORN at extraction 
site, with an ORN incidence of 5.8% (95% Confidence of Interval = 2.5–9.4, p < 0.001, I2 = 8322%).  
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Figure 1. PRISMA flow-chart of the inclusion process. 
This systematic review confirmed dental extraction after radiotherapy as the main risk factor of 
ORN and its incidence ranges between 6% and 11% (Figure 2). The considerable amount of missing 
data didn’t allow us to identify other possible risk factors for ORN onset.  
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Figure 2. Pooled data and box plot stratifying for pathological criteria. 
Although the most recently performed studies highlight a considerable decreasing of ORN 
incidence, the results confirm the recommendation to perform a dental evaluation and to remove oral 
foci before the beginning of radiotherapy.  
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1. Nadella, K.; Kodali, R.; Guttikonda, L.; Jonnalagadda, A. Osteoradionecrosis of the Jaws: Clinico-
Therapeutic Management: A Literature Review and Update. J. Maxillofac. Oral Surg. 2015, 14, 891–901.
2. Nabil, S.; Samman, N. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated
patients: A systematic review. Int. J. Oral Maxillofac. Surg. 2011, 40, 229–243.
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
Studies
























Proceedings 2019, 35, 27; doi:10.3390/proceedings2019035027 www.mdpi.com/journal/proceedings
Extended Abstract 
Clinical Validation of 13-Gene DNA Methylation 
Analysis from Oral Brushing: A Non Invasive 
Sampling Procedure for Early Detection of Oral 
Squamous Cell Carcinoma. A Multicentric Study † 
Davide B. Gissi 1,*, Umberto Romeo 2, Gianluca Tenore 2, Monica Pentenero 3,  
Giuseppina Campisi 4, Rodolfo Mauceri 4, Giuseppe Colella 5, Roberto De Luca 5, Rosario Serpico 6, 
Dario Di Stasio 6, Giacomo Oteri 7, Paolo Vescovi 8, Michele D. Mignogna 9, Noemi Coppola 9, 
Andrea Santarelli 10, Luca Morandi 11 and Lucio Montebugnoli 1 
1 Department of Biomedical and Neuromotor Sciences, Section of Oral Sciences, University of Bologna, 
40159 Bologna, Italy; lucio.montebugnoli@unibo.it 
2 Department of Oral and Maxillofacial Sciences, “Sapienza” University of Rome, 00100 Rome, Italy; 
umberto.romeo@uniroma1.it (U.R.); gianluca.tenore@uniroma1.it (G.T.) 
3 Oral Medicine and Oral Oncology Unit, Department of Oncology, University of Turin, 10043 Orbassano, 
Italy; monica.pentenero@unito.it 
4 Department of Surgical, Oncological and Stomatological Disciplines, Sector of Oral Medicine, University of 
Palermo, 90127 Palermo, Italy; giuseppina.campisi@unipa.it (G.C.); rodolfo.mauceri@unipa.it (R.M.) 
5 Multidisciplinary department of Medical, Surgical and Dental Specialty, Maxillofacial Surgery Unit, 
University of Campania “Luigi Vanvitelli”, 80100 Naples, Italy; giuseppe.colella@unicampania.it (G.C.); 
robertodeluca89@yahoo.it (R.D.L.) 
6 Multidisciplinary Department of Medical-Surgical and Dental Specialties, University of Campania “Luigi 
Vanvitelli”, 80100 Naples, Italy; rosario.serpico@unicampania.it (R.S.); 
dario.distasio@unicampania.it (D.D.S.) 
7 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 
University Hospital “Gaetano Martino”, 98124 Messina, Italy; oterig@unime.it 
8 Department of Medicine and Surgery, Oral Medicine and Laser Surgery Unit, University of Parma, 
43100 Parma, Italy; paolo.vescovi@unipr.it 
9 Head & Neck Clinical Section, Department of Neuroscience, Reproductive and Odontostomatological 
Sciences, Federico II University of Naples, 80138 Naples, Italy; mignogna@unina.it (M.D.M.); 
noemi.coppola91@gmail.com (N.C.) 
10 Department of Clinical Sciences and Stomatology, Marche Polytechnic University, 60121 Ancona, Italy; 
andrea.santarelli@staff.unipvm.it 
11 Department of Biomedical and Neuromotor Sciences, Functional MR Unit, IRCCS Istituto delle Scienze 
Neurologiche di Bologna, University of Bologna, 40139 Bologna, Italy; luca.morandi2@unibo.it 
* Correspondence: davide.gissi@unibo.it; Tel.: +39-0512088123
† Presented at the XV National and III International Congress of the Italian Society of Oral Pathology and
Medicine (SIPMO), Bari, Italy, 17–19 October 2019. 
Published: 11 December 2019 
1. Introduction
In a recent study our research group described a non-invasive sampling procedure based on
DNA methylation analysis of a set of 13 genes with a high level of accuracy (sensitivity 96.6%, 
specificity 100%) in the detection of squamous cell carcinoma of the oral cavity (OSCC) [1]. 
The purpose of the present study was to test the diagnostic performance of this non invasive 
sampling procedure in an italian multicentric study. 
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2. Materials and Methods
Oral brushing specimens were collected in ten different italian units of oral medicine. Each oral
medicine unit collected blindly 10 brushing specimens from patients affected by OSCC and an equal 
number of age and sex-matched healthy controls. 13-gene DNA methylation analysis was performed 
and each sample was considered positive or negative in relation to a predefined cut-off value. 
3. Results
181 out of 200 planned specimens were analyzed. DNA could not be amplified in 4 cases (2.2%). 
86/93 (92.5%) specimens derived from OSCC patients were detected as positive and 70/84 (83.3%) 
specimens derived from healthy donors showed a negative score. 
4. Conclusions
Data from multicentric study confirmed a high level of sensitivity of our procedure whereas
level of specificity is slightly lower if compared to our previous study. These data suggest that our 
procedure may be proposed as a first level diagnostic test with the aim to avoid a diagnostic delay in 
Oral Squamous Cell Carcinoma. 
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Oral Squamous Cell Carcinoma (OSCC) shows an early tendency to lymphatic spread rather 
than hematogenous. The surgical treatment cannot be considered oncologically complete if the neck 
is not evaluated [1]. According to TNM staging system, the management of early stage (T1/2) or 
clinically node-negative, is still controversial (Figure 1). Several studies have shown that tumour 
thickness and depth can be considered the most important prognostic factors; Depth of Invasion 
(DOI) means the cancer growth extension into the tissue while thickness concerns the entire mass [1]. 
The exact depth cut-off has not yet been well defined. A preoperative investigation of tumour 
thickness and DOI would provide useful informations for targeting those patients who need neck 
treatment. To measure these factors are available Magnetic Resonance Imaging (MRI), Computed 
Tomography (CT) and Ultrasonography (US) [2]. The limitation of MRI and CT is that within a 
thickness less than 5 mm, it could be difficult to differentiate the tumour from the surrounding 
tissues. With the introduction of intraoral probes, US allows the direct evaluation of tumour and also 
it has advantages like harmless, radiation free, easy-to-use, non-invasive, unaffected by metal 
artefacts. 
Figure 1. T1 tongue tumour. 
The aim of this study was to compare tumour DOI by US with histological sections and to insert 
the US in the OSCC diagnostic flow-chart [1,2]. 
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Twelve patients with histological diagnosis of OSCC T1 were undergone to ultrasound using an 
E-CUBE 15 EX scanner (Alpinion, Seoul, Korea) with a 8–17 MHz intraoral transducer like a
toothbrush (Figure 2). For each patient has been performed an intra-operative and post-operative
histological examination to establish tumour depth. Statistical analysis was made with SPSS 24 software
(IBM, New York, NY, USA).
Figure 2. DOI (A), thickness (B), diameter (C). 
By considering the presence of tumour infiltration, 90% sensitivity was found for intraoral 
ultrasound in comparison to histological evaluation. 9 true-positive, 2 false-positive and 1 
false-negative occurred in our patients. 
Using the Fisher Test, it was found that there was not a statistically difference between 
ultrasound DOI and histological DOI (chi-square = 0.218; p = 1000) Table 1. 
Table 1. Comparison between ultrasound and hystological DOI. 
Infiltration 
Total 
Infiltrating Not INFILTRATING 
Method 
Ultrasound 11 1 12 
Hystologic 10 2 12 
Total 23 1 24 
Although larger samples are needed, these preliminary results show that US is accurate to 
assess DOI level and it represents an useful and cost-effective device in the OSCC management [1,2]. 
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In the last years, the classification of odontogenic cysts and tumors has been highly debated, 
especially regarding odontogenic keratocyst (OKC). Indeed OKC, previously defined as keratocistic 
odontogenic tumor, has been re-introduced into the cyst group due to the lack of sufficient evidence 
to justify its classification as a neoplasm [1,2]. OKC is characterized by a thin keratinizing stratified 
squamous epithelial lining and a non-inflammatory fibrous connective wall. OKC may occur in 
association with the nevoid basal cell carcinoma syndrome (NBCCS), characterized by an autosomal 
dominant gene mutation with variable and usually high penetrance and expressivity. 
Due to the almost restricted expression of p63 in epithelial cells, its role in the regulation of 
proliferation and differentiation of craniofacial-structure, this study investigated immunohistochemical 
expression of p63 both in solitary OKC and NBCCS-related OKC. 
10 solitary OKC as well as 5 NBCCS-related OKC were analysed by immunohistochemistry for 
expression of p63. 4- m serial sections were incubated with the monoclonal anti-p63 antibody (clone 
4A4, Dako Cytomation, Glostrup, Denmark) diluted 1:50. 
A semi-quantitative assessment of p63 expression was performed: “ ” (stained cells: 0–5%); “+” 
(stained cells: 6–30%); “++” (stained cells: 31–50%); “+++” (stained cells: >50%). Staining intensity was 
graded on a scale of a semi-quantitative scale: 0 (no detectable); 1 + (weak); 2 + (moderate); 3 + (strong); 
4 + (very strong). 
In NBCCS-related OKC 2 cases showed negligible p63 expression (0–5%), 2 cases showed a 
percentage of stained cells of 6–30%, and 1 case demonstrated a significant expression (31–50%). In 
all solitary OKC, the number stained cells were comprised between 0 and 5%. Regarding staining 
intensity, in NBCCS-related OKC the nuclear staining of p63 was intense (3+) in all epithelial layers. 
On the contrary, in solitary OKC, the intensity of staining of p63 was moderate (2+) and reported only 
in basal-parabasal layer. 
In conclusion, these data suggest that that p63 diffuse and intense immunostaining could be 
useful to distinguish solitary OKC from NBCCS-related OKC. 
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Sjoegren’s syndrome (SS) is a chronic autoimmune disease characterized by sicca syndrome and 
systemic manifestations [1]. IFN -inducible protein-16 (IFI16) is a viral DNA sensor involved in 
infections and autoimmune diseases. In SS patients, IFI16 and anti-IFI16 antibodies can be detected 
in serum and salivary glands [2]. However, to date none of these findings were correlated with SS 
severity and disease activity. 
IFI16 and anti-IFI16 in serum, minor salivary glands and saliva were evaluated together with 
clinical characteristics and EULAR SS disease activity index (ESSDAI) of SS patients. 
Serum and tissue samples were analyzed as previously described [2], salivary anti-IFI16 IgG/IgA 
detection via ELISA based on horseradish peroxidase–conjugated rabbit anti-human IgG/IgA. 
Table 1 describes patient characteristics. Patient (a), with moderate systemic SS (Figure 1a), 
showed increased IFI16 expression in inflammatory and epithelial cells not only in nuclei, but also in 
the cytosol, very high serum IFI16 (472 ng/mL), and serum anti-IFI16 IgG (116 U/mL). Patient (b), 
with localized SS (Figure 1b), showed moderately increased nuclear expression of IFI16 both in 
inflammatory and epithelial cells and no serum IFI16/anti-IFI16 IgG. In patient (c), with mild systemic 
SS (Figure 1c), we observed poor inflammatory infiltrate, although salivary anti-IFI16 IgA (10 U/mL) 
and serum anti-IFI16 IgG (147 U/mL) were found. 
In saliva, IFI16 was not detected by Western blot. Recombinant IFI16 incubated at 37 °C was 
markedly degraded after 1h and completely degraded after 6 h in controls; completely degraded after 
1h in patient (a), and more slowly degraded in patients (b) and (c). 
Our results suggest that the expression and localization of IFI16 and anti-IFI16 may vary based 
on disease severity and activity of SS. Further experiments in a larger cohort of patients will allow us 
to better define the diagnostic and prognostic value of these biomarkers. 
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Table 1. Characteristics of patients. 
Parameter Patient (a) Patient (b) Patient (c) 
ESSDAI 12 0 3
RF + - - 
Anti-SSA/Ro +++ ++ +
Anti-IFI16 IgG U/mL Serum 116 (+) 102 (-) 147 (+) 
IFI16 ng/mL Serum 472 (++) 0.00 (-) 0.00 (-) 
Anti-IFI16 IgA U/mL Saliva 4.7 (-) 5.4 (-) 10 (+) 
Hypocomplementemia + - +
Hypergammaglobulinemia + - +
EULAR Sjoegren Syndrome Disease Activity Index, IFI16 IFN -inducible protein 16, RF rheumatoid 
factor, – negative, + positive, ++ high titre positivity, +++ very high titre positivity. 
Figure 1. Immunohistochemistry for IFI16 expression in minor salivary glands in three patients. IFI16 
staining is shown in brown and hematoxylin staining to highlight nuclei is in blue. (a) moderate 
systemic disease, (b) localized disease, (c) mild systemic disease. 
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Odontogenic cysts (OC) are one of the most frequent lesions affecting the jaws. These lesions are 
characterized by a pathologic cavity, either completely or partially covered by an epithelial tissue of 
odontogenic origin. OCs share similar features; therefore, the differential diagnosis requires a 
combination of clinical, radiological, and histological findings [1]. This study aims to perform an 
epidemiologic analysis of OCs treated from 1990 to 2019 at the “Ospedali Riuniti” General Hospital, 
Ancona, Italy, according to 4th Edition of WHO Classification of Head and Neck Tumours. 
The present study considered all the patients who underwent surgery for jaw cysts from January 
1990 to August 2019. Data were retrieved and catalogued from clinical records and from the archive 
of the Institute of Pathology, Marche Polytechnic University, Italy. Because of the 30-year period 
considered, histological slides of OCs were re-evaluated to confirm the diagnosis, according to the 
current WHO criteria [2]. From each case, they were extrapolated the following information: age, sex, 
diagnosis, site distribution, and relapses. 
Overall, 1942 patients were treated for jaw cysts, corresponding to 1862 patients with OC, of 
which 98 showing multiple OCs at the time of diagnosis, and 80 patients with nonodontogenic cysts 
(NOC). Furthermore, 50 patients showed at least one OC recurrence during follow-up. 
2126 surgical specimens were retrieved, corresponding to 2046 OCs and 80 NOCs. 50 patients 
developed 69 recurrences, mainly Odontogenic keratocysts (OKC). Mean age of occurrence for 
primary OC was 46.9 ± 17.1 years, with a higher frequency in males (M:F ratio of 1.79). Regarding 
localization, posterior mandibular and anterior maxillary regions were the most commonly affected 
sites (Mandible:Maxilla ratio of 1.42). Mean size of primary OC was 1.9 ± 1.0 cm (Table 1). 
Radicular cysts were the most frequently diagnosed, with 815 cases (39.83%), followed by 
Dentigerous cysts (21.51%), and OKC (13.54%) (Figure 1). All other OCs showed a very low 
frequency, reaching a total of 83 cases (4.06%) (Figure 2). Noteworthy, in 431 cases the 
clinicopathological data were insufficient to establish a certain diagnosis (21.07%). 
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Table 1. Demographic and clinical data of OCs (1990–2019). 








- Not specified 697 
Sex (n° of Patients) 
- Males 1194
- Females 668
Age (years) 46.9 ± 17.1 
Size (cm) 1.9 ± 1.0 
Figure 1. Annual frequency of diagnosed OCs in “Ospedali Riuniti” General Hospital, Ancona, Italy 
(red line). Radicular cysts (RC, orange line) were the most frequently diagnosed, followed by 
Dentigerous cysts (DC, blue line) and Odontogenic keratocysts (OKC, green line). 
Figure 2. Relative frequency of diagnosed OCs according to 3rd and 4th Edition of WHO 
Classification, respectively. In 2017 there was a significative simplification of OC classification; the 
most important changes regard the reintroduction of Odontogenic keratocyst (OKC) and Calcifying 
Odontogenic cyst (COC). DC = Dentigerous cyst; EC = Eruptive cyst; RC = Radicular cyst; ReC = 
Residual cyst; IPC = Inflammatory paradental cyst; ICC = Inflammatory collateral cyst; GCI = Gingival 
cyst of infant; GCA = Gingival cyst of adult; GC = Gingival cyst; GOC = Glandular odontogenic cyst; 
LPC = Lateral periodontal cyst; OOC = Orthokeratinized odontogenic cyst. 
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Although limited in its retrospective nature, these findings could be useful to determine the 
incidence and prevalence of OCs. Prevalence studies related to OCs should be conducted in each 
tertiary referral center, in order to improve current epidemiological data. 
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1. Introduction
Patients treated for Oral Squamous Cell Carcinoma (OSCC) showed a significant risk to
develop a loco-regional relapse during follow-up period. In clinical practice the follow-up strategy 
for early detection of recurrence or second primary tumors still consists of periodic visual 
examination and palpation of the oral cavity during the 5-year aftercare period. 
Our research group recently developed a non-invasive procedure to identify oral carcinomas at 
early stage starting from oral brushing, quantitatively measuring the DNA methylation level of a 
panel of 13 genes [1]. 
The procedure resulted highly related to the presence of a malignant process (sensitivity 96.6%, 
specificity 100%). This high accuracy stimulated us to apply our non-invasive diagnostic tool in a 
cohort of patients previously treated for Oral Squamous Cell Carcinoma. Aim of the study is to 
evaluate if 13-gene DNA methylation analysis by oral brushing may be a useful procedure to 
identify patients surgically treated for OSCC at risk of developing a secondary tumor. 
2. Materials and Methods
The study population included 49 consecutive surgically treated OSCC. Oral brushing sample
collection was performed during patient follow up almost 6 months after OSCC treatment, within 
the regenerative area after OSCC resection. In all brushing specimens the DNA methylation level of 
ZAP70, GP1BB, KIF1A, ITGA4, LINC00599, MIR193, MIR296, TERT, LRRTM1, NTM, EPHX3, FLI1 
and PARP15 was evaluated by quantitative Bisulfite-Next Generation Sequencing (NGS). Each 
sample was defined positive or negative in relationship to a specific algorithm and cut-off value [1]. 
Positive scores in the regenerative area after OSCC resection were analyzed together with other 
histologic poor prognostic factors for any relationship with appearance of loco-regional relapse. 
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3. Results
16/49 brushing specimens collected 6 months after surgery from regenerative area after OSCC
showed a positive score. 
During follow up period 7/49 (14.3%) patients developed a secondary OSCC during follow-up 
period (mean follow-up: 18.9 months): 6/7 patients showed positive samples from regenerative 
areas. The presence of a positive score resulted the most powerful variable related to the appearance 
of locoregional relapse, greater than presence of perineural invasion detected in the surgical OSCC 
sample. 
4. Conclusions
These preliminary results seem to indicate that our novel assay may be proposed as an indicator
of disease before appearance of clinical signs and symptoms in surgically treated OSCC patients. 
Further studies with larger cohort of patients, with adequate follow-up period and brushing 
sampling collection at different moments are needed to elucidate the prognostic potential of our 
assay. 
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Head and neck cancers represent the sixth most common cancer group in humans [1]. Amongst 
these, head and neck squamous cell carcinoma (HNSCC) is the most frequent. In Europe the 5-year 
survival rate for HNSCC ranges from 25% to 60%, depending on primary tumor site and stage. The 
objective of a number of ongoing studies is to explore innovative techniques that allow early and 
reliable diagnosis and at the same time offer the possibility to monitor the evolution of the pathology. 
The aim of this narrative review is to evaluate the role of biochemical molecular markers (liquid 
biopsy), such as DNA and RNA, in the diagnosis, prognostic outcome and treatment-monitoring in 
patients affected by HNSCC. 
A selection of articles published until September 2019 on Pubmed formed the basis of the 
narrative review. The following inclusion and exclusion criteria were set: studies on human blood, 
plasma or serum evaluating DNA and RNA expression in patients with HNSCC compared to healthy 
controls (a minimum of 20 samples for each group needed); studies not including patients affected 
by Oral Squamous Cell Carcinoma (OSCC) were excluded. Amongst a total of 133 studies found, 8 
met inclusion criteria (Figure 1). 
Figure 1. Flow-chart of the selection process for studies included in the narrative review. 
Amongst all analysed studies, only one did not find a significant difference in the concentration 
of the circulating markers between the test group and the control group. Four studies evaluated the 
concentration of the circulating biochemical markers for the purpose of the diagnosis; one study for 
the prognostic outcome; one study for both diagnosis and treatment monitoring; two studies 
evaluated all three outcomes (Table 1). 
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Although liquid biopsy is an effective tool used by clinicians to approach other cancer types, 
such as Small Cell Lung Carcinoma (SCLC), its effectiveness with respect to HNSCC has to be 
investigated to a deeper extent. The biopsy therefore remains the gold standard in the diagnostic 
process of these cancers. However, liquid biopsy offers an advantage in the monitoring process of 
treated patients as it is less invasive when compared to Computed Tomography (CT) and Positron 
Emission Tomography (PET). 
In the near future, biochemical molecular markers may lead the way to customized-patient 
therapy. 
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1. Introduction
Perineural invasion (PNI) represents cancer propension to spread through neuronal pathways
and hinders the ability to establish a surgical local control of Oral Squamous Cell Carcinoma (OSCC). 
Histologic evidence of PNI is a recognized poor prognostic factor related with an high risk of loco-
regional recurrence and/or presence of an occult lymphnode metastasis. 
Unfortunately, PNI can be evaluated only in surgical specimens of OSCC and not in 
preoperative incisional biopsies, rendering timely therapeutic planning impossible. 
Identification of a pre-operative reliable molecular marker related with presence of PNI may 
represent an attractive strategy. In this sense, recent studies showed that podoplanin is overexpressed 
in aggressive tumors and is associated with cervical lymphatic dissemination and poor survival in 
OSCC [1]. 
The aim of this study is to evaluate the relationship between Podoplanin altered expression in 
pre-operative incisional biopsy and presence of PNI in surgical OSCC sample and their prognostic 
role. 
2. Materials and Methods
The cohort of this study consisted of 85 consecutive OSCC patients (average follow-up: 21.46
months). In all cases a pre-operative incisional biopsy for histological assessment and 
immunohistochemical analysis of Popoplanin was performed. PNI evidence was histologically 
investigated in all samples after surgical exeresis of OSCC. 
3. Results
During follow-up period, 27/85 (31.7%) OSCC patients developed a second neoplastic event and 
15/85 (17.7%) patients died due to malignancy. 
75
Proceedings 2019, 35, 34 
32/85 (37.7%) OSCC surgical samples showed presence of PNI in surgical sample. In the 
population study PNI resulted the only independent clinico-pathological variable significantly 
related with appearance of a loco-regional recurrence and with disease-specific survival. 
Podoplanin overexpression was found in 44/85 (51.7%) in pre-operative incisional biopsies. 
Multiple Logistic Regression showed that Podoplanin overexpression in incisional biopsy 
samples is the only pre-operative variable significantly related to presence of PNI, indeed an altered 
expression of podoplanin was found in 30/32 PNI positive OSCCs with respect to 14/53 PNI negative 
OSCCs. 
4. Conclusions
The present study confirmed and highlighted the prognostic role of PNI in OSCC patients and
for the first time demonstrated that a positive expression of Podoplanin in pre-operative biopsy is 
significantly related with PNI status. Indeed, podoplanin showed high sensitivity and good 
performances as negative predictive marker for PNI presence and may be helpful for an accurate 
preoperative risk stratification of patients with OSCC. 
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High-dose radiotherapy (RT) for head and neck cancer has significant adverse effects on 
maxillofacial tissues, among which osteoradionecrosis (ORN) is the most severe and potentially life-
threatening. Although tooth extractions seem to be the main risk factor, few perspective studies 
evaluated protocols to minimize the ORN risk due to extractions [1]. The aim of this study is to 
evaluate incidence and risk factors of ORN in a cohort of patients receiving tooth extractions before 
RT and evaluate an algorithm about extraction decision. 
One-hundred and twenty-eight patients were recruited in this study: impacted third molars with 
radiographic sign of pericoronitis, teeth with periapical lesions, unrestorable teeth, periodontally 
compromised teeth (pocket probing depth > 5 mm, clinical attachment loss > 8 mm, grade 2 tooth 
mobility, II grade furcation involvement) were extracted under antibiotic prophylaxis. 
A 15-days interval between the last tooth extraction and the beginning of RT was recommended. 
Patients were visited at 15 days, 1, 3 and 6 months after the beginning of RT. Data of patients with a 
minimum of 6 months follow-up are presented in this report. 
ORN was defined as irradiated exposed necrotic bone, without healing for 3 months, in absence 
of cancer recurrence, and staged according to Notani et al. [2]. RT treatment plan were reviewed, and 
each post-extractive socket was contoured with the software Eclipse Treatment Planning System 
(Varian Medical System). The dose received by each socket was finally calculated. The protocol was 
approved by the Ethic Committee of Catholic University–Fondazione Policlinico Gemelli (Prot. 
OHHN-1, ID-2132). 
Out of 128 patients, 64 had a 6 months follow-up, 41 of whom received at least one tooth 
extraction, for a total of 183 teeth. Twenty-one days was the mean time interval before the beginning 
of RT. Three sites in 3 different patients (7.3% of patients) developed ORN, all in the posterior 
mandible and two of them also received chemotherapy. 
Tooth extraction has been recognized as a risk factor for the development of ORN, especially in 
the posterior mandible. In the preliminary results of our study, 3 ORN happened and the major risk 
factor was the anatomical site. These results are consistent with the current literature, suggesting that 
the proposed protocol can be a valid support in the decision-making process. Since ORN can be a late 
onset complication of RT, a longer follow-up must be performed to draw definitive conclusions. 
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Osteoradionecrosis (ORN) of the jaws is the most severe side effect, in some case life-threatening, 
of radiotherapy for head and neck cancer [1]. Tooth extractions before radiotherapy seems to lead to 
a reduction of ORN onset, nevertheless the real ORN rate and its risk factors are still unclear [2]. The 
aim of this systematic review is to determine the rate of ORN due to tooth extraction before the 
beginning of RT in patients affected by head and neck cancer and to identify any possible risk factor 
for ORN onset. 
PRISMA protocol was used to evaluate and present the results. PubMed, Scopus, and Web of 
Science were used as search engines: only English full-length papers of clinical trial and observational 
studies both prospective and retrospective, published in peer-reviewed journals, were investigated. 
Inclusion criteria: minimum sample size 10 patients who underwent extraction before radiotherapy 
in head and neck district; minimum 6 months of follow-up after RT; ORN diagnosis criteria clearly 
defined in the text; specified if ORN developed at extraction site or not. Cumulative meta-analysis 
was performed calculating the pooled proportion (PP) of ORN occurrence rate. Meta-analysis was 
performed at random effects model with the Der-Simonian Liard method. All the statistical analyses 
were performed with the software Open Meta-Analyst version 10. PROSPERO registration code is 
CRD42018079986. 
Among 2020 records screened, only 8 were included in this review (Figure 1). Sixteen of 494 
patients who underwent tooth extraction before radiotherapy developed ORN at extraction site, with 
an ORN incidence of 2.2% (95% Confidence of Interval = 0.8—3.9, p < 0.204, I2 = 2695%) (Figure 2). All 
cases of ORN due to pre-RT dental extraction were reported in mandible. 
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Figure 1. PRISMA flow-chart of the inclusion process. 
Figure 2. Pooled data and box plot stratified for studies. 
The considerable amount of missing data didn’t allow us to identify other possible risk factor 
for ORN onset (i.e., surgical protocol, time interval between the extraction and the beginning of 
radiotherapy, dose). Major efforts should be done to perform sounder methodological clinical 
investigations. It is general recommendation that patients should undergo a dental examination and 
oral foci should be removed before the beginning of radiotherapy for head and neck cancer, in order 
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to reduce the risk of occurrence of undesirable effects. Although tooth extraction prior to 
radiotherapy leads to a reduction of ORN incidence, this systematic review shows that ORN risk is 
still high and special attention should be posed to extraction site. 
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1. Introduction
The aim of this study was to investigate the prognostic role of methylation profile of 13 genes
starting from oral brushing collected in a group of patients affected by oral squamous cell carcinoma 
(OSCC). To this purpose, we analyzed the relationship between the methylation profile of each gene 
and the appearance of a loco-regional relapse in a study sample of OSCC patients. We also 
calculated a unique prognostic score with the aim to predict survival of OSCC patients. 
2. Materials and Methods
The study sample included 37 consecutive OSCC patients with a median follow-up period of 22 
months (range 1–59). 
Brushing cell collection was performed prior to any cancer treatment in the tumor mass. Two 
hundred forty-five CpG islands from a set of 13 previously described methylated genes in OSCC 
(ZAP70, KIF1A, LRRTM1, PARP15, FLI1, NTM, LINC0059, EPHX3, ITGA4, MIR193, GP1BB, 
MIR296, TERT) [1] were investigated by bisulfite-Target Next Generation Sequencing (NGS) using 
MiSEQ platform (Illumina, San Diego, CA, USA). 
Univariable Cox proportional hazards models were used to analyze the association between 
each of the CpG sites and survival. Then, a Cox proportional hazards lasso model was used to select 
the prognostic markers of the candidate CpG sites. Lastly, a cross-validated prognostic score was 
computed for each patient, based on individual values of methylation and non-zero regression 
coefficients. Kaplan-Meier estimates were calculated to compare the survivor functions of the two 
groups (High-risk of relapse group and low-risk of relapse group). Statistical significance of the 
log-rank test was set at 0.05. 
3. Results
Nine out of 37 (24%) OSCC patients developed a secondary neoplastic manifestation during the 
follow-up period. Cox proportional hazards lasso model selected 5 CpG sites significantly related 
with appearance of a second neoplastic event (ZAP70-position1, FLI1-position3, FLI1-position4, 
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ITGA4-position4 and MIR193-position3). A prognostic score for each patient was calculated, and 
OSCC patients were divided based on risk of relapse (high and low risk): 8/18 high-risk group 
patients developed a local relapse with respect to 1/19 low-risk group patients, this difference being 
statistically significant (p < 0.001). 
4. Conclusions
Our study showed that a prognostic score based on DNA methylation analysis might be a
useful indicator in surgical decision making, even if a larger cohort of patients is necessary to 
confirm these preliminary data. 
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TIMELESS is one of the main circadian genes. Different roles are described, such as replication 
fork stability, cell survival after DNA damage or replication stress by promoting DNA repair. 
TIMELESS deficiency increases genomic instability and its reduction increases Rad51 and Rad52 foci 
formation during S phase [1]. TIMELESS and PARP1 operate in a complex to mediate DNA repair. It 
is also showed that alteration in circadian rhythm is associated with cancer development and tumor 
progression, such as chronic myeloid leukemia, hepatocellular carcinoma, and breast cancer [2]. We 
wanted to summarize the role of TIMELESS in head and neck squamous cell carcinoma. To do so, we 
performed a literature review using these keywords: TIMELESS [All Fields] AND (“neoplasms” 
[MeSH Terms] OR “neoplasms” [All Fields] OR “cancer” [All Fields]). We found 54 studies. At the 
end of the selection process, 4 studies were considered suitable for the analysis of TIMELESS in 
HNSCC. In Ao et al. TIMELESS resulted downregulated in a HNSCC cell line. In Bjarnason’s study 
[3] through TS Enzyme Activity confirmed its downregulation in biopsy model. Hsu in 2011 [4] used
real-time quantitative RTN-PCR on 40 tissue samples with HNSCC to clarify whether the expression
levels of circadian clock genes were altered in tumor tissues. Data demonstrated that the expression
levels of PER1, PER2, PER3, CRY2, and BMAL were significantly downregulated in HNSCC (p < 0.01)
(Figure 1), showing its dysregulation in cancer. TIMELESS seems to play an important role in cancer
and further investigations are needed to investigate its role as prognostic marker or pharmaceutical
target.
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Figure 1. Tumor conditions and circadian clock gene expression in HNSCC patients. Tumor size (A), 
tumor invasion (B), survival (C) and age (D) of the 40 HNSCC patients were correlated to the 
expression of the nine circadian clock genes. The y axis represent the relative mRNA expression level. 
The relative expression in cancerous tissues is calculated by Ct. The expression in tumor size < 3 
cm (A), tumor invasion < 1 cm (B) and survival (C) is designated 1, and the relative expression in 
tumor size > 3 cm (A), tumor invasion >1 cm (B), and expire (C) is calibrated to obtain the folds 
changed, respectively Statistical significance * p < 0.05 evaluated with t test. 
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Primary Sjögren Syndrome (pSS) is a multisystem autoimmune disease which mainly involves 
exocrine glands, such as salivary and lacrimal. Pathogenesis is not completely understood even if is 
distinguished by lymphocyte glands tissue infiltration, which leads to anatomical modification and 
hypofunction. Age at diagnosis is typically between 3rd and 5th decade. European incidence per year 
is 3 to 11 cases on 100.000 subjects, with a female-male ratio of 10:1 and a 0.01% e 0.72% prevalence. 
Diagnostic criteria are resumed in the 2016 ACR/EULAR Consensus of Classification Criteria 
for pSS, and are based on the sum of weighted scores applied to 5 items: anti-SSA/Ro antibody 
positivity, focus score of 1 foci/4 mm2, abnormal ocular staining, a Schirmer’s test result of 5 mm/5 
min and an unstimulated salivary flow rate (SFR) of 0.1 mL/minute. The prognosis of pSS is 
favorable with a patient’s life expectancy comparable with general population. Quality of life is 
reduced by the diverse manifestations of the disease. Cardiovascular disease, infections, solid 
tumors, and lymphoma are the main causes of death [1]. 
The aim of this pilot study is to compare the salivary metabolome of pSS and healthy controls 
(HC). Cases were selected from a cohort of pSS patients; age and sex matched HC were recruited 
from a cohort of volunteers. Strict inclusion and exclusion criteria were applied, in order to select the 
most homogeneous study population. To all recruited patients was asked to not eat, drink, smoke 
and use oral hygiene products one hour before saliva collecting. Whole unstimulated saliva was 
collected into a sterile Eppendorf. SFR was contextually evaluated. All samples were immediately 
frozen into liquid nitrogen and stored into 80 °C refrigerator until analysis. 
7 pSS and 6 HC female patients were recruited. All samples were centrifuged at 15,000 rpm/10 
min, 4 °C. 100 μL of buffer were added to 500 μL of supernatant; the solution was inserted in the 
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NMR tube of a Bruker Avance III HD 600 MHz spectrometer for the 1H-NMR analysis. 
Mono-dimensional and bi-dimensional measurements were performed using different pulse 
sequences such as Carr-Purcell-Meiboom-Gill (cpmg) and different correlation sequence such as 
COrrelation SpectroscopY (COSY) and Heteronuclear Single Quantum Coherence (HSQC) (Figure 1). 
Software aided data analysis were performed. 
33 metabolites were detected. An high metabolite variability was observed. Normalized 
spectral matrix multivariate statistical analysis (PCA and PLS-DA) returned interesting results, 
describing significant differences of metabolites expressions between groups (Figure 1). 
Figure 1. Partial Least Squares Discriminant Analysis (PLS-DA). Chemo-metric differences between 
groups emerged (SS vs. HC); algorithm supervised analysis showed separation of variables’ clusters 
(metabolites). 
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1. Introduction
Patients undergoing in fixed orthodontic treatment could have higher risk in periodontal/gum
disease development, such as gingival hypertrophies. Different types of therapies have been 
proposed for the treatment of this condition, such as traditional surgery, laser therapy and the use of 
chlorhexidine mouthwashes [1–3]. The aim of this pilot study is to evaluate the use of a topical 
probiotic with Lactobacillus Reuteri in the treatment of patients with gingival hypertrophy in 
orthodontic therapy. 
2. Materials and Methods
For this study, 14 patients (10 females and 4 males) with gingival hypertrophy of the incisal
group in fixed orthodontic therapy, were considered (Figure 1). Topical probiotics with Lactobacillus 
reuteri DSM 17,938 and ATCC PTA 5289 were used to treat gingival hyperplasia. At the first session 
periodontal clinical parameters were recordered (T0) and after debridement, topical application were 
made. The probiotic gel is made by powdered tablets in a 1% Gel Carbopol; The gel was injected into 
the pockets until the spill, for 3–5 min the patient did not rinse the mouth and was advised not to eat 
and drink for about an hour. Systemic probiotics of Lactobacillus Reuteri taken at home 2 times a day 
were prescribed. After 1-month periodontal clinical parameters were re-evaluated (T1). 
Figure 1. 19 years old male patient before and after treatment. 
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3. Results
The mean age of the patient was 14.8 years old. All patients showed a complete regression of
gingival hypertrophies (Figure 2) at one month of follow up (100%). The mean value of plaque index 
(PI) before therapy was 69.71%, while at one month it was 18.57%.  
The average value of the bleeding index (BoP) was 37.85% while at one month after treatment it 
was 2.35%. 
Figure 2. 14 years old female patient before and after the treatment. 
4. Discussion and Conclusions
All gingival lesions regressed after treatment, while PI was reduced by more than 3.5 times. The 
average BoP values are reduced so as to be negligible. A previous study has tested the use of two 
mouthwashes for the treatment of this condition, but the authors concluded that “none of these 
principals, although the gingival condition improved, could reduce gingival enlargement to the 
clinically acceptable level of health [1]”. Other works suggest a surgical removal, with or without 
laser of the excess gum tissue [2,3]. No other works in the literature has used topical probiotics for 
the treatment of gingival hypertrophies in orthodontic patients, which from our observation proved 
to be effective and safe because they had no side effects. Studies with a larger sample and with greater 
follow-up are necessary to confirm these preliminary results. 
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Adenoid cystic carcinoma (ACC) is a basaloid tumour consisting of epithelial and myoepithelial 
cells in variable morphologic configurations, including tubular, cribriform and solid patterns. ACC 
accounts for 1% of head and neck cancers and 10% of salivary gland neoplasms. It is characterized by 
invasive growth, perineural infiltration, early local recurrence and late onset distant metastasis. 
Radical surgical excision, with or without postoperative radiotherapy, is the treatment of choice. 5-
year survival rate is approximately 35% and local recurrences occur despite combined treatment [1]. 
Thus, novel therapies are urgently needed to supplement the treatment currently available. The study 
of the molecular mechanisms involved in the neoplasm development is necessary to identify new 
prognostic markers. 
This study investigated the immunohistochemical expression of a panel of molecular markers 
(C-Kit, Ki-67, p53, and E-Cadherin) to evaluate the correlation with clinicopathological data and 
prognostic factors, to lay the foundation for further studying the pathogenesis and treatment of the 
ACC. 
The study included surgical resection specimens obtained from 17 ACC. Data were retrieved 
and cataloged from clinical records and from the archive of the Institute of Pathology, Marche 
Polytechnic University. 4- m serial sections were incubated with the polyclonal rabbit anti-human 
CD117 antibody (Agilent-Dako), diluted 1:50; with the monoclonal mouse anti-human Ki-67 antigen 
antibody (Agilent-Dako), diluted 1:50; with the FLEX monoclonal mouse anti-human p53 protein 
antibody (Dako Omnis); and with the FLEX monoclonal mouse anti-human E-Cadherin antibody 
(Dako Omnis), in a humidified chamber at room temperature for 1 h. To evaluate the extension of 
markers expression, the mean percentage of positive cells was determined from the analysis of 1000 
cells at ×40 magnification. Staining intensity of CD117 and p53, were scored as “-” (negative staining); 
“+” (weak staining); “++” (moderate staining); “+++” (intense staining). 
No significant associations between the evaluated markers and clinicopathological data were 
demonstrated. Closely related but not significant correlations were found analyzing the p53 
immunohistochemical expression. A lower expression was observed in cribriform compared to solid 
growth pattern (10.4% vs 38.7%) and in I-II respect to III-IV stage-disease (14.9% vs 45.2%). 
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The results not reveal a prognostic role for these molecular markers. However, p53 expression 
could be correlated to worst prognosis. The lack of relationships could be attributed the low records 
available, due to the rarity of this malignancy. So, further studies on larger series should be 
conducted. Literature data are extremely heterogeneous and although important advances have been 
made in exploring the biological bases of ACC, many critical factors remain elusive. Therefore, 
explore the ACC prognostic indicators is necessary for perfecting the multidisciplinary treatment, 
improving the curative effect. Moreover, should be performed molecular biology investigations to 
study the biological function of markers and lay the biological basis for personalized targeted 
therapies [2]. 
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One of the objectives of current researches is to be able to customize the treatment of cancer 
patients. This can be possible only by better stratifying patients based on the most significant 
prognostic factors [1]. The current staging system for oral cancer based on the 8th edition of American 
Joint Committee on Cancer (AJCC) [2,3] takes into consideration also depth of invasion and extra-
nodal extension (ENE) for patients’ stratification [4]. The aim of the present study was to 
retrospectively evaluate the prognostic value of tumor-stroma ratio in patients with Tongue 
Squamous Cell Carcinoma (TSCC) and to develop a prognostic model based on the most significant 
clinical-pathological features. Clinical and pathological data of 211 patients treated for TSCC were 
collected. 139 patients were re-staged according to the 8th edition of AJCC. Evaluation of TSR was 
performed on H&E slides and correlation with survival outcomes was evaluated. In particular, 
disease-specific survival (DSS) and disease-free survival (DFS) were analyzed A prognostic 
nomogram, based on significantly predictive variables included into a Cox Proportional Hazard 
model was developed. Low TSR showed to have a negative prognostic value in terms of Disease 
Specific Survival (DSS) and Overall Survival (OS) for both the 7th and 8th edition classifications. 
Stage, perineural invasion and Gender significantly correlated to the prognosis of TSCC patients 
primarily treated by means of surgery. The model built on such parameters showed a good predictive 
capacity, overperforming the AJCC 8 staging system in stratifying survival in TSCC. The model 
developed using Gender, TSR and Perineural Invasion and 8th edition of the AJCC staging system 
could improve TSCC patients’ stratification and treatment decisions and represents another step 
toward the long road for personalized treatment in TSCC patients. 
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1. Background
The association of Persistent Idiopathic Facial Pain (PIFP) and a congenital heart abnormality
has never previously been reported. We report a case in which the diagnostic workup performed for 
PIFP revealed a Patent Foramen Ovale (PFO), with right-to-left shunt (RLS) and 
hyperhomocysteinaemia due to a polymorphism in the gene coding for 5,10 Methylene 
TetraHydroFolate Reductase (MTHFR) (c677) with a homozygous mutation. 
2. Presentation of the Case
A 48-year-old female patient presented at the Oral Medicine Unit with a 10-month history of
left-side facial pain. The pain was deep, occurring daily and diffuse to the upper teeth irradiating to 
the ipsilateral jaw without any paroxysms. She had undergone several investigations and tooth 
extractions without any relief and had been unsuccessfully treated with amitriptyline, pregabalin and 
triptan. She had a history of venous thromboembolism occurring at the age of 32 years and never 
evaluated. Gliosis and carotid siphons tortuosity were found on Magnetic Resonance Imaging (MRI) 
of the brain (Figure 1a) and hyperhomocysteinaemia (18 mol/L) was identified. Transcranial 
Doppler Ultrasonography (TCD) with an agitated saline test was performed and showed a high 
degree of RLS (Figure 1b) while Transesophageal Echocardiography detected an interatrial septum 
aneurysm with PFO. Complete thrombophilia screening revealed a homozygosis mutation for 
MTHFR (c677, Ala--> Val). 
A complete remission of pain was reported three months after the percutaneous closure of the 
PFO and therapy with antiplatelet and folic acid supplementation. After six months the patient 
continues to stay in well-being only undergoing this treatment without the need for any selective 
drugs for PIFP. 
3. Conclusions
To the best of our knowledge, this is the first case described of facial pain secondary to a RLS
due to an asymptomatic PFO in a patient with a prothrombotic state in which the disappearance of 
pain after the percutaneous closure of the PFO supports the possible association between a RLS and 
PIFP. PFO with RLS has been suggested as a risk factors for cryptogenic stroke in younger patients. 
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Therefore, in our case, the early detection could be considered a possible lifesaver. However, the 
study leaves an unresolved question: namely whether the association is coincidental or causal. To 
address this point, the mechanism of action has to be further elucidated. This report shows that a 
careful evaluation of the clinical history, together with an interdisciplinary collaboration and a 
specific work up including neuroimaging studies is recommended in every case of facial pain in order 
both to achieve a more accurate and early recognition and to avoid diagnostic delay, which could 
sometimes be fatal for the patient. 
(a) (b) 
Figure 1. (a) Magnetic Resonance Imaging (MRI) of the brain and brainstem with and without 
intravenous paramagnetic contrast showed: 1–2 T2W TSE FSE TRA show gliotic areas of the white 
substance of the brain 3 3D FLAIR SAG SAT shows gliotic areas in of the white substance of the brain. 
4 GRADIENT AXIAL asymmetry and tortuosity of carotid siphons (b) Transcranial Doppler 
Ultrasonography (TCD) with the agitated saline test showed a high degree of shunt with uncountable 
microembolic signals (the “curtain effect”). 
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1. Introduction
Oral squamous-cell carcinoma, the most frequent malignant neoplasm of the oral cavity, has a
poor 5 years survival rate. 
The identification of specific salivary biomarkers can lead to a reduction of diagnostic delay. 
The aims of the present work are: 
1. to report the results of a pilot analysis on metabolic salivary composition of 20 healthy subjects.
2. to perform a systematic review designed to answer to the question: “Is there evidence that
support the use of salivary metabolomics for diagnosis of OSCC?”
2. Materials and Methods
Pilot study. Twenty healthy subjects (10 males and 10 females) aged between 20 and 25 years
were included. Enrolled subjects underwent a thorough dental examination, in order to assess the 
presence of inflammatory and/or infectious conditions in the oral cavity, which could interfere with 
the composition and analysis of saliva. 
Whole saliva (WS) and blood were collected at Centro Universitario di Odontoiatria in Parma. 
The metabolic profile of biofluids was determined by proton nuclear magnetic resonance (1H-NMR) 
in a JEZ 600 MHz ECZ600R spectrometer at the Interdepartmental Center for Measurements (CIM) 
of the University of Parma. 
The systematic review was performed searching Medline, Scopus and Web of Science, using as 
entry terms a combination of “saliva” or “salivary biomarkers” and “oral carcinoma”, “oral cancer”, 
“squamous cell carcinoma”, “salivary metabolomics”. endpoint of research was generally 2019. The 
quality of the studies was assessed by two independent reviewers based on the checklist proposed 
by the National Institute of Health (NIH). The level of evidence was assessed using the Oxford Center 
for Evidence-Based Medicine (CEMB) classification. 
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3. Results
The salivary metabolic analysis identified and quantified over 50 metabolites. Acetate was found 
to be the metabolite with the highest concentration, both in males and females (Figure 1). 
Comparing acetate with the second most concentrated metabolite (propionate) the first has a 
presence 9.5 times higher than the second. 
Figure 1. Salivary concentration of identified metabolites divided by gender. 
Thirteen papers out of 4198 fulfilled the inclusion criteria. No article obtained a “good” rating 
(0/13, 0%), 12 articles were classified as “fair” (92%) and 1 article as “poor” (8%). 
Most frequent risks of bias were the lack of sample size justification, the absence of concurrent 
controls, the choice to not blind the status of participants by the investigators. 
According to the CEMB classification the 13 articles have a low level of evidence (level 4). Most 
frequently investigated metabolites that revealed a strong association with OSCC were: pyruvic acid, 
glycine, proline and choline. 
4. Conclusions
Metabolic analysis of saliva is one of the most promising field for early diagnosis oral squamous 
cell carcinoma. 
The present study demonstrates the salivary metabolic composition of healthy subject and may 
serve as a reference to elucidate saliva alteration found in patient with malignant tumours. 
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1. Introduction
Pigmented oral mucosa lesions can have an exogenous or endogenous nature, depending on the
determining causes. Among the exogenous pigmentations are included those related to heavy metal 
ingestion or intoxication, metal implantation, drug ingestion and “bad habits” like pencil chewing. 
A physiological and medical anamnesis is important to investigate the etiology of pigmentations [1]. 
2. Case Report
A 87-years old man was referred to the Oral Pathology division of Papa Giovanni XXIII hospital 
in Bergamo for xerostomia and temporomandibular joint (TMJ) disorders. The patient’s medical 
history revealed cardiopathy, uncompensated vestibulopathy and seronegative rheumatoid arthritis. 
He was receiving treatment with Chloroquine (250 mg/die since 2016), Vitamin “D”, Cardioaspirin, 
Atorvastatin and an antihypertensive drug. The patient stated he never smoked. 
Intraoral examination showed a flat, homogeneous, grey discoloration regarding the whole hard 
palate mucosa. The pigmentated area was asymptomatic, symmetric and bilateral (Figure 1). 
Figure 1. Hard palate hyperpigmentation. 
The rest of the oral mucosa appeared to be moistened and healthy, without leucoplasic or 
eritroplasic areas. Neither functional limitation nor muscular pain was noticed through clinical exam 
of TMJ. 
The patient reported to have never noticed the palate pigmentation before; 15 days later it was 
still present without any clinical change. After the patient’s written informed consent an incisional 
biopsy was performed in local anesthesia; beside standard histopathologic examination, Prussian 
blue (Perls’) reaction was used to investigate hemosiderin staining (Figure 2). 
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Figure 2. Perls’ Prussian blue stained section. 
The clinical and histopathologic features confirmed the diagnosis of drug-induced oral 
pigmentation caused by chloroquine. 
3. Discussion
Oral mucosa hyperpigmentation is a rare side effect of antimalarial agents like chloroquine, used 
also for management of rheumatoid arthritis. 
The literature reported that prolonged systemic administration of this drug can determine the 
deposition of hemosiderin in the tissues of the oral cavity. Chloroquine chelates iron and/or melanin; 
moreover, melanocytes are stimulated in melanin production [2,3]. 
In most cases only hard palate is involved, but involvement of gingiva and labial or buccal 
mucosa has been reported too. For this type of oral pigmentation there is no a recommended 
treatment, the importance of an early diagnosis of chloroquine-induced hyperpigmentation of the 
oral mucosa is that it could be a marker of another adverse reaction: irreversible retinopathy. The 
drug binds pigmented ocular tissues and could lead to blindness. The patient should be referred to 
an ophthalmologist and, according to the rheumatologist, the drug should be discontinued or 
modified in the dosage. 
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Plasma cell mucositis (PCM) is an unusual plasma cell proliferative disorder of the upper 
aerodigestive tract. It is a rare disease and its etiology is not yet known, it is considered a benign 
condition of adults and there is no correlation in literature with the development of plasma cell 
neoplasm. Clinical features are an intensely erythematous mucosa with papillomatous, cobblestone, 
nodular, or velvety surface changes. Symptoms include dysphagia, oral pain and pharyngitis [1]. 
Generally, PCM patients have a previous history of autoimmune or immunologically mediated 
disease. Despite plasma cell mucositis often involves the oral and genital mucosa, there was no 
genital involvement in this circumstance. We described a case of PCM involving the tongue of a 
43-year-old-woman, the patient was referred to the Oral Pathology at the Faculty of Dentistry,
Magna Graecia University of Catanzaro, in August 2019. Her past medical history was
unremarkable. She reported a burning sensation in her mouth and local dysgeusia on the tip and the
right lingual border for 5 years (Figure 1). In the first place several diagnostic hypotheses were
proposed, the most of them discarded for incompatibility with blood and laboratory tests. The
patient underwent an incisional biopsy under local anesthesia. The specimen was stored in a tube
containing formalin 10% and sent to a laboratory for histopathological analysis. Microscopically, a
large area of ulceration of the coating epithelium subtended by dense plasma cell infiltrate was
observed. The final histopathological diagnosis was “Plasmacytosis of the mucous membranes with
restriction for the kappa chains”. This disease rarely manifests itself on the tongue, especially in
young patients with no comorbidities. The management of PCM is mainly aimed at reducing the
symptoms, in fact the patient was treated with systemic prednisone 50 mg/day [2]. Many therapeutic
treatments are able to stabilize but are not able to induce a complete remission. PCM is considered
an uncommon benign disorder with a favorable prognosis. It is important to differentiate the PCM
disease from other neoplastic conditions in order to achieve a better clinical management of the
patients.
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Figure 1. Ulcer localized on the tip of the tongue. 
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1. Introduction
Desquamative gingivitis (DG) is a descriptive term indicating the presence of erythematous,
erosive, desquamative and vesiculo-bullous lesions in the free/attached gingiva, usually expression 
of several chronic systemic conditions [1]. 
Optical Coherence Tomography (OCT) is a new biomedical technique based on the interaction 
of the infrared radiation (900–1500 nm) to the human tissues, allowing the visualization at high 
resolution of the micro-structural morphology. OCT is proposed in dermatology, ophthalmology 
and recently in oral medicine [2]. It could be recommended for managing the patients with chronic 
disease, such as DG. 
The aim of this paper is to report a case series of three patients affected by clinical DG valuated 
by OCT before diagnostic biopsy in order to assess the morphology of the lesions and to guide the 
oral medicine specialist to hypothetical differential diagnosis.  
2. Case Series
Three female patients (mean age 74 ± 9.2 years), with clinical DG, were consecutively recruited
at unit of Oral Medicine, and after informed consent, underwent to in vivo OCT examination. In 
details, we used VivoSight® OCT (Michelson Diagnosis) which is equipped with a flexible fiber 
optic probe. However, the probe, because it is used for dermatological purposes, is not of the 
optimal size for the oral cavity. In this way OCT allows to obtains a scan section with width of 6mm 
and focal depth of 2 mm. 
After photo record, OCT examination was performed on each patients in order to identify the 
most suggestive DG site for the incisional punch biopsy, successively performed by a punches 6 mm 
diameter (the same size area of OCT scans). 
Case 1–2: For both patients, DGs were characterized by erythematous, desquamative, 
hyperkeratotic lesions. In both cases Nikolsky’s sign was negative (Figure 1a). 
OCT scans showed: hyperkeratinization, unhomogeneity and decrease of the epithelial layers 
and increased sub-epithelial cellularity under basement-membrane (BM) (Figure 1b). 
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(a) 
(b) 
Figure 1. (Case 1) (a) Atrophic-erosive, desquamative and hyperkeratotic DG, (biopsy site 
underlined); (b) OCT scan of the same site of punch biopsy, with morphological details. 
Case 3: DG showed erythematous, desquamative, hyperkeratotic areas, associated with a 
positive Nikolsky’s sign (Figure 2a). 
OCT scan showed a compact epithelial layer entirely separated from the BM by interposed fluid 
that appears dark, and potentially suggestive of a sub-epithelial blister (Figure 2b) [3]. 
(a) 
(b) 
Figure 2. (Case 3) (a) Atrophic-erosive, hyperkeratotic and vesicular DG, (biopsy site underlined); (b) 
OCT scan shows evident detachment of the epithelium from BM zone. 
Histological reports of Case 1 and 2 were Oral Lichen Planus; whereas Case 3 was Mucous 
Membrane Pemphigoid (MMP). 
3. Conclusions
We presented three patients with similar clinical-features of DGs, that showed a morphological
diversity by OCT investigation. 
In details, in case 1–2 were present an alteration of epithelial layers with a greater sub-epithelial 
cellularity, reported in OCT scans could be evocative of a chronic inflammatory infiltrate, usually 
histologically described in OLP.  
In case 3 it was a clear evidence of a sub-epithelial blister that could early guider the clinician to 
a diagnosis sub-epithelial vesicular-bullous pathologies (I.E MMP). 
The results of our study, although reported to a small simple size, prompt a potential use of 
OCT in clinical management of DG. In particular, for preliminary assessment of the lesions, in order 
to suggest a more specific sites for histological investigation. 
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1. Introduction
The term choristoma applies to cohesive tumor-like mass composed by histologically normal
tissue in abnormal locations. Cartilaginous choristomas are a rare finding in the mouth where most 
frequently arise in the tongue and less commonly in sites such as the buccal mucosa, soft palate and 
gingiva.  
In literature cartilaginous choristomas of the lower lip have been described in 3 women [1]. 
We report a case of a cartilaginous choristoma occurring in the lower lip in a young man. 
2. Material and Methods
A caucasian 37-year-old man referred to our division complaining an asymptomatic and slow-
growing lesion at the lower lip. To the patient’s knowledge, the lesion was present since 12 months. 
There was no reported history of direct trauma or infection in that area before the appearance of the 
swelling. On examination, there was asymptomatic, mobile submucosal area within the lower lip. 
Due to the presentation and location, several entities were considered in the differential diagnosis: 
traumatic fibroma, mucocele, inflamed minor salivary gland, lipoma or a minor salivary gland 
tumour. In order to obtain the correct diagnostic interpretation, the lesion was then surgically excised. 
3. Discussion
The exact cause of a cartilaginous choristoma is unknown. Several theories have been proposed
to explain the origin of the cartilage in the soft tissues of oral cavity. However, the embryonic theory 
and the metaplastic theory are the two main theories favored in the literature. The first theory 
proposes that the lesions arises from heterotopic fetal cartilaginous remnants.  
The metaplastic theory suggests instead that cartilaginous choristomas develop from 
pluripotent mesenchymal cells either de novo or potentially stimulated by trauma, irritation or 
chronic inflammation [2]. 
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On gross examination the lesion excised appeared as a nodular formation of 1.3 cm in major 
dimension, covered by flat and congested mucosa. In section, this formation showed a white-
yellowish, focally translucent, surface and soft-elastic consistency.  
Microscopically the lesion consisted in a non-capsulated nodule of the sub-epithelial chorion, 
with well demarcated margins, composed by mature chondroid tissue admixed with fibrous and 
mature adipose tissue (Figure 1). There was no significant cytological atypia, neither necrosis or 
evident mitosis. The overlying mucosal layer was uninvolved without significant histological 
alterations. A mild and scattered lymphoid infiltrate was also associated. 
Figure 1. Hematoxylin-Eosin 5× (Insert: Hematoxylin-Eosin 20×). Non-capsulated sub-epithelial 
formation consisting in mature chondroid tissue with fibro-adipose component without any atypia 
or necrosis. 
4. Conclusions
This case report depicts a cartilaginous choristoma developed in a rare site.
Unlike the cartilaginous choristomas involving the tongue, where the prevalence is similar 
among males and females, the lip lesions, albeit reported only in a small number of cases, seems to 
affect mostly female subjects with a female/male ratio of 3:1. 
To our knowledge, this is the first case of a cartilaginous choristoma of the lower lip presenting 
in a male described in literature. 
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1. Introduction
Treatment of oral potentially malignant disorders (OPMD) and oral malignant lesions does not
simply ends with the complete removal of the affected tissues. Since then, the oral physician plays a 
key role in terms of secondary prevention, carried out through an appropriate guidance of the patient 
to a change of lifestyle, and regular post-therapy surveillance. Relapse for head and neck squamous 
cell carcinoma varies from 16% to 52% [2]. Patients with primary tumor diagnosis also have a higher 
chance to develop second primary tumors (SPTs), arising further than 2 cm from the primary site 
and/or 5 years later than primary diagnosis, due to an independent carcinogenesis leading to the 
onset of a new tumor [1,2]. Aim of the present study was to review retrospectively, from 2003 to 2018, 
how many patients, firstly diagnosed with an oral malignant neoplasm, experienced a subsequent 
malignant and/or premalignant disorder, in the form of new OPMD, cancerized OPMD, relapsed 
cancer or SPT. 
2. Methods
Electronic archive of the Oral Medicine Section of University of Turin, Italy was reviewed.
Inclusion criteria were the following: patients firstly diagnosed with a malignant neoplasm, who later 
developed at least one OPMD or another malignant neoplasm. The following data were acquired: 
histological diagnosis, site of occurrence, new OPMD, relapsed OPMD, SPTs and relapsed cancer. 
3. Results
A sample of 79 patients (41 F, 38 M; mean age 67.5 years) was finally examined, associated with
199 histological reports. Figures 1 and 2 show their distribution based on histology and anatomic site. 
Of the 199 lesions detected, 111 (55.8%) were premalignant, whereas 88 (44.2%) where 
malignant. Seventy-two of the 88 malignancies (81.8%) were diagnosed as oral squamous cell 
carcinoma (OSCC). Of 199 lesions, 70 could be categorized as relapsed lesions: 38 were diagnosed as 
OPMD and 32 as neoplasms. Of the remaining 129 new lesions, either detected 2 cm further from the 
primary site or 5 years after diagnosis, 62 were SPT, 6 severe OPMD with SPT-like features, and 61 
OPMD. 
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4. Discussion
In this case-series, tongue was by far the most affected site for premalignant and malignant
recurrent disorders. Rate of oral cancer relapse in our series aligned with that of the most recent 
literature (36.3% vs. range of 14–52% by Netto and co-workers) [2].  
Figure 1. Flow-chart showing the distribution for type of lesion and new lesions/relapses ratio. 
Figure 2. Distribution of the 199 lesions according to the anatomic site. 
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1. Introduction
Hydroxyurea (HU) is an anti-cancer agent commonly used in myeloproliferative Philadelphia
negative disorders as polycythemia vera (PV), essential thrombocitosis (ET) and myelofibrosis (MF). 
Most frequent side effects of HU are skin numbness or purple discoloration, skin ulcers or open sores 
and low blood cell counts. Using hydroxyurea may increase risk of developing other types of cancer, 
such as leukemia or skin cancer. Some recent studies underline the possibility of an oral toxicity, but 
its frequency seems to be quite rare. We present a cases series in which the oral lesions happened in 
patients in treatment with HU, focusing on their management. 
2. Methods
A total of 7 patients (3 males, 4 females, mean age 71), arrived from January 2018 to June 2019 to 
the Oral Medicine section of the Dental school Lingotto, University of Turin, were enrolled in this 
study. 4 of them were affected by PV, 1 by MF, 2 by ET. Patients were invited to an oral visit by their 
hematologist. The visit was performed by a doctor expert in oral medicine. When the diagnosis of 
oral mucosa ulcers was done, the first line treatment was chlorexihidine mouth rinses and a topical 
cortisteroid applied 3 times daily for 2 weeks (clobetasol 0.05%). Only if this treatment failed or a 
serious new episode happened, a reduction of HU dose or its suspension were evaluated. 
3. Results
Results are summarized in Table 1. 
Table 1. Characteristics of patients and treatments strategies. 





1 80 f PV 3 7 pos Clobetasol, HU suspension 
2 70 m PV 6 9 pos Clobetasol 
3 70 f PV 5 7 pos Clobetasol, HU riduction 
4 88 m MF 5 3 pos Clobetasol 
5 64 m PV 14 9 pos Clobetasol, HU suspension 
6 61 f ET 2 6 neg Clobetasol 
7 64 f ET 2 9 neg Clobetasol 
PV = polycythemia vera, ET = essential thrombocytosis, MF = myelofibrosis HU = hydroxyurea. 
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The clinical presentation of oral lesions was aphthous-like ulcers. None of the patients had a 
previous history of recurrent aphthous stomatitis. Oral toxicity appeared after a mean period of 5.2 
years. A complete resolution of oral ulcers was observed in 4/7 patients (57.2%), 3 patients had no 
response or new episode that lead to suspension of HU (2 pz, 28.5%) or its dose reduction (1 pz, 
14.2%). 
4. Discussion
This condition is considered an early complication, mainly within the first year [1,2]. Previous
studied reported that from 0.8 to1.8% of all patients treated with HU developed oral aphthous ulcers 
[2,3]. Our study, with a medium period of 5.2 years of HU, presents a later onset of the oral toxicity. 
Other authors [3] suggest a therapy based on mouthwashes with folic acid and vitamin A. In our 
practice, topical corticosteroids and chlorhexidine mouth rinses seem to be a good treatment for oral 
lesions, but, when failed, the reduction of the HU dose or its suspension are the only way to solve the 
problem. Good prospective could arrive from the new cytostatic agents (e.g., ruxolitib, anagrelide).  
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Heimler syndrome (HS) is rare autosomal-recessive disorder caused by mutations of peroxin 
genes, PEX1 and PEX6. Defects in peroxin genes alter peroxisome assembly and its metabolic 
pathways, essential for the metabolism of fatty acids, ether lipids, polyamines and amino acids, thus 
supporting the peroxisome biogenesis disorders (PBDs): a variety of severe conditions, among which 
HS is the mildest form. Heimler et al. first described HS in 1991 [1], and, since then, scientific literature 
has reported less than 12 families and less than 20 cases. HS is generally characterized by pre-lingual 
hearing loss, nail abnormalities, ocular involvements and dental anomalies [2]. Here we report a case 
of a 9-year-old female, whose genetic analyses revealed to be affected by HS and who underwent 
multi-disciplinary examinations to define her complete clinical features. She referred at the Eye clinic 
of the University of Campania “L. Vanvitelli” for ophthalmological evaluations. At the beginning, 
the presence of sensorineural hearing loss and early onset atypical Retinitis Pigmentosa, oriented 
toward the clinical diagnosis of Usher syndrome (US), another autosomal-recessive disorder, 
typically characterized by partial/total hearing loss and worsening vision loss. Hence, molecular 
genetic tests were performed to refine the diagnosis. After sequencing more than 2000 genes, it results 
two pathogenic variants of PEX1, thus excluding US and orienting toward HS. At this point, a multi-
disciplinary team approached the patient to identify the further HS features. In addition to 
ophthalmological and audiological findings, clinical and instrumental phoniatric and 
neuropsychological examinations revealed deficit in language skills and moderate intellectual 
disability; dermatologists confirmed the presence of leukonychia. Odontostomatological evaluation 
was performed by two oral pathologists expert in pediatric dentistry. After excluding facial 
disharmonies at the extraoral examination, the intraoral one revealed a mixed dentition, as expecting 
according to age [3]. The upper central incisors displayed white spots on the vestibular surfaces and 
the first permanent molars cusps were yellowish and hypoplastic. The X-ray orthopantomography 
revealed no agenesis and a pale reduction of the enamel density of canines and premolars, whose 
cusps appeared slightly hypoplastic. The patient reported mouth breathing, probably responsible for 
the anterior open bite and the high-arched palate. Oral mucosae were healthy and normochromic. 
Tongue and teeth were covered by a visible layer of dental plaque, which has been removed by 
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professional oral hygiene. To date the patient is under multidisciplinary follow-up for her various 
affections, included the dental ones. It is notably the unanimity of the literature in reporting dental 
defects in HS. Which differs among the reports is the ascription of these defects under the diction of 
“amelogenesis imperfecta” given by some authors, despite the lack of genetic tests supporting 
defective genes involved in amelogenesis. Hence, we retain the condition here presented closer to the 
molar incisor hypomineralization (MIH), whose causes are still not clearly defined [4]. 
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1. Background
Trigeminal Neuralgia (TN) is one of the most frequent and severe types of neuropathic facial
pain encountered by clinicians [1]. The first line medical approach generally involves treatment with 
first and second generation anticonvulsants [2]. However, unfavorable adverse events impair 
compliance with the treatment, especially in relation to elderly patients. Lacosamide (LCM) is a 
third-generation anticonvulsant drug; it is a functionalized amino acid, with a multimodal 
mechanism of action which is not completely clear (Table 1 and Figure 1) [3,4]. It has also come into 
consideration as a treatment for neuropathic pain. 
We have aimed to investigate the efficacy and safety of LCM as a monotherapy in a case of TN 
who had not responded positively to previous treatments on account of severe leukopenia induced 
by several of the anticonvulsants previously used. 
Table 1. Mechanism of action and advantages of treatment with Lacosamide. 
Mechanism of Action of Lacosamide 
Enhancing slow inactivation of VGSC peripheral (Nav 1.7 and Nav 1.3) and central (Nav1.7) 
Stabilization of hyperexcitable neuronal membranes 
Inhibition of neuronal firing 
Binds CRMP-2 changes in axonal outgrowth 
Advantages of Treatment with Lacosamide 
Excellent oral bioavailability 
Minimal serum protein binding 
Excreted unchanged by the kidney 
Drug-drug interaction are minimal 
No regular blood tests are recommended 
VGSC: Voltage-Gate Sodium Channels; CRMP-2: Collapsing Response Mediator Protein 2. 
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Figure 1. Lacosamide: Mechanism of action. From Dr D. Adamo et Dr. N. Coppola. 
2. Presentation of the Case
A 60-year-old female patient was referred to the Oral Medicine Unit of the University Hospital
of Federico II of Naples due to an acute exacerbation of TN, previously diagnosed by the Neurology 
Unit of our University. 
The severe and unilateral pain was in the right side of her face, characterized by paroxysms of a 
strong stabbing nature extending in the sensory distribution of the maxillary and mandibular 
trigeminal right area and described as like an electric shock. The pain lasted only for seconds, 
occurring over intervals of a few minutes, and was triggered by swallowing or touching the affected 
area, without any autonomic or other neurological symptoms. 
The patient was refractory to previous treatments (gabapentin, carbamazepine, lamotrigine and 
pregabalin) in terms of both the absence of any pain relief and the appearance of adverse events of 
leukopenia. We requested a routine blood test including a Complete Blood Count (CBC), glucose, 
electrolyte, blood urea nitrogen and creatinine levels, the erythrocyte sedimentation rate and an 
ECG evaluation. All results proved to be within normal limits. A Magnetic Resonance Imaging 
(MRI) of the brain and brainstem with and without intravenous paramagnetic contrast was required 
and proved to be normal except for a few subcortical white matter hyperintensities. An oro-facial 
evaluation and battery scales for an assessment of pain intensity and an evaluation of psychological 
profile were performed. 
We started the treatment with a low dosage of oxcarbazepine (300 mg/daily) and re-evaluated 
the patient with a request for a blood examination after one month. We discovered that the WBC 
count had decreased from 5500 to 1900 cells/μL. We waited until the WBC had returned to a normal 
level and we started the treatment with 100 mg twice/daily of LCM. Pain relief was obtained in three 
weeks of treatment without any variations in the white blood cell count. The value of white blood 
cells was evaluated every month for the first six months of treatment and no changes have been 
detected. Currently, the patient takes a maintenance dosage of 100 mg/daily without any adverse 
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events, remaining in a state of complete well-being without pain and with an improvement of 
psychological profile. 
3. Conclusions
LCM has shown efficacy and a good safety profile. It may be useful for patients who are either
subject to refractory TN which is not responsive to conventional therapy or are affected by 
significant adverse side effects. 
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1. Case Presentation
An 85-year-old man was referred at our Oral Medicine Unit for the presence of painful, multiple 
ulcerative lesions in the mouth. 
The patient reported the onset of the lesions several weeks before, and he was unable to eat or 
drink normally, thus being hospitalized due to electrolyte imbalance. 
Clinically, multiple ulcerative lesions were observed bilaterally on the buccal mucosa and also 
on the left soft palate (Figure 1). In addition, mild angular cheilitis-like fissures were observed on the 
lips. Neither the oropharyngeal and the upper aero-digestive districts nor the skin showed any other 
lesions. 
The patient’s anamnesis reported the presence of Rheumatoid arthritis, treated with methotrexate 
(15 mg IM weekly). 
Differential diagnosis included oral blistering diseases, chronic ulcerative stomatitis, 
methotrexate-induced ulceration, methotrexate-induced lymphoproliferative disorder, chronic 
granulomatous conditions, endocrinal or nutritional alterations. 
An incisional biopsy of the affected area was performed, along with DIF analysis, to confirm or 
rule out several autoimmune blistering disorders. The lesions healed after methotrexate was 
discontinued and topical corticosteroid therapy was started. 
(a) (b) 
Figure 1. (a,b) Clinical aspect of the lesions. Multiple ulcerations with perilesional velvety, sometimes 
cobblestone-looking, inflamed mucosa. 
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2. Histopathology
The histopathological examination revealed the presence of a chronic deep inflammatory infiltrate, 
completely composed of plasma cells, a feature that was confirmed by immunohistochemical analysis 
with CD138 (Figure 2). The infiltrate was polyclonal, with the production of both lambda and kappa 
chains, excluding thus any lymphoproliferative disorder or plasmacytoma. 
In situ hybridization for detecting the presence of EBV infection provided negative results. 
The final diagnosis was Plasma Cell Mucositis (PCM) [1]. Occasional relapses are managed with 
clobetasol ointment 0.05%. 
(a) (b) 
Figure 2. Histopathological features of PCM. (a) H&E stain revealed the presence of a subepithelial 
inflammatory infiltrate composed completely by plasma cells. (b) Immunohistochemical analysis 
with CD138 confirmed the prevalence of the plasma cells within the inflammatory infiltrate. 
3. Conclusions
PCM is a very rare immunological disorder of the upper aerodigestive tract that can affect the
oral cavity [2]. This case report is the first one that describes the onset of PCM associated to 
Methotrexate therapy, thus different from Methotrexate-induced mucocutaneous ulcer [3]. 
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Lipoma is a benign mesenchymal neoplasm, that origin from adipocytes, uncommon in oral 
cavity (less of 5% of the cases). It has a slow growth and often it is asymptomatic, so the diagnosis 
could be late. In oral cavity, buccal mucosa, tongue and mouth floor are often involved [1]. Lipoma 
is a submucosal lesion, sessile or pedunculated, covered by healthy mucosa, consisted of a yellow, 
lobulated, circumscribed and soft mass, in most cases not exceeding 1cm in diameter. Histologically, 
it is a mature white adipose tissue without atypia and it can be found in the variant of fibrolipoma [2]. 
When an oral lipoma occurs, a surgical treatment is required.  
A 46-year-old female patient with a negative medical and dental history came to our 
observation.  
The patient reported a painless swelling at mouth floor, occurring one year ago, that troubled 
chewing and swallowing. 
At oral examination it appeared like a 3 cm × 2.5 cm sessile lesion covered by normal mucosa, 
from which shine through a yellow color (Figure 1).  
Figure 1. Intraoral view of the lesion. 
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At Ultrasound examination, the lesion appeared hyper-echoic and not infiltrated [3]. 
At Magnetic Resonance Imaging (MRI), at T1-weighted, signal was high. The lesion was placed 
upper than muscles plane, with major longitudinal axis of 27 mm, next to genioglossus muscle and 
beyond the median raphe.  
An excisional biopsy was scheduled; the surgical approach was made through 445 nm diode blue 
laser (K-laser, Eltech s.r.l., Treviso, Italy) at 2Watt in Continuous Wave, with 320 m optical fiber. 
Blue laser has been used to make the initial vertical incision (Figure 2), it works by layers so it 
can isolate the superficial mucous layer from the lesion capsule, the lesion was isolated with 
Metzenbaum scissors and excised by laser. Laser permitted the control of bleeding, since its optimal 
hemostatic effect due to wavelength congenial to hemoglobin.  
Figure 2. Laser vertical incision. 
After the excision, the residual cavity was filled with iodoform gauze and 3-0 suture was applied. 
After 4 days, the gauze was removed in relation and an almost complete healing was observed. 
The specimen was histologically analyzed and it has resulted as lipoma. 
Two months follow-up shown a complete wound healing and no recurrences. 
Diode blue laser, used to approach to benign neoplasms like lipomas, can offer an advantage 
both in the isolation of the lesion with respect to the surrounding tissues and in the intraoperative 
visibility thanks to the coagulation. 
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1. Case Presentation
A 16-year-old girl presented at our attention with an asymptomatic nodular lesion on the tongue. 
Clinically, the lesion appeared as a submucosal smooth nodule, 5 mm in diameter, covered by a pink-
yellowish looking mucosa (Figure 1). On palpation, it was well defined, but not encapsulated. The 
lesion was located on the right posterior dorsum of the tongue, it had been slowly growing for a few 
months, and it was completely asymptomatic. The patient’s anamnesis revealed atopic dermatitis 
and pityriasis rosea. 
Figure 1. Clinical aspect of the lesion. A pink-yellowish submucosal nodule was detected on the 
posterior lateral aspect of the tongue. 
Clinically, the lesion was placed in differential diagnosis with other “soft tissue tumors”. Therefore, 
an excisional biopsy of the lesion was performed with subsequent histopathological analysis.  
2. Histopathology
The connective tissue displayed a well-defined proliferation of cells with a characteristic
granular cytoplasm. The cells had a characteristic granular eosinophilic cytoplasm positive to PAS 
staining. The neoplastic cells had a polygonal shape, large dimensions and indefinite margins 
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(Figure 2). The nucleus was roundish and with free chromatin. There was no nuclear atypia and the 
Ki-67 proliferation index was low. A peculiar histological element of the granular cell tumor was the 
presence of pseudoepitheliomatous hyperplasia (PEH). 
(a) (b) 
Figure 2. (a) Histopathological features of OGCT. The tumour was composed of large polygonal 
granular cells arranged in a pseudosyncitial pattern. The aspect is typical for GCT. (b) 
Immunohistochemical analysis revaled the tumour cells be positive for S-100, a marker that confirmed 
the origin from perineural tissues, like the Schwann cells [1]. 
3. Conclusions
Granular cell tumor (GCT) is a benign soft tissue neoplasm. GCT can develop throughout the
body but it shows a clear preference for the head-neck district. In particular, in 50% of cases it 
develops on the tongue, precisely on the lateral margins and back of the tongue [2].  
PEH places this lesion in a differential diagnosis with a well-differentiated squamous cell tumor [3]. In 
order to avoid dangerous diagnostic errors, which can lead to unnecessary lingual mutilation, it is 
essential to perform a correct biopsy test. Bioptic sampling must include both the epithelial lamina 
and the lamina propria, where the granular cell tumor develops. 
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1. Introduction
Oligodendrogliomas constitute 5% of all primary brain tumors and are the third most common
cancer among intracranial tumors [1]. Oral mucosal melanoma is uncommon, it develops following 
malignant transformation of melanocytes, occasionally with a poor prognosis [2]. 
2. Case Report
A 66 years old female patient went to our observation for a particular pigmented lesion on the
lower gum. At the anamnesis she reported suffering from temporal left oligodendroglioma, so she 
takes dintoina 3 times a day since 1996 when it is discovered. After surgery, in 1999 
oligodentroglioma relapsed and she was undergone to chemo and radiotherapy, and relapsed again 
in 2003 and in 2004 she was undergone to 4 times surgical intervention and chemotherapy. In 
February 95, she was submitted to rhizotomy of the element 36, with reconstruction of the amalgam 
abutments, root canal therapy of 35 with insertion of a molten post, both elements were covered with 
gold-resin crowns. Seven years after she presented an evident tattoo on the vestibular adherent 
gingiva, less accentuated by the lingual side, corresponding to the elements 35–36. 
Over the years it has had several inflammatory episodes concerning the left gingival tissue (on 
the same part of the brain problem) and never on the right. In January 2019, after 17 years, the 
pigmented lesion, stable for 16 years, was extended to element 33 e 34 both vestibular and lingual 
(Figures 1 and 2). Given the patient’s medical history and the rapid expansion of the pigmented lesion, 
to exclude malignant conditions, the patient was sent to the Department of Odontostomatological 
Sciences of Bologna and a biopsy was performed. “Bioptic fragment of oral mucosa with deposition 
of blackish pigment in the chorion, mainly in the perivascular area. Lesion picture compatible with 
c.d. Amalgam tattoo” was the histological diagnosis.
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Figure 1. Pigmented lesion, vestibular side. 
Figure 2. Pigmented lesion, lingual side. 
3. Discussion
The amalgam tattoo is an iatrogenic lesion caused by the traumatic implantation of dental
amalgam in soft tissues, whose diagnosis is evidenced by the position and the clinical appearance 
supported by the radiographic confirmation of metallic particles that are often too fine or widely 
dispersed to be visible on radiographs. Microscopic examination reveals that the amalgam is present 
in the tissues in two coexisting forms: solid metal fragments that surround the fibrous connective 
tissue or as numerous, thin, brown or black granules dispersed along collagen bundles around small 
blood vessels and nerves and are associated with a mild to moderate chronic inflammatory response, 
with macrophages engulfing small amalgam particles. Once the diagnosis of the amalgam tattoo has 
been established, no additional treatment is required except for aesthetic reasons. We have found 
only few cases in the scientific literature of gingival amalgam tattoo simulating malignant lesions 
such as melanoma [3,4]. 
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1. Introduction
Mucous membrane pemphigoid (MMP) is a rare, predominantly mucosal subepithelial
blistering disorder triggered by autoantibody reactivity to several basement membrane antigens 
including BP180, BP230, laminin 332, and type VII collagen. Disease control is usually achieved with 
steroids and mycophenolate mofetil, azathioprine, or dapsone. However, long term use of steroids is 
well known to expose the patient to the risk of moderate to severe side effects.[1] For this reason, the 
use of alternative therapies or corticosteroid sparing agents to control disease is highly attractive[1,2]. 
In the present paper we describe the management of a case of mucous membrane pemphigoid treated 
with topical application of heterologous PRP. 
2. Case Report
A 35 years old female patient affected by oral MMP and non-respondent to initial treatment with
local corticosteroids was selected for heterologous PRP- based compassionate treatment with the 
intention to avoid systemic steroid and immunosuppressant administration. The Pemphigus Disease 
Area Index (PDAI) was used to assess clinical disease activity before and after treatment. Pain level 
changes were assessed through VAS scale from 0 to 10. Periodontal plaque index(FMPS) and bleeding 
on probing(FMBS) indexes were also collected to assess any improvements in periodontal situation 
before and after treatment. Patient underwent 7 topical applications of heterologous PRP and 
endpoint for clinical evaluation was set, approximately 1 month following the last session. No clinical 
side effects were recorded. PDAI values improved from 10 to 3. VAS score, which was reported to be 
6/10 at the beginning of treatment (main complaint included the impossibility to eat crispy or hard 
food due to pain exacerbation and gingival bleeding) dropped to 2/10 at re-examination. Before 
treatment, levels of FMBS scored 30% but decreased to 9% at the end of PRP. Similarly, FMPS levels 
scored 26% at the beginning of treatment and dropped to 6% at the end of treatment. 
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3. Conclusions
Within the limits of a case report, topical applications of heterologous PRP seems to be a safe
procedure for the management of patients with oral mucous membrane pemphigoid. In our case, 
regenerative and immunomodulatory properties of PRP achieved not only a significant improvement 
in both signs and symptoms of diseases but also a better control of periodontal inflammation. PRP 
topical application is an attractive therapeutic option to be studied at larger scale as adjunctive steroid 
sparing treatment for MMP. 
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1. Introduction
Human Papillomavirus (HPV) is a DNA virus, belonging to papillomaviridae family. Its role in
ethiopathogenesis of ano-genital cancers has been largely documented. On the contrary, HPV status 
in Oropharyngeal Squamous Cell Carcinoma (OPSCC) presents several controversies, supporting by 
a substantial heterogeneity in HPV prevalence among studies and clinical reports. These 
uncertainties are primarily related to two strongly interconnected reasons: 
1. a non-univocal topographical classification of the OPSCC;
2. an extreme heterogeneity of the diagnostic procedures used to detect HPV status [1].
In respect to the last issue, there are several techniques to investigate HPV in human samples,
with advantages and disadvantages related to clinical applicability and sensitivity/specificity in 
relation to HPV oncological activity. Polymerase Chain Reaction (PCR) is the most sensitivity and 
widely used method to detect and to genotype HPV. However, p16 immunohistochemistry (IHC) is 
considered a more versatile tool to indirectly measure the HPV transcriptional activity. For these 
reasons, its use was proposed by the 8th edition of TNM classification to stage the Head and Neck 
Squamous Cell Carcinomas (HNSCCs), in relation to a better prognosis of HPV positive (+ve) OPSCC 
recently supported in literature [2,3]. However, there are several studies reporting the low specificity 
of p16 IHC in relation to HPV status, potentially conditioning the appropriate treatments of patients 
with OPSCCs [4,5]. In this scenario, the aim of this abstract is to report a case of patient with p16 
negative (-ve) OSCC, with HPV positivity by PCR investigation both in histological and on 
cytological samples. 
2. Case Report
A Caucasian man of 61-years old, with any diseases or comorbidities noteworthy, referred to
our Unit of Oral Medicine (Di.Chir.On.S./UNIPA) for the diagnostic assessment of a asymptomatic 
verrucous lesion localized at the right retromolar trigon (Figure 1). 
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Figure 1. Verrucous lesion localized at the right retromolar trigon. 
After informed consent, the patient underwent to: (i) oral rinse for HPV investigation (by PCR); 
and (ii) incisional biopsy both for HPV identification (by PCR and p16 IHC) and histological 
diagnosis. For PCR investigation, the HPV-DNA was extracted from oral rinse and biopsy sample 
with the use of the QIAamp Mini Kit (Qiagen). HPV genotypes were identified by the Ampliquality 
HPV-type express v3.0. 
The histological reports was: squamous carcinoma/p16 IHC-ve. 
On the contrary the microbiological examinations indicate a HPV positive status, supported by 
HR (High Risk) genotype 67 in both examined samples. 
3. Conclusions
We report a case of confirmed diagnosis of HPV-DNA+ve/p16-ve OSCC at the right retromolar
trigon. Exclusively according to the results of p16 IHC, the patient would have been resulted as 
negative HPV OSCC with a specific treatment. On the contrary, the use of more accurate technique 
of HPV investigation, highlighted a HPV-HR positivity. 
This status, in addition to other therapeutic and monitoring oncological approaches potentially 
prospective, presupposes a specific management of the infectious condition (i.e., genital 
investigation, also for the partner/s) which, in the absence of the supplementary microbiological 
investigations conducted, would have been precluded. 
In conclusion, it would be appropriate to consider, particularly for SCC in proximity to 
oropharyngeal areas, the necessity to use a combination of techniques (not only p16 IHC) for HPV 
status identification. 
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Fibrous dysplasia (FD) is a rare benign congenital condition characterized by the replacement of 
normal bone with fibrous connective tissue mixed with irregular bone trabeculae. The TAC Cone 
Beam represents the most effective mean for the evaluation of craniofacial FD (CFD). There are three 
possible approaches to the treatment of CFD: monitoring, pharmacological therapy and surgical 
treatment [1]. The aim of the study was to clarify on the basis of the present diagnostic means the best 
one to define the most appropriate therapeutic approach in the case shown in our work ie a woman 
of about fifty years of Brazilian origin, who came to us with an asymptomatic deformation of the left 
mandibular body. 
In addition to the exams already in our possession, the patient was invited to perform a bone 
scan to evaluate radiopharmaceutical uptake and the possible presence of other skeletal lesions, as 
indicated by the hospital protocol for cases of suspected fibrous dysplasia. From the performed 
scintigraphic examination a significant asymmetry of the distribution of the osteotropic tracer on the 
left lower jaw was highlighted. 
To confirm the diagnostic suspicion of fibrous dysplasia, a biopsy was performed. 
Having ascertained the nature of the lesion, a conservative surgical approach was therefore 
deemed appropriate, aimed at restoring the bone size of the mandibular body without intervening 
on the branch, where the lesion did not have an extension such as to cause aesthetic alterations (Figure 1). 
The surgery involved an osteotomy with removal of the hypertrophic segment and a curettage 
of the bone gap with removal of fibro-osseous particulate and of an included dental element. The flap 
was then closed by a single interrupted suture which was then removed after one week; the patient 
was monitored until the wound was completely healed [2]. 
The final result was satisfactory with a restoration of facial aesthetics and no neurological 
consequences (Figure 2). 
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Figure 1. Clinical aspect during the surgery procedure. 
Figure 2. Final result after 6 months.
FD is a rare condition that can frequently involve the facial district. The indication for surgical 
treatment is not absolute, but a careful evaluation must be performed by the clinician, based on the 
location of the lesions and the aesthetic and functional implications that these may entail, reserving 
a more radical approach to cases of suspected neoplastic evolution. 
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The formation of an oro-antral communication following avulsion of the lateral and posterior 
teeth of the maxilla is not an exceptional event in dental practice; it can undergo spontaneous 
resolution or the formation of a fistula that requires surgical treatment in order to create an absolutely 
hermetic barrier between the oral environment and the maxillary sinus [1]. The aim of the study was 
to provide a review of the literature on the surgical techniques currently in use for the resolution of 
oro-antral communications, that are the trapezoidal, rotated vestibular, rotated palatine, buccal fat 
pad and double-layered flap techiniques; therefore to describe the central theme of the study that is 
the technique of mucogingival plastic surgery called modified double-layered flap techinque 
moderately invasive and less subject to medium and long term recurrences [2]. 
We performed a review of the methods used to solve small oroantral communications (Figure 
1) and carried out a case report on the alternative technique proposed by the Odontostomatology
Unit of the Galliera Hospital in Genoa, ie the modified double-layered flap technique.
Figure 1. Example of a small oro-antral communication treated with the technique proposed.
The intent therefore remains to propose a valid protocol that is not a substitute but an alternative 
to the pre-existing ones, which have already been exhaustively described in the literature. The present 
protocol (Figure 2) has also been recognized and published by the authoritative source of the British 
Journal of Oral and Maxillofacial Surgery. 
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Figure 2. U-shaped anchorage to the vestibular fornix: the palatal flap constitutes the inner lining and 
the displacement of the vestibular flap optimally closes the primitive defect.
With regards to the satisfactory results obtained, we can state that this method is predictable. 
The oro-sinus and in particular the alveolus-sinus communications are mostly sequelae of 
previous dental treatments and avulsions. The dentist is required to diagnose and identify the most 
appropriate therapeutic approach. Among the various techniques available, the modified double-
layered flap technique is certainly a valid choice, as it has good predictability [3]. 
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The formation of an oro-antral communication, a not uncommon event in dental practice, may 
lead to spontaneous resolution or to the formation of a fistula that requires surgical treatment in order 
to create an absolutely hermetic barrier between the oral environment and the maxillary sinus [1]. 
The aim of the study was to provide a summary review of the literature on the surgical 
techniques currently in use for the resolution of oro-antral communications, that are the trapezoidal, 
rotated vestibular, rotated palatine, buccal fat pad and double-layered flap techniques; then to 
describe the central theme of the study, that is the technique of mucogingival plastic surgery with the 
use of a dorsum of tongue flap (Figure 1) if it is not possible to use adjacent tissue to close the 
communication. 
Figure 1. In this case we decided to use the technique of mucogingival plastic surgery with the use of 
a dorsum of tongue flap because it wasn’t possible to use adjacent tissue to close the communication. 
In fact, when the tissues adjacent to the oro-antral or oro-nasal communication are unsuitable 
for the closure of a large sized fistula, a muscolar-mucosal flap from the tongue dorsum can be used 
and rotated upwards. 
Once this initial phase is performed, the peduncle of the flap is dissected and the excess will be 
repositioned to partially reconstruct the area of the dorsum of tongue used. We prepared a case report 
and we have photographs of the clinical situation after 20 years the surgery was performed 
(Figure 2). 
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Figure 2. We see the clinical situation after 20 years the surgery was performed. 
With regards to the satisfactory results obtained, we can state that this method is predictable. 
It’s very important also the early diagnosis that allows the clinician to plan a therapeutic treatment 
that offers the best guarantees of success [2]. 
The intent therefore remains to propose a valid protocol that is not a substitute but an alternative 
to the pre-existing ones, already exhaustively described in literature in the specific case described [3]. 
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Malignant neoplasm of the salivary glands account for 3% to 6% of all head and neck cancers. 
The incidence of malignant salivary gland tumors is considerably higher in minor salivary glands 
(MSG) accounting for 30% of all salivary cancers [1] and can present themselves in a very elusive 
fashion because of the heterogeneity in subsite and wide spectrum of histological subtypes. The 
surgical therapy depends on site, stage, and histological grading [2]. 
The aim of this study is to highlight the importance of achieving a preoperative histological 
diagnosis focusing on histological subtype and grading in order to sketch out a targeted surgical 
therapy. 
The authors selected all cases of MSG malignancies treated from 2000 to 2018 from the Complex 
Operating Unit of Odontostomatology of University of Bari. All the patients in the diagnostic phase 
underwent to clinical examination, high definition intraoral ultrasonography, TC/MRI, 
pre-operative FNAB/FNAC with cytological/histological and immunohistochemical examination. 
Surgical therapy was: conservative for low-grade malignancies (LGM), and resective with neck 
dissection for high-grade malignancies (HGM). 
The authors selected 146 patients. In all cases the histological diagnosis and grading was 
achieved in the pre-operative phase. 94 were diagnosed as LGM and 52 as HGM. About the LGM: 
• Twelve cases were diagnosed as Polymorphous Low Grade Adenocarcinoma (PLGA): 9 M and
3 F, mean age 54, 10 on palate and 2 on cheek;
• Forty-one cases were diagnosed as low-grade Mucoepidermoid Carcinoma: 29 F and 12 M,
mean age 37, 33 on the palate, 4 on the cheek, 2 on the lip and 2 on the tongue;
• Thirty-four cases were diagnosed as low-grade Adenoidocistic Carcinoma: 18 F and 16 M, mean
age 61, 29 on the palate, 1 on the cheek, 3 on the lip and 1 on the tongue;
• Seven cases were diagnosed as Intercalated Duct Carcinoma: 3 F and 4 M, mean age 64,
localized on the palate.
About the HGM:
• Nine cases were diagnosed as Clear cell Carcinoma: 4 F and 5 M, mean age 63, 8 on the palate
and 1 on the lip;
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• Nineteen cases were diagnosed as High-grade Mucoepidermoid Carcinoma (of which 5 clear
cell high grade mucoepidermoid carcinoma, 6 on long-standing Pleomorphic Adenoma): 14 F
and 5 M, mean age 41, 16 on the palate, 1 on the cheek, 1 on the lip and 1 on the tongue;
• Thirteen cases were diagnosed as high-grade Adenoidocistic Carcinoma (of which 3 clear cell
high grade mucoepidermoid carcinoma, 2 on long-standing Pleomorphic Adenoma): 5 F and 8
M, mean age 54, 10 on the palate, 2 on the cheek and 1 on the lip;
• Eleven cases were diagnosed as basaloid or undifferentiated carcinoma: 5 F and 6 M, mean age
62, 9 on the palate and 2 on the cheek.
In conclusion, preoperative FNAB/FNAC for histological diagnosis of MSG malignancies is
mandatory in order to make decisions on the type of surgical treatment. 
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1. Sardar, M.A.; Ganvir, S.M.; Hazarey, V.K. A demographic study of salivary gland tumors. SRM. J. Res.
Dent. Sci. 2018, 9, 67–73.
2. Baddour, H.M.; Fedewa, S.A.; Chen, A.Y. Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of
the Minor Salivary Gland. JAMA Otolaryngol. Head Neck Surg. 2016, 142, 67–73.
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
138
Proceedings 2019, 35, 63; doi:10.3390/proceedings2019035063 www.mdpi.com/journal/proceedings
Extended Abstract 
Oral Leiomyosarcoma or Low-Grade 
Myofibrosarcoma: Report of a Challenging 
Differential Diagnosis † 
Melania Lupatelli 1, Giovanni Agrò 1, Alessandro Fornari 2 and Monica Pentenero 1,* 
1 Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano (TO), Italy; 
melanialupatelli@gmail.com (M.L.); dr.giovanni.agro@gmail.com (G.A.) 
2 Pathology Division, San Luigi Gonzaga Hospital, 10043 Orbassano (TO), Italy; alefornari77@gmail.com 
* Correspondence: monica.pentenero@unito.it; Tel.: +39-0119026419
† Presented at the XV National and III International Congress of the Italian Society of Oral Pathology and
Medicine (SIPMO), Bari, Italy, 17–19 October 2019. 
Published: 12 December 2019 
Soft tissue spindle cell neoplasms represent less than 1% of all malignancies [1]. The pathological 
definitive diagnosis is challenging due to the presence of atypical histopathological and 
immunohistochemical (IHC) features; in more than one-third of cases the assessment of the surgical 
specimen allows to refine the first diagnosis from incisional biopsy.  
A 31-year-old woman was referred for a painful ulcerated fast-growing swelling on the right 
posterior palate, with palpable cervical lymphadenopathy (Figure 1). Her past medical history is 
notable for thyroid and breast carcinomas. Incisional biopsy showed atypical spindle cell 
proliferation arranged in fascicles, with wavy nuclei and prominent nucleoli, low mitotic activity and 
no necrosis. IHC just demonstrated low positivity for smooth muscle actin; pan-cytokeratin, desmin, 
S100, CD34, CD31, CD10, ß-catenin were not found. These features were suggestive for a low-grade 
myofibrosarcoma (LGMS). Imaging (MRI, PET/CT, CT) showed a local spread to pterygopalatine and 
infratemporal fossa and regional node involvement. Neoadjuvant chemotherapy (epirubicin + 
ifosfamide) was performed before wide surgical resection. Assessment of the surgical specimen 
highlighted positive IHC for caldesmon protein leading to a final diagnosis of leiomyosarcoma 
(LMS). On account of multiple tumours, a NGS multi-gene panel testing including PTEN, BRCA1, 
BRCA2, TP53, ATM and CHEK2 was performed. ATM heterozygous mutations in exon 24 and 
CHECK2 homozygous mutation in exon 4 were found.  
Figure 1. Submucosal ulcerated mass on the right side of the hard palate. 
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LMS represents approximately 3% to 10% of H&N sarcomas [2]. The common morphological 
pattern includes broad fascicles of spindle cells with blunt ended, brightly eosinophilic cytoplasm, 
cigar-shaped nuclei and occasional perinuclear vacuoles. LMS normally shows positive IHC for 
mesenchymal smooth muscle antigens, while desmin is variably positive. IHC for S-100 protein, 
epithelial, neurofilaments, factor VIII–related and angiosarcoma is usually negative. Different 
tumours with myofibroblastic origin and LMS share similar morphological and IHC patterns making 
the differential diagnosis challenging. LGMS, whose definition was revised in 2013, originates from 
myofibroblasts, mesenchymal spindle-shaped cells with ultrastructural features of fibroblasts and 
smooth-muscle cells. In LGMS, malignant myofibroblasts differ from LMS for palely eosinophilic 
cytoplasm and sometimes round-shaped or vescicular nuclei with indentations and small indistinct 
nucleoli. IHC staining shows variable positive reactions for actin and/or desmin; heavy positivity to 
caldesmone is more rarely observed when compared to smooth muscle cells. Wide surgical resection 
with clear margins is the mainstay management for oral LMS, with a five-year survival rate of 55%. 
Local recurrences are frequent and distant metastases occur especially in lungs. Other than this, LMS 
arising from the oral cavity has a high rate of regional involvement. Sometimes sarcomas occur in 
heritable cancer predisposition syndromes: recent studies reported multiple genes involved in the 
development of LMS, among which ATM and CHEK2. Genetic studies could lead to novel therapies: 
to date AKT/MTOR pathways seem to be the most promising potential therapeutic targets especially 
in high-grade LMS.  
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1. Introduction
In recent years, works have shown that probiotics have beneficial localized effects. Probiotic
treatment is effective against diseases and infections of the skin and mucous membranes [1]. Several 
studies on the probiotic Lactobacillus Reuteri (L. Reuteri) have demonstrated anti-inflammatories 
and antimicrobials effects [2]. 
2. Materials and Methods
A 48-year-old female patient with non-plaque and tartar gingival papilla swelling between the
upper incisors 1.1–1.2, went to our observation (Figure 1). She takes drugs for hypertension and 
vitamin D supplement, suffers from periodontal diseases in a good state of maintenance and was 
subjected to professional oral hygiene sessions every 4 months. It was decided to perform a biopsy, 
scheduled 2 weeks later. To restore the oral probiotic microbiota L. Reuteri have been suggested. 
Tablets of Lactobacillus Reuteri DSM 17938 ATCC PTA 5289 have been prescribed as home therapy 
twice a day, for two weeks, dissolving them slowly in the mouth after careful oral hygiene, taking 
care to rub the tablet with the tongue against the swollen papilla. At the check the gum appeared 
during the normalization phase, so the treatment was prolonged for another two weeks, and the 
biopsy has been postponed (Figure 2). 
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Figure 1. Patient before using probiotics L. Reuteri DSM 17938 ATCC PTA 5289. 
Figure 2. Patient 4 weeks after therapy with L. Reuteri DSM 17938 ATCC PTA 5289. 
3. Results
4 weeks of follow-up were carried out. The gingival papilla is completely healed after treatment 
with L. Reuteri. 
4. Discussion and Conclusions
Oral treatment with tablets containing the probiotic strain of L. Reuteri induces in most patients 
a significant reduction in the proinflammatory cytokine response and an improvement in clinical 
parameters [3]. L. Reuteri is known for its secretion of 2 bacteriocins, reuterine and reutericiclina, 
which inhibit the growth of a wide variety of pathogens; it also has a strong ability to adhere to host 
tissues with localized anti-inflammatory and antimicrobial effects [2]. Probiotics present a new ray 
of hope in periodontal therapy with a proven track record of safety and efficacy [2,3]. The use of 
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topical probiotics in the treatment of gingival hypertrophy could be considered a valid alternative to 
conventional treatments. Further studies must be performed to confirm this starting result. 
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1. Introduction
Lips are a complex anatomical structure with a significant functional and aesthetic role which
can be affect by numerous pathologies with different etiology [1]. Furthermore, lips often reveal to 
be the first site of manifestation of important systemic diseases [2]. This emphasizes the role of the 
dentist in the early detection of these disorders. 
2. Purpose
Aims of this work are to describe an unusual case of adverse labial solar reaction and to make a
brief review of the literature of pathologies included in the differential diagnosis. 
3. Case Report
A 78-year-old woman patient was visited, in February 2019, for the sudden appearance of a
lesion on the lower lip. Her medical history showed: chronic renal failure (CRF) and consequent 
cardiovascular disease. The patient underwent hemodialysis three times a week and her 
medications consisted of: furosemide, calcium carbonate, calcitriol and sodium polystyrene 
sulfonate for the CRF treatment and amlodipine, carvedilol, telmisartan and low molecular weight 
heparin for the cardiovascular disease treatment. Upon clinical examination, an irregular lesion was 
found localized on the entire surface of the lower lip characterized by active bullous lesions and 
completely eroded areas, partially ulcerated covered by clots and fibrin (Figure 1a). Further 
evaluation did not reveal other lesions in the upper lip, buccal mucosa, perioral and general skin. 
The patient reported a sun exposure shortly before the lesion appeared. Clinical features initially 
suggested a malignant or premalignant disease for which an incisional biopsy was planned that was 
no longer performed following the brief healing of the lesion occurred in five days (Figure 1b). The 
patient reported having used, as an emergency treatment, the mucilaginous gel from the 
parenchymatous leaves of Aloe vera, with subsequent immediate relief.  
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(a) (b) 
Figure 1. Clinical presentation of the lesion and subsequent healing. (a) Vesiculobullous lesion on the 
lower lip; (b) Resolution of the lesion. 
4. Literature Review
A search of the National Library of Medicine’s PubMed Database was conducted using the
word “lip” together with one or more of the following key words: “cancer”, “actinic cheilitis”, 
“erythema multiforme”, “burn”, “bullous infection”, “pemphigoid” and “pemphigus” in the last ten 
years. Inclusion criteria were any labial disease included in the differential diagnosis: malignant and 
premalignant pathologies, vesiculobullous, ulcerative and infectious diseases, adverse drug 
reactions and chemical burns. The initial search strategy yielded 2197 potentially relevant 
publications, of these, 636 studies were included in the review.  
5. Result and Conclusions
The review did not lead to any clinical case similar to the one examined, which presents a very
complex diagnostic decision-making approach. In literature, however, numerous cases of crusted 
vesiculobullous photodermatoses have been attributed to cases of pseudoporphyria (PP) [3]. 
Development of PP has been associated with sun exposure, CRF, hemodialysis and medications 
including diuretics and unlike porphrya cutanea tarda, hypertrichosis and sclerodermoid changes 
are not seen in PP, all factors present in this case. 
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1. Background
Lymphangiomas are benign congenital malformations arising from the lymphatic system. A
hamartomatous nature has been claimed for this heterogeneous cluster of disease, which is 
characterized by abnormal development of lymph nodes, leading to lymph collection and 
subsequent swelling [1,2]. In particular, in the head and neck district lymphangiomas occur with 
high frequency, representing almost 75% of cases. Orofacial lymphangiomas can be congenital, or 
develop by two years of age. The submandibular space and the posterior triangle of the neck are the 
most affected regions, followed by parotid area, tongue, and floor of the mouth [3]. The lesions are 
generally characterized by slow growth, although rapid enlargement can be observed in cases of 
infection or trauma. As a peculiar characteristic, lymphangiomas do not tend to spontaneous 
regression, often making necessary a surgical approach to the lesion, due to an impairment in 
function and aesthetics. 
2. Case Report
A 11-year-old female patient was referred to the Unit of Dentistry and Oral Surgery, University
of Pisa, for the development of a moderate swelling of the mouth floor. At clinical examination, the 
patient showed an asymptomatic tumefaction involving the right side of the mouth floor, causing 
lingual displacement (Figure 1). Considering medical history, the patient was affected by juvenile 
idiopathic arthritis, and was under pharmacological treatment with methotrexate and adalimumab. 
Several pathologic conditions entered differential diagnosis. However, sublingual ranula was 
strongly suspected due to the localization and the rapid development of the lesion [4]. 
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Figure 1. Clinical aspect of the lesion. A bluish fluctuant swelling covered can be observed in the 
right side of the mouth floor. 
Head and neck MR was performed to better investigate the lesion, revealing the presence of a 
large mass occupying the right half of the mouth floor, and characterized by hyperintensity in T2 
(Figure 2). 
Initially, surgical approach was performed, with the marsupialization of the lesion and bioptic 
sampling. Histology revealed the presence of lymphatic channels in a connective tissue stroma, 
characterized by focally disorganized and thinned epithelium, and peripheral lymphoid aggregates. 
Figure 2. T2-weighted MR axial images. 
Second surgery with the complete removal of the lesion was then performed. At 6-month 
follow-up, no signs of recurrence were observed. 
3. Conclusions
Lymphangiomas usually develop early in childhood. In this peculiar case, lymphangioma
developed in a 11-year-old patient, showing sudden presentation and rapid enlargement. Histology 
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was fundamental in discriminating the nature of the lesion. Surgical approach lead to resolution of 
the case and complete healing at 6 months, consistently with the non-recurring nature of the disease. 
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1. Background
Clear cell odontogenic carcinoma (CCOC) is a rare malignant odontogenic tumor histologically
characterized by sheets and lobules of vacuolated and clear cells. To date, only 107 cases have been 
reported in literature since its first description by Hansen et al. in 1985 [1]. Initially classified as a 
benign neoplasm with the tendency to local invasion., in 2005 the World Health Organization 
redefined CCOC as a malignant tumor of odontogenic origin, characterized by local recurrence and 
presence of nodal metastases. Due to its infrequency, diagnostic criteria, protocols, and prognosis of 
CCOC are often not fully understood [2,3]. Additionally, CCOC shares comparable clinical and 
pathological characteristics with other diseases, possibly leading to misdiagnosis [4]. 
2. Case Presentation
A 64-year-old female patient was referred to the Unit of Dentistry and Oral Surgery, University
of Pisa, for the evaluation of a gingival tumefaction in the anterior mandible. Considering medical 
history, the patient was affected by diabetes mellitus and hypertension, and was under 
pharmacologic treatment with Metformin, Levothyroxine, and Amlodipine. 
At clinical examination, the patient showed an ulcerated gingival mass localized in the right 
mandible, associated with grade III mobility of tooth 43 (Figure 1). Panoramic radiograph showed a 
multilocular mixed area involving the right side of the mandible (Figure 2). CT-scan showed an 
osteolytic lesion with bicortical bone destruction. Incisional biopsy was performed, and on the basis 
of the histopathologic examination a diagnosis of amelobastic carcinoma was made. Head and neck 
MR and total body PET-CT were performed to further investigate the lesion. Radical surgery 
included hemimandibulectomy and lymph node dissection, obtaining clear resection margins. A 
fibula osteoseptocutaneous flap was employed for the reconstruction of the post-surgical 
composite-tissue defect of the mandible. interestingly, second histology of the surgical specimen 
revealed a diagnosis of CCOC (positive immunodetection for anti-AE1/AE3, anti-CK19). 
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Figure 1. Clinical aspect of the lesion, involving alveolar ridge and tooth 43. 
Figure 2. Panoramic radiograph. Radiolucent inhomogeneous area involving the right side of the 
mandible. 
3. Conclusions
COCC is a rare tumor with major diagnostic difficulties. Immunohistochemistry analysis plays
a key role in differential diagnosis with other odontogenic tumor. As suggested in other studies, the 
best treatment for COCC is wide local excision combined with regional lymph node dissection.
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1. Introduction
Ulcerative aftosis are peculiar painful lesions widely observed with common histological and
pathological aspect with doubtful etiology and fewer predictable treatments [1]. These lesions are 
considered with primary importance in detection of some systemic issues and are often related to a 
wide number of pathological immune and stress-related impairments [2,3]. Elective treatment ranges 
from light topical anesthetics to ialuronate-based topical medications. As a bacterial thesis is 
proposed but never widely accepted, treatment oriented in antimicrobial way are very common, but 
presents few predictable results due to high heterogeneity. Here we evaluate a Photobiostimulation 
tissue-healing protocol [4]. 
2. Materials and Methods
Three patients were observed, diagnosed and treated in private practice office.
Patient history 1. Male aged 47 years, suffering from anxiety no systemic disease. He does not 
suffer from recurrent aphthous, referring only few episodes. 
Patient history 2. Female aged 34, Hashimoto thyroiditis, recurrent aphthous stomatitis for 2 and 
a half years. Slow healing of mouth ulcers episodes (Figure 1). 
Patient history 3. Female aged 60. Gluten intolerance, absent systemic diseases. 3 Episodes of 
recurrent aphtosis per year (always single and minor). 
Stimulation was performed using light Laser B-cure 808 nm wavelenght, 250 mw power (Erika 
Carmel Ltd., Jerusalemm, Israel). It was applied directly on mouth ulcerations for 6 consecutive 
minutes. The device does not include projective tips, there are no probes to be applied.  
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Figure 1. Patient before using the laser. 
3. Results
All patients showed minor and major improvements. After 24 h, no pain symptoms were
reported. After 2 days, partial or complete healing of the lesions was observed (Figure 2). 
Figure 2. Patient two days after using the laser. 
4. Discussion and Conclusions
Photobiostimulations protocols can be applied in the treatment of oral ulcerative lesions in
recurrent cases. More reports and in vitro studies are needed to perform severe and well designed 
clinical protocols. 
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1. Introduction
Detection of labial lesions in one of the more common addictional tasks for dental clinicians.
These lesions are common, painful and eligible for healing trouble due to occlusion issues and 
comorbility factors: salivary flow rate, micotic acute opportunistics sub infections and systemic health 
impairments. Angular cheilitis is one of the most common labial lesion in commissural space. Painful, 
symmetrical and often hemorragic. Traditional treatment consist in antimicotic topical preparations 
such Clotrimazole, Antimicrobial topical ointment and Ialuronate derived lubricants. Advanced non 
responsive lesions could be treated with fillers and invasive infiltrative medication. Antimicrobial-
Photodynamic therapy demonstrated high efficacy with Gram + and Gram  bacterial species. Here 
we suggest a clinical protocol used in well-wounded labial lesion using photosensitizers and diode 
light. 
2. Materials and Methods
Four patients (3 females and 1 male) were treated with same protocols in private practice office. 
After lesion check and diagnosis of angular cheilitis labials lesions were treated with topical 
Toluidine Blue High Viscosity (CMS Dental, Copenaghen, Denmark) 1 mg/mL solution gently 
applied on the exposed dermal surface (Figure 1). After sensitizer exposition, a 4 watt, 630 nm wave 
length, light emission were performed for a ten cycles of 30 s (Fotosan 630® CMS dental—
Copenaghen, Denmark). After the photosensitizer was removed.  
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Figure 1. Patient before using Fotosan 630. 
3. Results
7 days follow up were performed (Figure 2). Three patients showed complete and integral
Resitutio ad integrum. Only one patient with severe occlusion issue shown a partial healed wound and 
non-integral epithelial growth after 30 days. 
Figure 2. Patient 7 days after using Fotosan 630. 
4. Discussion and Conclusions
Physical activity and chemical properties of a PDT and sensitizer adjuvancts may be used in
treatment of severe non responsive labial lesions due to their antimicrobial and bacteriostatic 
properties. 
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Medication-Related Osteonecrosis of the Jaw (MRONJ) and Squamous Cell Carcinoma (SCC) 
are two distinct nosological entities that can affect the oral cavity, with different etiopathogenesis 
and histology. Nevertheless, the bone exposure surrounded by altered mucous tissue as a clinical 
manifestation of a therapy with anti-resorptive drugs can look similar to the clinical scenario 
observed in cases of oral carcinoma. Hence a correct diagnosis can be challenging [1,2]. 
A 71-year-old female patient, no smoker and no alcohol drinker, underwent treatment with 
Alendronate for osteoporosis for 4.5 years. The patient was referred by a Colleague with a 
preliminary diagnosis of MRONJ to the Oral and Maxillofacial Surgery Unit, University of Bologna, 
for the management of the symptomatic bone exposure. This scenario appeared about a month 
before and was preceded by swelling about two months before in the upper left molar alveolar 
region rehabilitated with a prosthetic bridge 10 years before. The clinical examination confirmed the 
presence of bone exposure in the reported site surrounded by an affected soft tissue on the palatal 
and buccal side: the mucosa appeared strongly inflamed with a granulomatous appearance and with 
rolled edges (Figure 1).  
Figure 1. Clinical examination. 
The panoramic x-ray did not show any sign of pathology. The Cone Beam CT revealed the 
presence of an oro-sinus communication of about 1 cm diameter, thickening of the sinus mucosa; the 
residual alveolar bone showed structural alterations with a chromatic radio-opaque and radio-lucent 
areas irregularly distributed (Figure 2).  
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Figure 2. CBCT: paraxial cuts. 
The first diagnostic option was MRONJ. Nevertheless, the particular conformation of the oral 
mucosa, the strong pain complained by the patient and the rapidity of occurrence usually does not 
match with a MRONJ scenario due to an adverse reaction to Alendronate, especially if had been 
assumed only for 4.5 years. The histological exam, carried out on an incisional bioptic portion of 
mucosa, reported the diagnosis of SCC involving the sub-mucosal layers, moderately differentiated, 
with signs of perineural infiltration. Hence, the patient was sent to the Maxillofacial Surgery Unit, 
Sant’Orsola-Malpighi Hospital of Bologna for surgical treatment in general anesthesia. We are 
waiting for the final histological report.  
In conclusion, this singular case highlighted that the correct diagnosis is to be reached only with 
a careful anamnestic and clinical evaluation and a consequent peculiar diagnostic path. This goal can 
be reached only after a deep sharing of knowledge between the members of a specialized team that 
can take in consideration all the diagnostic options, even the less probable ones.  
Furthermore, a question must be addressed, in our opinion, as soon as possible: which way and 
which relevance can the anti-resorptive drugs therapy influence the bone infiltration of an oral 
cavity SCC with? 
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Metabolome is the comprehensive assembly of metabolites in biologic tissues and/or fluids. The 
study of metabolic profiles may give important information about the health status. Recently, many 
researches have been focused on saliva diagnostics, based in its abundant production and easier way 
of collection [1].  
The present study reports the differences in concentration of bacterial short-chain fatty acids 
(SCFA) in 3 different types of saliva (parotid–PS; submandibular/sublingual–SMS; whole saliva–WS) 
and serum. Moreover, urea concentration, a nitrogen source, has been correlated to bacterial 
metabolism in PS, SMS, WS.  
Ten healthy males and 10 females, aged between 20 and 25 years, were enrolled. Subjects with 
hyposalivation (modified Saxon’s test < 5 mL/5 min) and/or with evidence of periodontal disease 
(periodontal screening and recording–PSR > 3 in one of the sextant) and/or caries (decay missing 
filled teeth–DMFT > 5 teeth with active carious lesions) were excluded. Subjects with full mouth 
bleeding score (FMBS) and full mouth plaque score (FMPS) > 25% were treated through non-surgical 
periodontal therapy, 15 days before saliva collection. Saliva and serum samples were collected 
between 9 and 11 a.m. Subjects were asked to avoid intense workout for 12 hours before collection, 
as well as food, beverage different from water and toothpaste or mouthwash. The metabolic profile 
was evaluated by Proton Nuclear Magnetic Resonance (1H-NMR). Statistical analysis was performed 
through contingency tables, using the chi-squared test (p < 0.05 significant of association). 
Among the metabolites identified in saliva, the SCFA-formate (1C), acetate (2C) and propionate 
(3C) were produced by bacterial flora. Acetate was the most abundant metabolite in all types of saliva 
followed by propionate and formate. The acetate concentration determined was 2556.4 μM in WS, 
676.4 μM in PS and 354.4 μM in SMS. In serum, acetate concentration is 56.9 μM indicating the 
endogenous contribution of the total amount of this metabolite. Propionate was 14 times less 
concentrated in PS and SMS and 9 times less in WS than acetate. Formate is produced by a different 
metabolic pathway and were present in lower concentration and 57.7 μM in WS, 27.2 μM in PS and 
22.9 μM in SMS. Differences of the 3 metabolites in the 3 typologies of saliva are statistically very 
significant (p < 0.0001). 
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When each SCFA is compared to urea (acetate vs. urea; propionate vs. urea and formate vs. urea) 
differences are statistically very significant (p < 0.00001), indicating an inverse relationship among the 
three different typologies of saliva. 
To the best of our knowledge this is the first study which takes into account the metabolic 
contribution of SCFA to the SMS composition. Three of the metabolites most commonly produced by 
bacteria spp. are found in significantly higher concentration in WS respect to PS and SMS, indicating 
a differential presence of bacteria spp., among the three types of saliva.  
Particularly, the very high concentration of acetate supports the hypothesis of the presence in 
the oral cavity of peculiar species of “acetogenic” bacteria.  
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Radiotherapy (RT) is an effective treatment for head and neck cancer. A multimodal approach 
combining RT with surgery and chemotherapy has produced a significant increase in patients’ 
survival rates. Patients who undergo RT may experience several adverse oral effects, among which 
Osteoradionecrosis (ORN) is the most severe, and tooth extractions in irradiated jaws are considered 
as the most severe risk factor.  
It is recommended that patients undergoing head and neck RT should have a dental assessment 
before the start of the RT to minimize the risk of developing ORN by removing oral foci. Sadly, not 
all patients are referred to a dentist before the beginning of the RT; thus, some patients might require 
dental extractions during or after radiotherapy. In these circumstances, endodontic treatment is 
generally preferred to extractions even in non-restorable elements [1].  
A preoperative diagnostic digital radiograph was taken to assess the apical status and the dental 
conditions. All periapical radiographs showed the absence of a periapical radiolucency. All therapies 
were performed by the same surgeon in a single visit. An intraoperative, a postoperative and follow-
up radiographs were taken. The maintenance of a normal contour and width of the periodontal 
ligament and the absence of clinical signs and symptoms were considered radiographic and clinical 
success [2].  
All patients, after a 277-days (584-90 days) mean follow-up, were asymptomatic, and no teeth 
presented periapical radiolucency. No ORN was detected in the area of treated teeth. The 
administered radiation dose in the periapical area of treated teeth was calculated by contouring a 0.5 
cm3 on the radiotherapy planning CT-scan. The patients received a total mean dose of 65 Gy, and the 
periapical mean dose was 39.36 Gy (range 22.4–63.4 Gy).  
The success rate was 100%, regardless of the dose of RT received at the apex of the teeth or the 
time since patients underwent head and neck radiotherapy. No ORN was observed. 
The novelty of this study was the measurement of the periapical radiation doses received by 
each treated tooth, since a correlation between apical periodontitis and radiation dose in irradiated 
patients has been shown [3]. However, the absence of ORN onset confirms the safety of the 
endodontic therapy in irradiated patients. A higher sample size is required to assess the success rate 
of primary root canal therapy in irradiated patients and to establish a correlation between success 
and radiation dose.  
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1. Introduction
Several studies in the literature show that Low Level Laser Therapy (L.L.L.T) is effective in the
treatment of oral symptomatic soft tissue lesions such as recurrent aphthous stomatitis, herpes 
labialis, mucositis, erosive lichen planus. 
Fissured cheilitis labialis is a lesion that affects the center of the lower lip characterized by 
fissures, desquamation, erythema and crusts. The aetiology is usually multifactorial, due to a primary 
infection and/or non-infectious causes, such as mechanical irritation, nutritional deficiency or other 
dermatological conditions. Drug therapy is usually a combination of topical antifungals and 
antibacterials and glucocorticosteroid [1]. 
2. Materials and Methods
A 21 years old male patient went to my observation for a refractory lesion in the lower lip.
(Figure 1) The anamnesis was negative for systemic pathologies. A diagnosis of fissured cheilitis 
labialis was made. The patient has reported suffering for years of this pathology, which was 
refractory to any type of topical therapy, also on a cortisone basis. The patient was subjected to 3 
sessions of L.L.L.T with Nd: YAG laser (impulses of 25 ms, 1.55 w and 50 j/cm2) for 3 application of 4 
min each whit a 3-min intermission at the day 3, 6, 10. 
Figure 1. Labial fissured cheilitis. 
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3. Results
After the first photobiomodulation session we already noticed a marked improvement in the
tissues. At 10 days from the first treatment with L.L.L.T the complete and total healing of the lesion 
was obtained with restitutio ad integrum of the affected area (Figure 2). 
Figure 2. Labial lesion healed After L.L.L.T. 
4. Conclusions
In L.L.LT, the energy of the laser beam is absorbed by the intracellular chromophore resulting
in a specific response: increased cellular metabolism, improved blood circulation, increased ATP 
production, proliferation of all cells involved in tissue defense and repair, increased cellular 
respiration, increased growth factor release and new collagen synthesis. The L.L.L.T. has proved to 
be an extremely effective therapy in refractory fissured chelitis labialis [2–4]. 
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1. Lugovi -Mihi , L.; Pilipovi , K.; Crnari , I.; Šitum, M.; Duvan i , T. Differential Diagnosis of Cheilitis—
How to Classify Cheilitis? Acta Clin. Croat. 2018, 57, 342–351, doi:10.20471/acc.2018.57.02.16.
2. Avci, P.; Gupta, A.; Sadasivam, M.; Vecchio, D.; Pam, Z.; Pam, N.; Hamblin, M.R. Low-level laser (light)
therapy (LLLT) in skin: Stimulating, healing, restoring. Semin. Cutan. Med. Surg. 2013, 32, 41–52.
3. Hamblin, M.R. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem.
Photobiol. 2018, 94, 199–212, doi:10.1111/php.12864.
4. Spanemberg, J.C.; Figueiredo, M.A.; Cherubini, K.; Salum, F.G. Low-level Laser Therapy: A Review of Its
Applications in the Management of Oral Mucosal Disorders. Altern. Ther. Health Med. 2016, 22, 24–31.
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons 
Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
164
Proceedings 2019, 35, 74; doi:10.3390/proceedings2019035074 www.mdpi.com/journal/proceedings
Extended Abstract 
Nevus in the Oral Cavity † 
Daniela Sorrentino 1,*, Sem Decani 2, Camilla Zenoni 1 and Andrea Sardella 1 
1 Dipartimento di Scienze Biomediche, Chirurgiche e Odontoiatriche, Università degli Studi di Milano, 
20100 Milano, Italy; camilla.zenoni@gmail.com (C.Z.); andrea.sardella@unimi.it (A.S.) 
2 ASST Santi Paolo e Carlo, Ospedale San Paolo, UO Odontostomatologia II, 20141 Milano, Italy; 
sem.decani@hotmail.it 
* Correspondence: danielasorrentino1983@gmail.com; Tel.: +39-329-802-7264
† Presented at the XV National and III International Congress of the Italian Society of Oral Pathology and
Medicine (SIPMO), Bari, Italy, 17–19 October 2019. 
Published: 12 December 2019 
1. Introduction
The aim of this study is to describe a clinical case of a young female patient with oral nevus.
Pigmented lesions of the oral cavity represent a variety of clinical entities, ranging from physiologic 
changes to manifestations of systemic illnesses and malignant neoplasms. Oral pigmentations have 
either a melanocytic (endogenous lesions, including racial pigmentations, melanotic macules, 
melanocytic nevi, malignant melanoma) or a nonmelanocytic origin (exogenous lesions: amalgam 
tattoos). Although they may show similar clinical presentations, different treatments apply. 
Therefore, differential diagnoses pose a challenge in some cases. Microscopic examination can be 
necessary to rule out an early-stage melanoma [1–3]. 
2. Case
A 20-years-old woman was referred to the San Paolo Hospital in Milan due to the diagnosis of
a pigmented lesion in the oral cavity during a routine examination. Intraoral examination showed 
the presence of a painless, exophytic neoformation, covered whit dark spots, located on left 
mandibular gingiva, behind the wisdom tooth (Figure 1). The consistency was elastic-soft. The patient 
denied smoking and alcohol consumption. 
Figure 1. Clinical picture. 
3. Treatment
Therefore, an excisional biopsy was performed, under local anesthesia. The incision for biopsy was 
elliptic, and the lesion was completely removed, and the surgical area was sutured. The removed material 
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was fixed in 10% formalin and sent for anatomohistopathological examination. The diagnosis of composit 
melanocityc nevus was confirmed. After a week the suture has been removed (Figure 2). 
Figure 2. Postoperatory clinical picture. 
4. Conclusions
Pigmented lesions represent uncommon diagnoses at an oral pathology service. Often these
lesions are found in routine examination. Nevi, while uncommon, can occur in the oral cavity, and 
should be differentiated from other pigmented lesions, including oral melanomas that, although also 
rare, have a high mortality rate. When the nevi occur, they are most often found in females, in the 
third and fourth decade of life and the most common histological type is located on the palate and in 
the buccal mucosa. In this light, visual inspection of the oral cavity should be done very carefully, 
and the ideal treatment is the removal of the pigmented lesion whit a safety margin of 2 mm. 
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1. Introduction
The aim of this paper is to describe a case of a young female patient with oral pain caused by the 
presence of bilateral mandibular tori. The tori are exostoses formed by a dense cortical and limited 
amount of bone marrow, covered with a thin and poorly vascularized mucosa. These common 
intraoral exostoses (prevalence 20–25%) are usually located on the palatal midline or on the lingual 
side of mandibular bone. In most cases this kind of exostoses don’t cause pain or other symptoms 
and they aren’t considered pathological. They can affect pronunciation and interfere with swallowing. 
The development of tori can be due to genetic, environmental and functional factors.  
2. Case
A 34-years-old woman presented at the oral medicine department of the San Paolo Hospital in
Milan. The patient reported long-lasting oral pain, exacerbated by mastication and swallowing and 
the previous presence of ulceration of the oral mucosa. The clinical oral examination showed a thin 
layer of oral mucosa covering bilateral double prominent mandibular tori, aching on palpation 
(Figure 1). The anterior ones measured 8 mm, the posterior one located on the left side measured 15 
mm and the one on the right side measured 18 mm. Although tori removal is not always mandatory, 
according to the clinical features and the history of persistent pain, we decided to proceed with 
surgical removal.  
Figure 1. Mandibular tori. 
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3. Treatment
The surgery was conducted under local anesthesia. After a paramarginal incision, a
mucoperiostal lingual flap from 19 to 30 tooth, the removal of exostosis was performed by 
piezoelectric surgery and sutures were placed (Figure 2). The samples were sent to pathological 
anatomy department for histological analysis. Postoperative medication will consist of antibiotics, 
analgesics and anti-inflammatory medicine.  
After two weeks the patient arranged a new appointment. She referred an improvement of the 
symptoms. At the clinical examination soft tissue healthiness, completely healing of the surgical 
wound and no sign of inflammation were observed.  
Figure 2. Post-operatory picture, after tori removal. 
4. Conclusions
Although tori removal is not always necessary, there are situations in which it could be indicated:
prosthetic rehabilitation or necessity of autologous bone graft. In the event that the patient reports 
long-lasting oral pain due to the exostosis, the removal is strongly recommended. 
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1. Introduction
Nivolumab is an anti-programmed cell death receptor-1 (PD-1) antibody recently approved for
the treatment of melanoma, non-small-cell lung cancer, and several other solid tumours including 
head and neck cancers. By blocking the programmed cell death receptor-1 (PD-1), a checkpoint for 
the activation of the immune system, Nivolumab proved to enhance pre-existing immune responses 
inducing tumour recognition and attack. However, anti PD-1 blockage and related immune 
activation has also been related to adverse events including immunological skin, gastrointestinal, 
liver, endocrine system and other organ systems disorders. So far only few case reports have 
described lichenoid lesions triggered by nivolumab and restricted to oral cavity. In all, clinical 
appearance was that of multiple oral ulcers with histological features of lichenoid inflammation [1]. 
In this report we describe a case of reticular/erosive lichenoid lesions associated with nivolumab 
monotherapy.  
2. Case Report
A 60 years old women was referred by her dentist for the appearance of burning oral lesions non 
responding to conventional treatments. At examination, reticular bilateral striae in a context of 
atrophic ulcerative erosion could be noted. The patient had received a diagnosis of thyroid aden 
ocarcinoma in 2017 and had been treated with nivolumab monotherapy ever since. In 2019 she 
switched from a 240 mg/2 weeks regimen to a 480 mg monthly administration. 2 months after the 
change in the therapeutic regimen lesions appeared. The patient was also taking ranipril for blood 
pressure control. An incisional biopsy was taken revealing a band-like infiltrate mainly composed of 
lymphocytes with evidence of basal membrane aggression. Direct immunofluorescence was negative. 
Given the close change in cancer therapy and in absence of other putative factors, a diagnosis of 
lichenoid lesions associated with anti-PD-1 antibody inhibitors was made. In accordance with her 
oncologist, the patient preferred not to suspend nor change nivolumab therapy giving priority to 
tumour response. For the same reason the patient preferred to delay therapy with local/systemic 
steroid as symptoms did not impact significantly on her quality of life. She is currently on regular 
follow up. 
3. Conclusions
Lichenoid lesions associated with anti-PD-1 antibody inhibitors may manifest not solely as oral
ulcerative lesions but may adopt different clinical variants being thus undistiguishable from oral 
lichen planus. Given the recent approval of anti-programmed cell death receptor-1 (PD-1) antibodies 
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for many solid tumors the use of anti-PD-1 antibody inhibitors is expected to grow. Consequently, 
despite only few cases of oral lichenoid adverse reactions have been described and yet data regarding 
their clinical management is still limited, dentists should be informed of their existence in order to 
avoid delays in diagnosis and treatment. It is still unclear if concurrent medications may have a role 
in the pathogenesis. 
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Medication-related osteonecrosis of the Jaw (MRONJ) is an uncommon but potentially serious 
side effect of treatment with antiresorptive or antiangiogenic drugs among oncologic and 
osteoporotic patients. Clinical examination and radiological exams are mandatory for diagnosis and 
staging; nevertheless, even after II level exams, as Computed Tomography, MRONJ understaging is 
frequent [1]. Moreover, the association with pus discharge, chronic sinusitis and neurologic 
pathology is frequent, especially for Stage II and III lesions. To date, the treatment is still 
controversial, but many studies in the current literature state that only surgical removal of necrotic 
bone guarantees complete healing, especially for high stage lesions [1]. This surgical approach 
produces severe bone loss, with difficult aesthetic and functional prosthetic rehabilitation, because 
bone regeneration with autologous or heterologous graft cannot be performed among these patients [2]. 
The aim of the current study was to describe diagnostic and therapeutic protocol for patients affected 
by MRONJ, and subsequent rehabilitation with removable prosthesis (RP). 
For the current study, authors selected 41 patients from the database of MRONJ of the Complex 
Operating Unit of Odontostomatology comprehending 301 patients with 389 treated lesions. The 
inclusion criteria were: 
1. Diagnosis of Stage III MRONJ according with AAOMS criteria
2. Surgical treatment of MRONJ with complete healing after not less than 6-months follow-up
3. Total edentulism of upper and/or lower jaw after treatment
All lesions were diagnosed and treated according to our protocol. Patients’ anamnestic data
were collected; Rx OPT and multislice spiral CT with 3D reconstruction were performed for the 
staging. Patients underwent marginal bone resection including at least 1 cm of vascularized bone 
tissue. The depth of resection was pinpointed by the bleeding evaluation of bone tissues. Surgery was 
complemented by using piezosurgical device for osteoplasty and with the application of a medical 
device made of hyaluronic acid and amino acids. Subsequently, after complete lesions healing 
without recurrence, the selected patients underwent prosthetic evaluation and RP were inserted. All 
dentures underwent relining with soft materials to reduce risk of trauma on gingival tissue, and 
patients underwent periodic follow-up (once-a-month for the first year, then 3-times a year). 
Overall, after a follow-up time of not less than 3 years, all patient showed complete healing of 
MRONJ without signs and symptoms of recurrence. Removable prosthesis allowed a good functional 
and aesthetic rehabilitation, with patients’ satisfaction. Periodic relining with soft materials were 
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performed (generally every 3 months). Decubitus ulcers of oral mucosa were evaluated, especially 
after the first insertion of prosthesis, but they always healed after dentures adjustments and relining. 
In these cases, application of a gel compound with hyaluronic acid and amino acids was prescribed 
to accelerate wound healing thus reducing the risk of MRONJ occurrence. In no one case MRONJ 
onset was evaluated. 
Advanced Stages of MRONJ always require surgical treatment producing severe bone loss with 
aesthetic and functional deficit. In these cases, RP could be valid solution for patients. Nevertheless, 
considering that ill-fitting RP could produce MRONJ, periodic relining with soft materials and 
continuous adjustment are mandatory to avoid this complication. 
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Nowadays dynamic computer-based image navigation has become ordinary for hospital-based 
surgical specialties such as neurosurgery, otolaryngology and maxillofacial-surgery, its use for 
osteonecrosis curettage is considered “off-label” and isn’t reported in literature. The surgical 
navigator is a technological-tool which relate the real anatomy of a patient to his radiological images, 
showing the exact three-dimensional intraoperative position of surgical-instruments. In particular, 
ImplaNav (BresMedical, Sydney, Australia) is composed of an infrared-camera and reference 
systems that are placed on the patient and on surgical-handpiece, whose position is detected in real-
time by camera.  
In this report we expose the innovative use of navigated ultrasonic surgery in the treatment of a 
bilateral medication-related osteonecrosis of the jaw (MRONJ) stage 2b [1] involving the right 
mandibular canal’s roof in molar region, which is why the patient reported paresthesia to lower right 
lip, and incurred following the lower first molars’ extraction in a 75-year-old male patient, subjected 
to 43 previous administrations of Zoledronate (from January 2014 to June 2017) for the treatment of 
bone metastases from stage IV follicular-thyroid carcinoma. 
In order to operate with navigator’s aid, the patient’s pre-operative cone-beam computed-
tomography (CBCT) was performed by positioning a reference system on dental arches, fixed with 
an impression material, according to ImplaNav protocol [2]. 
The surgery was conducted as in-office procedure (Figures 1 and 2) under local anesthesia, after 
antibiotic-prophylaxis with Amoxicillin + Clavulanic-Acid 1 g/8 h and Metronidazole 250 mg/8 h, 
both from 3 days before the operation. The preparation of the buccal and lingual flaps and their 
subsequent suturing have been performed in order to ensure an optimal vision and primary wound 
closure. 
Compared to the traditional multi-blade burr mounted on a straight-handpiece, the well-known 
atraumaticity of ultrasonic-surgery allowed the respect of nerve-vascular bundle and a reduced 
trauma on the bone. The navigation added to the simultaneously clinical finding of bleeding bone, 
the possibility of a constant comparison between clinical vision and CBCT monitor vision, allowing 
a rapid and complete removal of the radiographically detected altered bone. 
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Figure 1. The reference systems placed on the patient and on the surgical-handpiece are detected by 
the infrared-camera. In this way, the monitor can show in real-time to the surgeon the exact three-
dimensional position of the surgical-instruments compared to the preoperative-CBCT. 
Figure 2. The intraoperative screenshot of the monitor shows the position of the ultrasonic tip 
compared to the preoperative-CBCT. The screenshot emphasizes how the surgeon, with the aid of the 
ultrasonic navigation system, can operate safely and accurately working in close proximity to the 
vascular-nerve bundle involved in the osteonecrosis. 
The patient continued the antibiotic therapy according to aforementioned posology for another 
7 days and, to date, has undergone checks at 1, 2, 4 and 12 weeks. During these visits a healing by 
first intention was appreciated in the absence of signs and symptoms of inflammation, however, 
paraesthesia remains, even if, as reported by the patient, in improvement. 
The navigated ultrasonic surgery, respect to conventional free-hand surgery, has reduced the 
timing of surgery and tissue injury and increased the accuracy, mini-invasiveness and safety, 
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maximizing the control of surgical-instruments and respecting the noble structures. The positive 
outcome of this first case of MRONJ, managed with navigated ultrasonic surgery, suggests the 
possibility of using this method in further cases in order to confirm the aforementioned advantages 
and standardize the technique. 
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Ameloblastic fibrosarcoma (AFS) is defined as a malignant mesenchymal tumor in which the 
epithelial component is cytologically benign and the mesenchymal component shows cytological 
features of malignancy [1]. AFS is the most common subtype of odontogenic sarcomas and is 
considered to be the malignant counterpart of fibromas of odontogenic origin [2].  
AFS can occur in patients of any age, with more frequent manifestations in the third decade, 
predominantly male (M:F ratio of 1.5). Histologically, stromal component of AFS is characterized by 
malignant features of sarcoma. 
Clinically, AFS grows progressively, resulting painful in many cases and causing dysesthesia or 
paresthesia when it involves the nerves. The non-specific symptomatology makes diagnosis difficult. 
AFS always appears as a radiolucent lesion with irregular margins, mainly located in the mandible. 
Although treatment is predominantly surgical, recurrence and metastasis rates are high. 
A 55-year-old patient was reported for the evaluation of a worsening swelling from right 
mandibular area accompanied by pain on palpation. 
Palpation revealed a non-tender, non-fluctuant and hard swelling. The neck was soft with no 
evidence of lymphadenopathy or tenderness. Radiographic examination was conducted using 
panoramic radiograph and Cone Beam Computed Tomography (CBCT), revealing a radiolucent 
lesion on the left mandible, closely associated with the element 4.5 and the mandibular canal. 
Under general anesthesia a mucoperiosteal flap was conducted in vestibular surface of right 
mandibula from 4.7 area to 3.2. Using piezoelectric bone scalpel. Osteotomy was performed and the 
lesion were enucleated. 
Histopathology showed malignant features of sarcoma, such as nuclear crowding, with 
hypercellularity and variable degrees of cytological atypia. On the contrary, the odontogenic 
epithelial component is bland and cytologically benign. The histopathological features suggested 
diagnosis of AFS. 
A new resection, after planning on stereolithographic models, was necessary for the extension 
of the surgical margins and to reduce the risk of recurrence, with the colleagues of the Sant'Orsola 
hospital in Bologna. Post operation period was favorable for the patient. 
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Follicular lymphoid hyperplasia (FLH) of the oral cavity is a rare and poorly understood 
lymphoproliferative disorder which may be confused clinically and histologically with malignant 
lymphoma. The condition has been described in different districts: notably skin, gastrointestinal tract, 
lungs, nasopharynx, larynx, and breasts. Rarely, the oral cavity may be involved [1]. The disease 
occurs in a wide age range, namely 38 to 79 years old patients. FLH is more common in women (ratio 3:1) 
[2]. Clinically, the manifestation is a firm, painless, nonulcerated, slowly growing mass or swelling 
on the one side of the palate. Occasionally, the lesions may be multifocal, and the patients may have 
bilateral involvement. Usually, the lesion is soft and either colored or non-colored [3]. 
A 45-year-old female non-smoking patient came to our hospital complaining of relapsing-
remitting pain on bilateral buccal mucosa. 
She was suffering from Hashimoto’s Thyroiditis, but she was not assuming any replacement 
therapy. She underwent bimaxillary Orthognathic Surgery several years ago. 
Clinical examination revealed the presence of bilateral atrophic lesions surrounded by white 
striae, involving the buccal mucosa (Figure 1). The clinical suspect was of a symptomatic lichen 
planus. An incisional biopsy of the left buccal mucosa was performed and the pathological 
assessment showed hyperplastic aspect of the epithelium but otherwise unremarkable. The 
subepithelial tissue contained a dense follicular lymphoid infiltrate. The interfollicular tissue 
contained small lymphocytes, occasional large lymphocytes, plasmacells and a few eosinophils 
(CD20+, CD3+, Regular: Bcl2, Bcl6, CD10, Mib1) (Figure 2). An incisional biopsy was repeated on the 
right buccal mucosa with the same pathological assessment. The specimens were analysed by a 
second pathologist, who confirmed the diagnosis.  
To complete the diagnostic process, in agreement with the haematologist, blood exam, an 
ultrasonography of the abdomen, a chest x-ray and a protein electrophoresis were performed. The 
exams ruled out any systemic involvement. The joint assessment of such results and of the previous 
investigations allowed the diagnosis of oral lymphoid hyperplasia. The patent has been followed up 
for 10 months with no sign of worsening of the lesions, which remained light symptomatic. 
Oral manifestations of FLH, have been reported in just around 30 cases; they showed the 
presence of swelling in particular of the hard palate. To the best of our knowledge, this is the first 
reported case of bilateral buccal mucosa involvement mimicking lichen planus. 
FLH is a rare and benign lymphoproliferative disorder, interdisciplinary efforts are mandatory 
to avoid diagnostic time delay.  
178
Proceedings 2019, 35, 80 
Figure 1. Clinical aspect of the FLH. 
Figure 2. Pathological assessment: H&E staining (A); magnification ×4, positive IHC staining for CD3 
(B); magnification ×20 and CD20 (C) magnification ×20. 
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1. Introduction
Oral squamous cell carcinoma (OSCC) is often preceded by “oral potentially malignant
disorders” (OPMDs), “morphological alterations amongst which some may have an increased 
potential for malignant transformation”, including leukoplakia, erythroplakia, oral submucous 
fibrosis, oral lichen planus, and actinic keratosis 1 .  OSCC pathogenesis is a multistep process in 
which multiple genetic events occur that alter the normal functions of oncogenes and tumor 
suppressor genes 2 . Recently, tissues autofluorescence (AF) has demonstrated a better efficiency in 
detection of oral mucosa alterations. However, few studies providing the molecular validation of 
this application are available. The aim of this study was to analyze the gene expression of 45 genes 
using RNA sequencing evaluating the accuracy of AF imaging compared to white light for 
determination of bioptic margins in OPMDs and OSCC. 
2. Material and Methods
The study population was represented by 7 patients with suspicion of OPMD or OSCC. After
medical anamnesis, the lesions were evaluated under white light and then with VELscope ™ (Figure 1). 
Bioptic specimens were taken at 3 different sites for each lesion: centre (L), white light margin (MC) 
and AF visualized margin (MF) (Figure 2). Custom-made TaqMan arrays containing 45 were used to 
perform gene expression analysis. Data were analyzed by Multiple t test considering significant a 
p value < 0.05. Gene Ontology was used to biological pathway analysis. Analyzed genes were 
involved in important growth pathways such as support of cell proliferation, cell adhesion and 
angiogenesis 3 . 
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(a) (b) 
Figure 1. (a) Example of an OPMD (leukoplakia) on the right cheek viewed under white light; (b) 
Leukoplakia displaying loss of autofluorescence when visualised using VELscope. 
Figure 2. The regions where three biopsies were taken: at the centre of the lesion (L), clinical margin 
(MC), and autofluorescence margin (MF). 
3. Results
The analysis was carried out on a total of 21 samples. Multiple comparisons were performed
between the samples. An overview of the statistically significant DEGs across the all samples 
analyzed, provided in Table 1, shows a greater molecular difference between the L vs MC or L vs MF 
margins in comparison with MC vs MF margins, in both groups. However, the existence of DEGs 
between the MC and MF margins supports the importance of the molecular distinction between 
these two bioptic margins (Table 1). In patients with leukoplakia, up- and down-regulated genes in 
MC margin were involved in the mechanisms of regulation of apoptosis, cell motility, collagen 
metabolism and the immune response. In patients with OSCC the MC margin has showed a partially 
overlapping molecular profile with the L sample. The molecular divergence between MC and MF 
margins is the most important finding of our study.  
Table 1. Number of DE genes in the whole set of samples analyzed. 
 Margins DEGs (n°) 
OSCC 
L vs MC 22 
L vs MF 21 
MC vs MF 10 
OPMD 
L vs MC 21 
L vs MF 20 
MC vs MF 9 
4. Conclusions
The present study portrays a molecular dysregulation decreasing from the centre to the
different detected margins of lesions. Our results suggest that a “partially transformed” cell 
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population exists in MC and support the accuracy of AF, with respect to the white light alone, in the 
margin identification during the OPMDs or OSCC biopsy.  
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